Western University

Scholarship@Western
Electronic Thesis and Dissertation Repository
7-18-2011 12:00 AM

Mutant Cx43 in Skin Differentiation and Disease
Jared M. Churko, University of Western Ontario
Supervisor: Dr. Dale W. Laird, The University of Western Ontario
A thesis submitted in partial fulfillment of the requirements for the Doctor of Philosophy degree
in Anatomy and Cell Biology
© Jared M. Churko 2011

Follow this and additional works at: https://ir.lib.uwo.ca/etd
Part of the Skin and Connective Tissue Diseases Commons

Recommended Citation
Churko, Jared M., "Mutant Cx43 in Skin Differentiation and Disease" (2011). Electronic Thesis and
Dissertation Repository. 240.
https://ir.lib.uwo.ca/etd/240

This Dissertation/Thesis is brought to you for free and open access by Scholarship@Western. It has been accepted
for inclusion in Electronic Thesis and Dissertation Repository by an authorized administrator of
Scholarship@Western. For more information, please contact wlswadmin@uwo.ca.

MUTANT Cx43 IN SKIN DIFFERENTIATION AND DISEASE

(Spine title: Mutant Cx43 Expression in Skin)
(Thesis format: Integrated Article)

by

Jared Markam Churko

Graduate Program in Anatomy and Cell Biology

A thesis submitted in partial fulfillment
of the requirements for the degree of
Doctorate of Philosophy

The School of Graduate and Postdoctoral Studies
The University of Western Ontario
London, Ontario, Canada

© Jared M Churko 2011

THE UNIVERSITY OF WESTERN ONTARIO
School of Graduate and Postdoctoral Studies

CERTIFICATE OF EXAMINATION

Supervisor

Examiners

______________________________
Dr. Dale Laird

______________________________
Dr. Ross Johnson

Supervisory Committee
______________________________
Dr. Lina Dagnino
______________________________
Dr. Martin Sandig
______________________________
Dr. Dan Belliveau
______________________________
Dr. David Litchfield
______________________________
Dr. Paul Walton

The thesis by

Jared Markam Churko
entitled:

Mutant Cx43 in skin differentiation and disease
is accepted in partial fulfillment of the
requirements for the degree of
Doctorate of Philosophy

______________________
Date

_______________________________
Chair of the Thesis Examination Board

ii

Abstract
Connexin43 (Cx43) is expressed within keratinocytes, dermal fibroblasts, and the hair
follicle epithelium. Since Cx43 is so widely expressed in resident cells of the skin, we
speculated that this connexin would play an essential role in skin homeostasis, hair
growth and wound healing. Mutations in the gene which encodes Cx43 lead to a disease
called oculodentodigital dysplasia (ODDD) and patients expressing the frame-shift
mutants (fs230 or fs260) develop a skin disease called palmar plantar hyperkeratosis. In
addition, patients with ODDD often develop hair which is dry, sparse, and slow growing.
To study skin abnormalities associated with ODDD, hair growth and wound healing
assays were performed on a mouse model of ODDD (G60S mice). Cutaneous wounds
performed on the G60S mice healed slower than wounds performed on wild-type (WT)
littermate mice suggesting that fibroblasts and/or keratinocytes expressing mutant Cx43
may be impaired in their ability to heal wounds. Fibroblasts derived from G60S mice and
from two ODDD patients expressing the D3N and V216L Cx43 mutant revealed defects
in the ability of fibroblasts to proliferate, migrate, and differentiate into myofibroblasts
while keratinocytes derived from the G60S mouse demonstrated an enhancement in cell
proliferation but no change in migration. To investigate the ability of keratinocytes
expressing mutant Cx43 to differentiate, organotypic epidermal cultures were engineered
to express full-length Cx43 or various ODDD mutants (G21R, G138R, G60S, fs230 and
fs260). In comparison to full-length Cx43, organotypic epidermal cultures expressing the
fs260 mutant significantly lowered the levels of endogenous Cx43, levels of Cx26, and
developed nuclei within the stratum corneum. Hair regrowth was also found to be
delayed in the G60S mice and this delay was attributed to a reduction in the mitotic
activity of hair follicle cells. In addition, hair fibers from G60S mice were thinner,
shorter, displayed cuticle degradation in the distal region and nodule formation in the
proximal hair fiber region when compared to WT derived hair fibers. Collectively, our
results suggest the mutant Cx43 impairs the function of fibroblasts during wound healing
and a reduced proliferation of the hair follicle epithelium likely leads to defects in hair
growth observed in ODDD patients.
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Chapter 1

1

Connexins, oculodentodigital dysplasia and skin
abnormalities

1.1 Gap junctions
Gap junctions are aggregates of protein channels formed between apposing cells that
facilitate intercellular communication by allowing the passage of small molecules and
metabolites from one cell to another (Alexander and Goldberg, 2003). These intercellular
channels assemble from connexin (Cx) subunits named after the molecular weight of
each family member (e.g. Cx43 has a molecular weight of 43 kD) (Sohl and Willecke,
2004). Six connexins oligomerize within a cell and are transported to the plasma
membrane in a configuration known as a connexon (Fig. 1.1). Connexons at the plasma
membrane can open and close to exchange molecules with the extracellular environment
in a state known as a hemichannel (Goodenough and Paul, 2003). When one connexon
docks with a connexon from an adjacent cell, a gap junction channel is formed. These
channels laterally diffuse and aggregate into a semi-crystalline state known as the mature
gap junction or a gap junction plaque where they open and close to facilitate intercellular
communication (reviewed in Herve et al., 2007).
Gap junctions are one of the most interesting and unique structures found between
adjoining cells. The importance of these novel structures is highlighted by the fact that
virtually all cells found in solid tissues express connexins and assemble gap junctions.
The mature gap junction domain itself consists of tightly aggregated connexin channels
which are thought to extrude all other integral membrane proteins (Makowski et al.,
1984). However, gap junctions are highly dynamic subject to remodeling and rapid
turnover (Laird et al., 1991). Nucleation, growth, remodeling, internalization, and
turnover of the gap junction domain are all critical for establishing the appropriate
physiological levels of intercellular communication in all tissues and organs (reviewed in
Laird, 2006).
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Figure 1.1 An overview of the life cycle of connexins.
Connexins are co-translationally inserted into the endoplasmic reticulum (ER). Properly
folded connexins are transported to the Golgi apparatus where six connexins oligomerize
to form a connexon prior to delivery to the plasma membrane. At the plasma membrane
connexons may function as hemichannels or dock with connexons from an adjacent cell
to form a gap junction channel. Gap junction channels aggregate to form a mature gap
junction also commonly referred to as a gap junction plaque. Gap junctions are
internalized into specialized double-membrane structures called connexosomes (also
called annular gap junctions) prior to delivery to lysosomes for degradation.
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1.2 Historical perspective on the identification of the gap
junction domain
The term gap junction comes from electron microscopy studies where a between the two
electron opaque domains of apposing cells was observed in a junction-rich region
between two closely apposed cardiac myocytes (Revel and Karnovsky, 1967). Sometime
after this

initial

observation, low-resolution electron microscopy and

X-ray

crystallography imaging revealed the first three-dimensional structure of the gap junction
channel (Caspar et al., 1977; Makowski et al., 1977). These channels were composed of
hexagonal arrays with a central pore embedded into two opposing lipid bilayers. The size
of the central pore could be deformed with the addition of the divalent cation chelator
EGTA (Unwin and Ennis, 1984), and later analysis of isolated Cx26 gap junctions
determined that this pore diameter can decrease from 15 Å to 6 Å after the addition of
calcium (Muller et al., 2002). These structural changes in the pore diameter suggested
that gap junction channels can be manipulated to form two functional states; the open and
closed state. While higher resolution of the gap junction channel was obtained from Xray diffraction analysis of Cx43 with a portion of the C-terminal tail truncated (Unger et
al., 1999), our understanding of the general arrangement of connexins within the
connexon has not substantially changed. Confirmation of the structural organization of
the connexon in split gap junctions and other gap junction preparations was acquired with
the advent of atomic force microscopic imaging where resolution limits of 10 Å were
obtained (Hoh et al., 1991; Hoh et al., 1993; Muller et al., 2002; Oshima et al., 2007).

1.3 Molecular compositions of the gap junction domain
Humans express 21 different members of the connexin family, and the connexin topology
in the membrane appears to be essentially the same for all connexin family members
(Sohl and Willecke, 2003). Four transmembrane domains subdivide the primary connexin
structure into a defined N-terminal, C-terminal, two extracellular, and one intracellular
domain. These domains have classically been defined as having unique functional roles
and can promote the opening and closing of the gap junction channel. Briefly, the
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extracellular loops facilitate the binding of one connexon to a connexon of an adjacent
cell (Herve et al., 2007). The N-terminus contributes to voltage gating (Purnick et al.,
2000), while the C-terminus and the distal end of the intracellular loop can regulate the
channel by sensing the intracellular pH (Ek-Vitorin et al., 1996; Ek et al., 1994). In
addition, high-resolution imaging of connexons composed of Cx26 without an Nterminus suggests that the N-terminal domain can physically plug the gap junction
channel (Maeda et al., 2009; Oshima et al., 2007). Phosphorylation of the C-terminal has
also been shown to promote the opening and closing of the gap junction channel as well
as signaling the gap junction to be both assembled and degraded (Solan and Lampe,
2009).
With members of the connexin family being expressed throughout multiple cell types and
tissues, it is no surprise that multiple connexins expressed in a single cell may interact
with each other. Early immunolocalization studies localized two different connexin
family members (Cx26 and Cx32) to the same gap junction plaque (Zhang and
Nicholson, 1994), and these connexins were further found to intermix within the same
connexon (Sosinsky, 1995) (Fig. 1.2). Various combinations of connexins within the gap
junction channel can now be classified into distinct groupings (Goodenough and Paul,
2009; Laird, 2006). Connexons containing only one type of connexin are termed
homomeric channels, while mixed connexons of two or more different connexins are
termed heteromeric (Fig. 1.2). If a connexon from one cell is docked with a connexon of
a different type from an apposing cell, the resulting channel is heterotypic as opposed to
homotypic channels, where the same connexon is found in both cells (Laird, 2006).
Although a wide variety of gap junction channels can be formed by these combinations,
not all connexins have the ability to oligomerize with each other. For example, Cx40 and
Cx43 (He et al., 1999), Cx43 and Cx45 (Martinez et al., 2002), and Cx26 and Cx32 have
all been shown to co-oligomerize, but Cx26 cannot oligomerize with Cx43 (Gemel et al.,
2004). Restrictions among which connexins can intermix compartmentalize intercellular
communication between cells of different origins or functions. The various connexin
permutations within a connexon may also play an important role in many normal and
disease cellular environments by selectively
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Figure 1.2 Structural combinations of connexins within a connexon and a gap
junction
Classically, connexins can dock and oligomerize within the same family member and
form homotypic, homomeric gap junctions. Some connexin family members are not
compatible with each other and will not dock or oligomerize together (Cx26 is not
compatible with Cx43 and these two family members will not dock or oligomerize
together). Gap junction channels can however be formed by connexon docking with
compatible connexons from a different family member. These gap junction channels are
termed heterotypic, homomeric channels (Cx26 can dock with Cx32). Finally if Cx26 and
Cx32 co-oligomerize and dock, the resulting gap junction channel is both heterotypic and
heteromeric.
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regulating the transjunctional molecules that are exchanged. Since gap junction channels
composed of only one connexin may be specialized for the passage of a specific solute
and another connexin may be specialized for the passage of a different solute, varying the
ratio of each connexin subunit within a single channel may promote, or even inhibit, the
passage of solutes containing intermediate properties of the two solutes. For example,
oocytes expressing heteromeric gap junctions composed of both Cx43 and Cx40 are more
sensitive to acidification-induced uncoupling than their homomeric channel equivalents
(Gu et al., 2000).
Once connexons are transported to the plasma membrane, gap junction channels formed
from docked connexons aggregate into dense concentrations of tens to hundreds of gap
junction channels (Zampighi et al., 1989). Gap junctions are unique and represent a
functional domain distinct from any other junctional complex. Given that the average
turnover time for connexins and gap junctions is 1–5 hours, gap junctions are in a
constant state of change and dynamically respond to the physiological demands of the
cell (Beardslee et al., 1998; Laird et al., 1991). Earlier electron microscopy studies
suggest that gap junctions mature from a loosely packed state, termed a formation plaque,
to a more densely packed semi-crystalline structure (Johnson et al., 1974). Fluorescent
recovery after photobleaching of Cx43-containing plaques also suggests that not all gap
junctions possess the same fluidity in the gap junction plaques (Simek et al., 2009)
suggestive of immature states of assembly. By measuring the recovery of green
fluorescent protein (GFP)-tagged Cx43 in a photobleached region of gap junction plaques
(as identified by their punctate fluorescence), the mobility of Cx43 within the gap
junction plaque can be classified into two distinct mobile states. Highly mobile GFPtagged Cx43 may represent immature nascent plaques, while low mobility Cx43 may
represent mature densely packed plaques. In addition, connexins have been shown to
have multiple protein binding partners, and connexins bound to scaffolding proteins
within the gap junction plaque may regulate the surface dynamics of connexons within a
gap junction plaque (reviewed in Laird, 2010). For example, the binding of ZO-1 to the
distal C-terminal tail of Cx43 has been reported to regulate the gap junction plaque size,
and this interaction may further regulate the turnover or stabilization of gap junctions at
the plasma membrane (Maass et al., 2007).
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1.4 Cx43 and oculodentodigital dysplasia
The most ubiquitously expressed connexin is Cx43 and the expression of Cx43 has been
noted in multiple tissues including but not limited to the heart (Manias et al., 2008), bone
(Civitelli, 2008), brain (Sohl et al., 2005) and skin (Risek et al., 1992). Given the
ubiquitous expression of Cx43 in the human body, it is conceivable that germ line
mutations in the GJA1 gene which encodes for the Cx43 protein can lead to a disease
affecting many organs. This was indeed discovered in 2003 when the disease
oculodentodigital dysplasia (ODDD) was linked with mutations in the GJA1 gene
(Paznekas et al., 2009).
ODDD is a disease which commonly manifests as microphthalmia, microcornea, enamel
hypoplasia, and type III syndactyly (Gillespie, 1964). ODDD is a rare condition with less
than 1000 cases having been fully documented. In these documentations however, 62
distinct mutations in the gene encoding Cx43 have been reported to cause ODDD and the
majority of these mutations are dominant missense mutations (Paznekas et al., 2009)
(Fig. 1.3).
While ODDD patients commonly develop abnormalities affecting the eyes, teeth and
digits, recent studies suggest that other tissues and cell types expressing Cx43 may also
demonstrate reduced function or disease. For example, ODDD patients have also been
reported to manifest cerebral white matter hypomyelination (Gutmann et al., 1991),
incontinence (Loddenkemper et al., 2002), and paresis (Gutmann et al., 1991;
Loddenkemper et al., 2002). In addition, Cx43 is highly expressed in the skin and patients
with ODDD have also been reported to develop skin disease (van Steensel et al., 2005;
Vreeburg et al., 2007).
Palmar plantar hyperkeratosis is a skin disease developed by some ODDD patients. This
disease results in an enlarged stratum corneum in the palms and weight bearing areas of
the feet (Braun-Falco, 2009). Patients expressing the fs260 (van Steensel et al., 2005)
mutant or the fs230 (Vreeburg et al., 2007) mutant have been reported to develop
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Figure 1.3 Schematic composite of reported Cx43 ODDD mutants
To date, sixty-two Cx43 mutants have been reported to cause ODDD. These mutations
are found throughout multiple regions of the primary Cx43 amino acid sequence and the
majority of these mutations are missense mutations. Currently, three ODDD mouse
models (G60S, I130T, or the G138R) have been engineered to study ODDD.
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palmar plantar hyperkeratosis, however, a recent report of a patient expressing the fs230
mutant did not develop palmar plantar hyperkeratosis (Alao et al., 2010). Since both of
these mutants result in a drastic reduction in the C-terminal tail of Cx43, it remains to be
determined if C-terminal tail truncations are specifically linked with palmar plantar
hyperkeratosis.
Approximately twenty-five percent of patients with ODDD have also been reported to
develop hair abnormalities (Paznekas et al., 2009). These patients have been reported to
develop hair which is curly, thin, dry, dull, sparse, and slow growing (Gorlin et al., 1963;
Kelly et al., 2006; Kjaer et al., 2004; Paznekas et al., 2009; Sugar et al., 1966; Thoden et
al., 1977). In addition, hair fiber structural changes (nodules along the hair fiber) were
also reported in a patient expressing the L11P mutant (Kelly et al., 2006). Determining
how Cx43 affects the growth and differentiation of the hair follicle may lead to successful
therapies to treat ODDD-linked hair abnormalities.
To further understand how mutant Cx43 can lead to ODDD, three ODDD mutant mouse
models have been developed that harbor single missense mutations (G138R
(Dobrowolski et al., 2008), G60S (Flenniken et al., 2005) and I130T (Kalcheva et al.,
2007)). These mice display many phenotypic features seen in ODDD patients (syndactyly
and craniofacial abnormalities) and these mice are a valuable resource to study how
ODDD patients develop skin disease and hair abnormalities. To date, the only reported
hair defect observed in these ODDD mouse models was sparse hair observed in
approximately 30% of G138R mice (Dobrowolski et al., 2008). It would be interesting to
determine if G138R mice also developed defects in hair growth, regeneration, or hair
fiber structure or if other ODDD mouse models also develop hair defects. One of my
aims was to investigate how mutant Cx43 impacts hair follicle development and hair
structure using both the G60S mouse model of ODDD and human hair samples from
ODDD patients.
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1.5 Connexin expression in skin development
The fully formed epidermis is composed of four distinct layers in thin skin: the stratum
basale, stratum spinosum, stratum granulosum, and stratum corneum (Fig. 1.4). Together,
these layers form a protective coating which blocks many mechanical and environmental
insults the human body procures over time. Keratinocytes within the basal layer maintain
stem cell-like characteristics and play an important role in the renewal and regeneration
of damaged skin (Houben et al., 2007). Keratinocytes in the stratum basale also rest on a
basement membrane and have a high proliferative index (Smith, 2003). As keratinocytes
in the stratum basale differentiate, they form the stratum spinosum and stratum
granulosum. During the formation of the stratum corneum, differentiated keratinocytes in
the stratum granulosum, called corneocytes, undergo cell death and release keratins,
loricrin, and involucrin. Paradoxically, although this layer contains no living cells, this
layer is active. Enzymes such as transglutaminase 1 and 3 crosslink many of these
proteins to protect the skin from mechanical insults in this layer (Hitomi, 2005), while
lipid ceremides give the skin its waterproof property (Hill et al., 2006).
Nine different connexin family members have previously been reported to be expressed
in the rodent epidermis (Cx26, Cx30, Cx30.3, Cx31, Cx31.1, Cx37, Cx40, Cx43, Cx57)
(Goliger and Paul, 1994; Kretz et al., 2004; Richard, 2000) and these connexins are
expressed in regional and temporal expression patterns during development. During the
embryonic E12-E14 stage of rat epidermis development, the epidermis is composed of
two cellular layers; the outer periderm and the inner basal layer. Both Cx43 and Cx26 are
expressed in these layers and prior to the periderm layer undergoing apoptosis, Cx26
expression is down-regulated (Risek et al., 1992). Later in rodent epidermis development
(E17-E20), Cx43, Cx45, Cx31.1, and Cx37 have all been reported to be expressed in the
basal layer while Cx26, Cx37, Cx31 and Cx43 are restricted to the stratum spinosum and
stratum granulosum (Butterweck et al., 1994; Goliger and Paul, 1994; Risek et al., 1992).
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Figure 1.4 Connexin expression in unwounded and wounded epidermis
The epidermis is composed of four layers in thin skin: stratum basale, stratum spinosum,
stratum granulosum, and stratum corneum. In unwounded epidermis Cx43 (red), Cx31.1
(blue), Cx40 (purple), Cx31 (green), Cx37 (orange), Cx30 and Cx26 (both in yellow)
localize to various epidermal layers in the adult rodent epidermis. Twenty-four hours
after the epidermis is wounded, the expression of Cx30 and Cx26 shifts from being
expressed in the stratum granulosum to all epidermal layers whereas the expression of
Cx31.1 is drastically reduced. Cx40 and Cx43 levels also decrease at the wounded
margin and Cx40 is localized to the stratum basale after wounding.
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In the adult mouse epidermis (Fig. 1.4) Cx40 and Cx43 have been reported to be
expressed within the stratum basale (Butterweck et al., 1994; Kamibayashi et al., 1993).
In humans, 10% of the keratinocytes in the stratum basale do not express Cx43 and these
cells are reported to have stem cell like characteristics (Matic et al., 2002). In the stratum
spinosum, Cx43 is highly expressed while in the stratum granulosum, no Cx43
expression is observed (Butterweck et al., 1994). Cx37 is expressed in the stratum
spinosum and stratum granulosum (Goliger and Paul, 1994) while Cx31.1 was found to
be predominantly expressed in the lower basal layer and in the lower stratum spinosum
(Goliger and Paul, 1994). Cx26

and Cx30 expression is restricted to the stratum

granulosum in the rodent epidermis however, one study observed Cx26 to be expressed in
the upper stratum spinosum in human epidermis as well (Wiszniewski et al., 2000) while
an additional study could not localize Cx26 to any epidermal keratinocytes (Salomon et
al., 1994). In addition, Cx31 was observed to be expressed in the stratum granulosum and
in the upper stratum spinosum (Kretz et al., 2003). Immunolocalization of other
connexins however, has not been investigated to date.
In the dermis, human dermal fibroblasts are reported to express Cx43, Cx45 and Cx40
(Wright et al., 2009). Cx43 has also been reported to be expressed in the arrector pili
muscle, sweet glands, sebaceous glands, and the hair follicle (Choudhry et al., 1997). In
the development of the human hair follicle, both Cx26 and Cx43 expression could be
observed within the hair peg (Arita et al., 2004). As the hair follicle grows, Cx26 was
reported within the outer root sheath and the inner root sheath but absent in the hair
matrix. Cx43 however was prominently expressed with the inner root sheath, hair matrix
and weakly expressed within the outer root sheath. Later in development (163 days
estimated gestational age), intense Cx26 expression was found in the outermost layer of
the outer root sheath while Cx43 was highly expressed within the innermost layer of the
outer root sheath (Arita et al., 2004). Cx43 expression during the anagen stage of rodent
hair follicle growth has also been reported to be expressed in the inner and outer root
sheath, the dermal papilla, and the proliferating matrix. However, during catagen, Cx43
expression is absent in the inner root sheath (Risek et al., 1992).
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Given that connexins are expressed throughout development in the various layers of the
skin, connexins may also play an active role in regulating skin regeneration.

1.6 Regulation of connexin expression and localization
during wound healing
When the skin is injured, the epidermis and dermis must reform the wounded area.
Complete healing of cutaneous wounds can take up to multiple weeks and the selective
expression of different connexins throughout the healing process may play distinct roles.
Within the first 24 hours of wounding, Cx26 and Cx30 expression increases in all strata
(Fig. 1.4). In addition, there is a drastic decrease in the expression of Cx31 and Cx31.1
with Cx31 expression becoming evident in the stratum basale (Goliger and Paul, 1995;
Kretz et al., 2003). Cx43 levels previously expressed in the stratum basale and stratum
spinosum in the unwounded epidermis, are now lowered in all epidermal layers at the
wounded edge (Brandner et al., 2004; Goliger and Paul, 1995; Kretz et al., 2003; Lampe
et al., 1998). Keratinocytes residing in the basale layer also selectively express the
phosphorylated S368 species of Cx43 to suggest that, not only does the expression
pattern of different connexins change during wounding, but also the active state of
connexins, as denoted by their state of phosphorylation, may also change (Richards et
al., 2004). The differential expression of connexins during wound healing may therefore
allow the selective permeability of small molecules to promote either the proliferation or
differentiation of keratinocytes. This is supported by a study which demonstrated that
when keratinocytes were induced to differentiate under high calcium condition, Cx43 and
Cx26 levels decreased while the levels of Cx31 and Cx31.1 increased (Brissette et al.,
1994). This change in connexin expression also selectively decreased the gap junctionmediated passage of neurobiotin, carboxyfluorescein and Lucifer yellow dyes but did not
affect the ability of keratinocytes to pass the synthetic nucleotide
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S-labeled cytidine

triphosphate (Brissette et al., 1994). In the future, determining which molecules
selectively pass through various heterotypic and heteromeric gap junction channels will
be critical to our understanding of how changes in connexin expression and regional
localization can affect the intercellular signaling networks.
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The overall mechanisms of how connexins regulate wound healing are not fully known,
but some studies suggest that wound healing is enhanced when Cx43 levels are lowered.
Since Cx43 null mice die from right ventricular outflow tract abnormalities (Reaume et
al., 1995) and Cx26 null mice die in utero due to a placental defect, it is difficult to use
these knockout mice to study wound healing. To overcome this early lethality, Cx43 has
been conditionally knocked out after birth in mice engineered to express a tamoxifeninduced cre-recombinase in cells with a floxed Cx43 gene (Cx43Cre-ER(T)/fl mice). Tail
wounds performed after tamoxifen-induced Cx43 deletion resulted in faster wound
healing when compared to the control mice (Kretz et al., 2003). In addition, by wounding
mouse skin and applying Cx43 siRNAs and Cx43 targeting antisense, wounds were
observed to heal faster (Ghatnekar et al., 2009; Mori et al., 2006; Qiu et al., 2003). Mouse
organotypic epidermal cultures also demonstrated faster wound closure after the Cx43
mimetic peptide Gap27 was used to transiently block the interaction between connexons
(Kandyba et al., 2008). By deciphering the role that connexins play in keratinocyte or
dermal fibroblast proliferation, migration and differentiation, mechanistic insight into
how connexins can impact the overall wound healing process could be achieved.

1.7 Cx43 and Cx26 in keratinocyte proliferation
During the initial stages of wound healing (Day 1 to 3 post wound), keratinocytes at the
wounded edge increase their proliferation rate (Coutinho et al., 2003) and migrate under
the coagulum. Since Cx43 levels go down and Cx26 increase at the wounded edge, these
connexins are suggested to play distinct roles during proliferative and migrational events
in the early stages of wound healing. Mechanistically it is not surprising to observe a
reduction in the plasma membrane pool of Cx43 since it has been documented to play a
role in cell to cell adhesion (Prochnow and Dermietzel, 2008). With a net reduction in
adhesion, cells would be permitted to proliferate and begin their migration into the
wounded area. However, the role of connexins in general is more complex since Cx26
and Cx30 expression increases in all epidermal layers after wounding (Kretz et al., 2003).
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The role of Cx26 in keratinocyte proliferation is supported by evidence that persistent
Cx26 expression maintains the wounded epidermis in a hyperproliferative state (Djalilian
et al., 2006). Cx26 and Cx30 have also been found to be highly expressed in non-healing
chronic wounds (Brandner et al., 2004) and in keratinocyte-derived skin tumors (Haass et
al., 2006). In addition the expression of Cx30 was up-regulated in human psoriatic skin,
irradiated skin, as well as primary keratinocytes subjected to irradiation further
supporting the role of Cx30 in hyperproliferation (Lemaitre et al., 2006). While both
Cx26 and Cx30 are spatially and temporally co-regulated during wound healing and these
connexins can form heterotypic channels, it is possible that mutations in the genes
encoding these connexins may result in a similar skin disease phenotype. This turns out
to be the case in Clouston syndrome and Vohwinkel’s syndrome.
Clouston's syndrome is a disease caused by mutations in the GJB6 (Cx30) gene. Patients
with Clouston's syndrome develop nail dystrophy, palmar plantar hyperkeratosis, slow
growing, fine, dry, brittle and sparse hair (Clouston, 1929). Mutant Cx26 expression also
causes several skin diseases including Vohwinkel's syndrome (Maestrini et al., 1999).
Vohwinkel's syndrome results in starfish-like acral keratoses, papular and honeycomb
keratoderma, palmar plantar hyperkeratosis, constricting bands around the digits and
moderate hearing loss. One symptom shared by both Clouston's syndrome (Cx30
mutations) and Vohwinkel's syndrome (Cx26 mutations) patients is an epidermal
thickening in the palmar and the plantar regions of the hands and feet (palmar plantar
hyperkeratosis). This phenotype could also be observed in the tail epidermis of a mouse
model of Vohwinkel's syndrome where the D66H mutant Cx26 was expressed in the
epidermis under the control of the keratin 10 promoter (Bakirtzis et al., 2003a). While it
is tempting to correlate the epidermal expression of Cx26 and Cx30 with the proliferation
of keratinocytes and palmar plantar hyperkeratosis, palmar plantar hyperkeratosis is also
observed in patients with oculodentodigital dysplasia (van Steensel et al., 2005; Vreeburg
et al., 2007) and in patients with erythrokeratodermia variabilis (Cx31, Cx37, Cx31.1
mutations) (Richard et al., 1998; Strober, 2003). Since mutations in the Cx26, Cx30,
Cx31, Cx37, Cx31.1 and Cx43 gene can result in palmar plantar hyperkartosis, functional
gap junctional communication may be an important component in order to maintain
proper skin homeostasis.
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The transient and systematic decrease in Cx43 levels at the wound edge during wound
healing suggests that Cx43 expression may slow the proliferation of keratinocytes. In
mice expressing 85% lower epidermal Cx43 levels (tamoxifen-induced Cx43Cre-ER(T)/fl) a
compensatory increase in Cx30 was observed which appeared to support cell
proliferation (Kretz et al., 2003). Mouse wounds treated with an antisense
oligodeoxynucleotide against Cx43 also lead to an increase in cell proliferation at the
wounded edge (Mori et al., 2006). Furthermore, when a Cx43 mimetic peptide which
blocks connexon docking, Gap27, was treated on porcine and human keratinocytes, an
increase in proliferation was observed (Pollok et al., 2010). Since Cx43 levels naturally
decrease during the initial stages of wound healing, strategic reductions in Cx43 levels
appear to also promote keratinocyte proliferation and assist in wound healing.
While in vivo studies suggest that down-regulation of Cx43 promotes the proliferation of
keratinocytes, sparsely plated human keratinocytes grown in vitro however, express
Cx43. Only after confluency is reach, was a down-regulation of Cx43 observed (Gibson
et al., 1997). In addition, undifferentiated primary mouse keratinocyte cultures also
express high levels of Cx43 and these levels go down after Ca+2 induced differentiation
(Brissette et al., 1994). The in vitro versus in vivo differences observed in the expression
of Cx43 suggest that monolayer keratinocyte cultures may not truly represent the basal
keratinocyte phenotype present in the in vivo environment. Since primary keratinocytes
are cultured in media and not subjected to the same air-liquid interface, and/or since
cultured keratinocytes may not be grown on the same basement membrane proteins in
which keratinocytes interact with in vivo, keratinocytes grown in culture may more
appropriately represent an active stratum spinosum. Therefore, keratinocytes grown on
different extracellular matrix proteins or under organotypic epidermal conditions may be
required to more accurately represent the role of Cx43 in vivo.

1.8 Cx43 in dermal fibroblast proliferation
While the majority of connexin-linked wound healing studies have focused on the role of
connexins in keratinocytes, the role that dermal fibroblasts play in wound healing is less
clear. Unlike keratinocytes, Cx43 is up-regulated in dermal fibroblasts at the wound edge
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(Coutinho et al., 2003). This suggests that connexin expression and response to injury
may be dependent on the cell type assessed. Since fibroblasts proliferate in the wounded
area, an increase in Cx43 expression might suggest that Cx43 expression in fibroblasts
enhances proliferation. However, the proliferation rate of fibroblast cell lines derived
from Cx43-deficient cell lines (Cx43+/ −) did not differ from fibroblasts derived from the
Cx43-expressing cell lines (Cx43+/+) (Yamakage et al., 1998). In contrast, fibroblasts
derived from the murine cardiac tissue from Cx43+/ − deficient mice demonstrated an
increase in cell proliferation (Zhang et al., 2008). This suggests that not all fibroblast
populations are the same and that fibroblasts derived from different organs may be more
dependent on the expression of Cx43. By studying a wide variety of Cx43 mutants and
by assessing how each mutant affects different cell types, a greater understanding of how
Cx43 modulates proliferation may be achieved.

1.9 Cx43 in migration
Keratinocytes, macrophages, neutrophils and fibroblasts all migrate into the wounded
skin area to repair the injured tissue. Thus, Cx43 modulation may also manipulate the
migration of keratinocytes and fibroblasts after wounding. In a scratch wound assay,
connexin mimetic peptides, Gap26 and Gap27 (that reduce the cell surface levels of
Cx43) increased the migration rate of both human keratinocytes and human fibroblasts
(Wright et al., 2009). In addition Gap27-treated mouse keratinocytes exhibited enhanced
migration into a wounded epidermis (Kandyba et al., 2008). The enhancement in cell
migration may have involved disrupting the cell adhesion properties (Prochnow and
Dermietzel, 2008) or communication properties (Kumar and Gilula, 1996) between cells
rather than possibly affecting the intracellular protein binding partner interactions with
Cx43 (Laird, 2010). This is supported by a study which demonstrated that reducing total
Cx43 by Cx43 antisense oligodeoxynucleotide enhanced the migration of mouse dermal
Swiss 3T3 fibroblasts (Mori et al., 2006).
In a wound environment, extracellular matrix proteins may regulate Cx43 levels. Since
migrating keratinocytes are not exposed to basement membrane proteins (Larjava et al.,
1993) and keratinocytes at the wounded edge have reduced Cx43 levels (Wright et al.,

22

2009) it is possible that only when keratinocytes are able to synthesize and deposit
basement membrane proteins, a decrease in keratinocyte migration (O'Toole et al., 1997)
and an increase in Cx43 expression will be observed. This is also supported in a study
which demonstrated that human keratinocytes adhered to laminin 332 had greater Cx43
levels and gap junctional coupling in comparison to keratinocytes plated on collagen or
fibronectin (Brandner et al., 2004; Lampe et al., 1998).

1.10 Cx43 in keratinocyte differentiation
Once keratinocytes have migrated into the injured area, keratinocytes differentiate into
multiple epidermal strata (basale, spinosum, granulosum and corneum) to reform the
epidermal barrier. Since connexins are differentially expressed during keratinocyte and
fibroblast differentiation, they may also play an important role in regulating this
differentiation process. Mice lacking Cx31 (Gjb3(-/-)) develop an epidermis and did not
show any skin defects (Plum et al., 2001). In addition, mice lacking both Cx31 and Cx43
were not found to have any epidermal differentiation defects at fetal day 17.5 (Kibschull
et al., 2005). Histological analysis of the epidermis in these mice revealed a normal
epidermal morphology and did not show any differences in the expression of keratin 14,
keratin 10, keratin 6, Cx26, loricrin and filaggrin. While skin abnormalities were not
found in the fetal epidermis, connexin expression may regulate epidermal differentiation
and regulation after birth.
To investigate if Cx43 reduction can impact the stratification of the epidermis, Langlois
et al. knock-downed Cx43 levels by shRNA administration to rat epidermal organotypic
cultures (Langlois et al., 2007). Reducing Cx43 in these cultures resulted in a disruption
of organotypic epidermal architecture while increasing the terminal differentiation
makers loricrin and involucrin (Langlois et al., 2007). This would suggest that not only is
the expression of Cx43 important for maintaining epidermal tissue architecture, but
disrupting Cx43 expression in the epidermis may also damage the epidermal barrier and
thus activate the differentiation pathway to reform the epidermal barrier.

Interestingly,

the shRNA-induced reduction of Cx43 also resulted in a decrease in Cx26 levels in
organotypic cultures. In addition, Cx26 levels were also lower in the adult skin of mutant
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mice selected for their heterozygous expression of the Cx43 G60S mutant (Langlois et
al., 2007). Thus, the transdominant effect of Cx43 on Cx26 or some sort of cross-talk
between these connexins may underlie skin disorders observed in patients with ODDD.
While the majority of ODDD-causing Cx43 mutants do not result in clinically diagnosed
skin abnormalities, two frameshift mutants have been associated with palmar plantar
hyperkeratosis. Since Cx26 is absent in uninjured forearm skin but weakly expressed in
the basale layer of plantar skin region (Lucke et al., 1999), the palmar plantar phenotype
may be due to the transdominant nature of Cx43 on Cx26 (Lucke et al., 1999; Rouan et
al., 2001). The interplay between Cx43 mutants and Cx26 defects is also supported by the
observation that tail constricting bands are observed in mice expressing a Cx43 Cterminal truncation (Maass et al., 2004) and in mice expressing the D66H Cx26 mutant
(Bakirtzis et al., 2003a). In addition, while only some ODDD-linked Cx43 mutants lead
to skin defects, Cx26 mutants are strongly associated with human and mouse skin
disease. Mice expressing the D66H Cx26 mutant were shown to have a propensity for
premature cell death. This premature cell death may weaken the epidermal barrier of the
skin and activate the basale keratinocytes to reform the epidermis. Overstimulation of the
keratinocytes may also increase the thickening of the epidermis (Bakirtzis et al., 2003a)
and lead to palmar plantar hyperkeratosis. It is interesting to note however that others
have shown that Cx26 D66H mutant did not interfere with the formation of the epidermal
water barrier during late embryonic development (Bakirtzis et al., 2003b) and that the
deafness-associated mutant human Cx26 (R143W) was shown to improve the epithelial
barrier in vitro (Man et al., 2007). Evaluation of Cx26 levels in keratinocytes engineered
to express skin disease associated Cx43 mutants and Cx43 mutants not associated with
skin disease may clarify how some ODDD mutants are more potent at causing skin
disease.

1.11 Cx43 in fibroblast differentiation
While most studies have investigated the role that connexins play during epidermal
wound healing involving keratinocytes, the role that fibroblasts play in the skin wound
healing process cannot be neglected. While dermal fibroblasts are embedded in a
collagen mesh, about 30% of fibroblasts were found to be in contact with one another
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through fibroblast processes. These fibroblasts were also thought to be in communication
with one another since Cx43 was localized at the points of cell to cell contact (Langevin
et al., 2004). Since fibroblasts play a crucial role in forming the provisional granulation
tissue, long term collagen secretion, and in contracting the wounded area (myofibroblast
differentiation), modulation of connexin expression may impact the role that fibroblasts
play during wound healing (Darby and Hewitson, 2007).
In Mori et al., knockdown of Cx43 was shown to enhance fibroblast-dependent wound
healing (Mori et al., 2006). In this study, mouse wounds treated with Cx43 antisense
oligodeoxynucleotide (asODN) had significant increases in the levels of hydroxyproline
and mRNA for collagen type alpha1 and TGFβ1 when compared to control treated
wounds. An increase in myofibroblast differentiation and wound contraction was also
found after treatment with Cx43-asODN (Mori et al., 2006). In addition, the application
of asODN was shown to decrease the amount of granulation tissue and scarring in the
wound healing of burns (Coutinho et al., 2005).
In contrast to these studies, other mouse studies suggest that decreasing Cx43 levels
impairs the ability of fibroblasts to heal wounds.

Fibroblasts derived from Cx43

knockout (KO) mice demonstrated a reduced ability to contract as well as failed to
elongate (Ehrlich et al., 2000). In ventricular remodeling after myocardial infarct, Cx43deficient mice had reduced levels of myofibroblast formation and also were less active in
collagen deposition (Zhang et al., 2010). This defect was attributed to impaired TGFβ1
signaling (Zhang et al., 2010). In addition, reduced myofibroblast differentiation was also
found when cardiac fibroblasts were treated with Cx43 antisense oligodeoxynucleotides
(Asazuma-Nakamura et al., 2009). This suggests that TGFβ1 signaling may require
normal Cx43 expression to differentiate fibroblasts into myofibroblasts. If this is true,
mutant Cx43 expression in fibroblasts may impair the ability of dermal fibroblast to
contract a wounded area.
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1.12 Hypothesis and objectives
To date, the mechanisms by which mutant Cx43 can impact skin development and
differentiation is not fully understood. In addition, cutaneous wound healing in patients
with germ line mutation in the Cx43 gene has not been investigated. Since many ODDDlinked Cx43 mutants can traffic to the plasma membrane (McLachlan et al., 2005), the
protein binding partners which interact with Cx43 may still be intact (reviewed in Laird,
2010).

In addition, ODDD-linked Cx43 mutants act to knockdown but not abolish

Cx43-based GJIC (Gong et al., 2006; McLachlan et al., 2005). It will be interesting to
determine if mice with chronically reduced levels of Cx43 exhibit differences in their
wound healing response. In addition, given that Cx43 is expressed in keratinocytes,
dermal fibroblasts, and the hair follicle epidermal cells, mutant Cx43 expression may
affect the proliferation, migration and differentiation of these cells. It is therefore
hypothesized that the processes which regulate wound healing and hair follicle
differentiation in the epidermal and dermal compartment will be impaired by the
expression of mutant Cx43.
The specific objectives of the project were to:
1. Determine the role of Cx43 in dermal fibroblast proliferation, migration and
differentiation by using human ODDD fibroblasts and a mutant mouse model of
ODDD.
2. Determine the role of Cx43 in keratinocyte proliferation, migration and
differentiation by using primary keratinocytes derived from a mutant mouse
model of ODDD.
3. Determine the role of Cx43 in epidermal maintenance, growth, and differentiation
by using epidermal organotypic models of keratinocytes expressing mutant Cx43.
4. Determine whether mice expressing mutant Cx43 display defects in hair follicle
structure, growth, and regeneration.
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Chapter 2

2

Human dermal fibroblasts derived from
oculodentodigital dysplasia patients suggest that
patients may have wound-healing defects

It is well known that Cx43 is expressed within the epidermis and dermis of the skin and
that the expression of Cx43 changes during wound healing. Since ODDD patients
systemically express mutant Cx43, mutant Cx43 expression in resident cells of the skin
may impair the ability of both fibroblasts and keratinocytes to heal wounds. This chapter
focuses on the use of the Cx43 G60S mutant mouse model of ODDD to determine if
mutant G60S Cx43 expression impairs the ability of skin wounds to heal. In addition, we
have also employed the novel use of ODDD patient and unaffected family member
derived fibroblasts to determine if cells expressing the D3N or V216L mutants affect the
ability of fibroblasts to proliferate, migrate, and differentiate into myofibroblasts.

A version of this chapter has been published:
Churko, J.M., and Shao, Q., Gong, X., Swoboda, K.J., Bai, D., Sampson, J., and Laird,
D.W. (2011) Human dermal fibroblasts derived from oculodentodigital dysplasia patients
suggest that patients may have wound-healing defects. Human Mutation, Apr;32(4):45666.

37

2.1 Introduction
The human GJA1 gene (OMIM *121014) encodes the gap junction protein Cx43 (Solan
and Lampe, 2009). The ubiquitous expression of Cx43 and primary function in
establishing gap junctional intercellular communication (GJIC) has led to this connexin
being one of the most widely studied members of the connexin family. GJIC plays a
critical role in many physiological processes ranging from more passive roles in cell and
tissue maintenance to a highly active role in synchronization of electrical coupling
(Kizana et al., 2007). Not surprisingly, dysregulation of either connexin expression or
mutations in genes encoding connexins has led to a wide array of human diseases.
In 2003, Paznekas and colleagues successfully mapped a developmental disorder known
as oculodentodigital dysplasia (ODDD) to mutations in the GJA1 gene (Paznekas et al.,
2003). Presently, 62 mutations have been mapped to the GJA1 gene and linked to ODDD
(Paznekas et al., 2009). ODDD is a rare, mostly autosomal dominant inherited disorder
affecting the development of a variety of tissues and organs. Though ODDD patients
exhibit some consistent features such as syndactyly, camptodactyly, craniofacial
abnormalities, enamel loss and microdontia, other less common features include
glaucoma, neurological defects (progressive spastic paraparesis), neurogenic bladder and
even heart and skin diseases (Paznekas et al., 2009). Missense mutations are by far the
most widely found type of mutations, but two frame-shift mutations have also been
identified (van Steensel et al., 2005; Vreeburg et al., 2007). Surprisingly, two autosomal
recessive mutations have been reported and one of these results in the premature
truncation of Cx43 after only encoding 33 amino acids, effectively resulting in a near
complete Cx43 knockout (Richardson et al., 2006). GJA1 gene mutations are found
throughout the expanse of the gene but the vast majority of the mutations occur in the
first two thirds of the gene. At present, over 15 specific mutations have been engineered,
over-expressed and studied in reference cell systems to assess the ability of the mutant
Cx43 to traffic, assemble and form functional channels (Churko et al., 2010; McLachlan
et al., 2005). Intriguingly, all of the Cx43 mutants examined under these conditions have
severely compromised intercellular channel forming abilities and exhibit moderate to
severe dominant-negative effects on co-expressed endogenous Cx43. Thus, these in vitro
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studies would predict that patients harboring autosomal dominant Cx43 mutants are
operating on far less than 50% normal Cx43 function.
A well-documented limitation of mutant overexpression studies is the difficulty in
matching the expression level of the mutant and wild-type counterpart to equal the 1:1
expression level expected to be found in patients. To overcome this shortcoming, three
mouse models of ODDD have been generated in an attempt to mimic the
genotype/phenotype relationship found in the human disease. The first of these models
was engineered in 2005 through an ethylnitrosurea screen where a mouse, designated
Gja1Jrt/+, was found to harbor a G60S point mutation (Flenniken et al., 2005). While this
mutation has not yet been identified in the human population, the mouse phenotype was
characterized to closely match the clinical symptoms exhibited by ODDD patients. This
mouse model has been used extensively and has shed insight into the molecular
mechanisms underlying ODDD. In more recent years, two additional mouse models have
been engineered to reflect human mutations of interest. The first one was designed to
generically express an I130T Cx43 mutant (Cx43I130T/+) (Kalcheva et al., 2007) and the
second constitutively expressed the G138R mutant (Cx43G138R/+) (Dobrowolski et al.,
2008). Given the recent generation of these mice, they are only beginning to be studied as
mouse models of ODDD. Seminal publications describing these mice indicate that while
they manifest common characteristics of ODDD, there are unique features to each mouse
strain that will require further study.
Although mutant Cx43 expression in reference cell models and genetic mouse models of
ODDD are valuable tools to investigate the cell mechanisms associated with ODDD, they
may not fully reflect the pathophysiologic aspects of ODDD exhibited by patients. In the
current study, we attempt to bridge this shortcoming by isolating and culturing the first
primary culture cells from ODDD patients. Here we recruited two ODDD families to
obtain human skin tissue specimens for the establishment of matched fibroblast cell lines
from both patients and unaffected close relatives. We further compared our findings to
fibroblasts derived from the Gja1Jrt/+ (G60S) mouse model to assess potential
human/mouse differences. We found that fibroblasts obtained from these patients are
significantly different from their genetically matched control fibroblasts in their
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proliferation, migration and differentiation into myofibroblasts. Here we suggest that
wound healing in ODDD patients may be delayed and propose a mechanism by which
fibroblasts may exacerbate disease in these patients.

2.2 Materials and methods
2.2.1 Human fibroblast cultures
Fresh skin biopsy samples obtained from patients and unaffected relatives were placed in
ice cold DMEM (25 mL, Cat#11960-044, Invitrogen, Carlsbad, CA) containing 10% fetal
bovine serum (FBS, Cat# A12617DJ, Invitrogen, Carlsbad, CA) prior to being cut into
small pieces and transported into a second dish containing DMEM with 10% FBS and
100 U/ml penicillin & 100 µg/ml streptomycin (Cat #15140-122, Invitrogen, Carlsbad,
CA), and incubated at 37 C in a humidified chamber containing 5% CO2. The media was
changed once a week for 3-4 weeks. Cells were subcultured once they reached
confluence by treating with trypsin (0.05% trypsin with 0.25 EDTA, Cat# 25200-056
Invitrogen, Carlsbad, CA). For long-term storage, collected cells were resuspended in
cryopreservation media (DMEM with 10% FBS, 1x antibiotic/antimycotic and 10%
DMSO-filtered (Cat# D2650, Sigma-Aldrich, St. Louis, MO) and aliquoted into
cryotubes. Cells were stored in liquid nitrogen. Human fibroblasts were sent to the
University of Western Ontario for further analysis as approved by the Office of Research
Ethics at the University of Western Ontario. All fibroblasts cells were cultured in DMEM
supplemented with 10% fetal bovine serum, 100 U/ml penicillin, 100 µg/ml streptomycin,
and 2 mM glutamine and incubated at 37 °C in humidified air with 5% CO2. In
subsequent experiments, results were compared from passage-matched fibroblasts used
from passages 2 to 6.

2.2.2 Extraction of genomic DNA for sequencing
Genomic DNA was extracted from peripheral blood leukocytes and/or fibroblast cells of
all individuals by standard methods with proteinase K (Cat# 51104, Qiagen DNA Blood
kit, Qiagen, Mississauga, Ontario). PCR amplification of the Cx43 gene was performed
by using Cx43 primers of the forward 5’-TGGGACAGGAAGAGTTTGCAC-3’ and
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reverse 5’-CACCTGGTGCACTTTCTACAGCAC-3’ and the sequencing of Cx43 gene
by

using

primer

1:

5’-GGTGGCCTTCTTGCTGATCC-3’,

primer

2:

5’-

TGGGCAGGGATCTCTTTTGC-5’ and primer 3: 5’-GGTTGCCCAAACTGATGGTG.

2.2.3 Dye coupling assay
A preloading assay was used to quantify GJIC in primary fibroblast cultures as described
previously (Goldberg et al., 1995). Briefly, a subpopulation of primary fibroblasts was
loaded with the gap junction permeable dye, calcein-AM (Cat# D1430, Molecular
Probes, Eugene, OR), and the gap junction impermeable dye, DiI (Cat# D282, Molecular
Probes, Eugene, OR). The preloaded cells (~ 100 cells) were seeded onto a monolayer of
unlabeled primary fibroblast cells, and after 3 h, samples were observed and images
recorded with a Leica DM IRE2 inverted epifluorescence microscope. The instances of
calcein dye transfer from the DiI-labeled source cells were counted, and successful dye
transfer was declared if there was clear evidence of dye transfer to at least one cell
adjacent to DiI donor cell. Three independent trials were performed for each cell line.
Standard errors were calculated, and the control and mutant cells were compared with a
Student’s t-test.

2.2.4 Patch-clamp electrophysiology
The intercellular electrical coupling conductance between control or mutant fibroblasts
was assessed by using the dual whole cell patch-clamp technique as previously described
(Gong et al., 2006). Human fibroblasts were plated on glass coverslips in cell culture
dishes at low density for 24-48 hours. Isolated fibroblast cell pairs with side-to-side
contacts were chosen for double patch-clamp recording. Data acquisition and analysis
were performed via Digidata 1322A interface and pClamp9 software (Axon Instruments
Inc., Union City, CA). Gap junctional conductance (Gj) was determined and presented as
mean ± SEM. Online series resistance compensation at 80% was applied to improve the
accuracy of measured Gj. A Student’s t-test was performed to determine statistical
significance (**, p < 0.01).
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2.2.5 Immunocytochemistry and immunohistochemistry
Cells were grown on glass coverslips and fixed with ice-cold 80% methanol/20% acetone
at 4°C for 20 min and rinsed with PBS 3 times before immunolabeling. Antibodies to the
gap junction protein, polyclonal Cx43 (1:500; Cat# C6219, Sigma-Aldrich, St. Louis,
MO) mAb GM130, a 130 kDa Golgi matrix protein antibody (1:100; Cat# 610822, BD
Transduction Laboratories, Mississauga, ON), and an intermediate filament, mAb
vimentin antibody (1:500; Cat# MAB3400, Millipore, Temecula, CA), were used.
Primary antibody binding was detected with appropriate Alexa-488 (anti-mouse Cat#
a11017, anti-rabbit Cat# A11008) or Alexa-555–conjugated anti-rabbit (Cat# A21429) or
anti-mouse (Cat# A21425) (1:500; Invitrogen, Carlsbad, CA) secondary antibodies.
Nuclei were stained with Hoechst 33342 (1:1000; Cat# H3570, Molecular Probes,
Eugene, OR) or DAPI (1:1000; Cat# D3571, Molecular Probes, Eugene, OR). Cells were
imaged with a Zeiss LSM 510 META confocal microscope as previously described
(Simek et al., 2009).

2.2.6 Wound healing assay
The wound healing assay was approved by the Office of Research Ethics at the
University of Western Ontario. Eleven adult G60S mutant mice and eleven WT control
mice were anesthetized with isofluorane gas and the dorsal back skin surface was shaved
using #40 clippers. Prior to performing a punch biopsy, a three stage incision site
preparation (betadine soap/alcohol/betadine scrub) was performed on the shaved surface
and a sterile disposable 5 mm bore biopsy tool was used to obtain a 5 mm full-thickness
excisional epidermal and dermal skin biopsy. Buprenorphine (0.05mg/kg) was
administered once during anesthesia recovery, and additional doses (8-12h) were
administered if the mice looked stressed. The area of wound closure was measured after
day 1, 3, 6, 9, and 12 from images taken at these time points. Wound area calculations
were performed using ImageJ and the resulting wound area was graphed using Graphpad
Prism 4.0. A two-way ANOVA (repeated measures) from data points Day 3, 6, and 9
with a Bonferroni post-hoc test was performed to determine statistical significance
(*p<0.05).
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2.2.7 Punch biopsy migration
Circular skin punches were cultured ex vivo as previously described (Stephens et al.,
1996). Fresh 5 mm dermal punch biopsies from postnatal day 4 WT and G60S littermate
mice were placed on culture wells either precoated with 10 µg/mL fibronectin (Cat#
356008, BD Bioscience, San Jose, CA), 0.3 µg/mL laminin 332 (V) (Cat# CC-145
Chemicon, Billerica, Massachusetts), or 2 mg/mL bovine collagen type I (Cat# 354236,
BD Bioscience, San Jose, CA). Dermal punch biopsies were incubated at 37oC for one
hour to facilitate adhesion of the dermal punch biopsy to the culture well and growth
medium, (DMEM Cat# 11960-044, Invitrogen, Carlsbad, CA, 10% FBS Cat# A12617DJ,
Invitrogen, Carlsbad, CA , 100U/mL pen/strep, Cat# 15140-122, Invitrogen, Carlsbad,
CA and 2 mM glutamine, Cat# 25030149, Invitrogen, Carlsbad, CA) was gently added to
the culture wells to surround the punch biopsy. Cultures were then incubated at 37oC and
5% CO2 for 24 hours and extra media was placed in each culture well to fully submerge
the punch biopsy. After four days, the growth media was aspirated and cultures were
fixed with ice-cold 80% methanol/20% acetone for 10 minutes. Cultures were then
washed and stored in PBS until imaged. Eight images were taken around the
circumference of the skin explants with a Zeiss 510 microscope and the total area of
cellular migration from the explants was calculated. Total cellular area of migration was
then graphed using Graphpad Prism 4.0. Student’s t-test between punch biopsies derived
from WT and G60S on the same substrate (collagen I, fibronectin, plastic or laminin 332)
was performed to determine statistical significance (*p < 0.05).

2.2.8 Human fibroblast migration
Human fibroblasts were seeded at cell density of 1x104 cells per culture well in a 12-well
tissue culture dish. Once confluent, the growth media was removed and a 1000 µL pipette
tip was scraped down the center of the culture well. Culture wells were then washed 2X
with Opti-MEM (Cat# 11058-021, Invitrogen, Carlsbad, CA) and 1 mL of Opti-MEM
was added to each culture well. Time-lapse imaging was performed using a Zeiss 510
microscope equipped with Axiovision software. Time-lapse monolayer closure images
were acquired every 15 minutes for 48 hours. Migration was quantified by measuring the
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area fibroblasts transversed into the scraped area 24 hour after a scrape was performed.
To calculate the average migration distance the area was divided by the field of view
height and graphed. Student’s t-test between D3 and D3N fibroblasts or between V216
and V216L fibroblasts was performed to determine statistical significance (*p < 0.05).

2.2.9 Fibroblast proliferation
To examine cell proliferation, 1x104 control or mutant fibroblasts were plated in 6-well
dishes and allowed to grow in growth medium. At days 2, 4 and 6, cells from replicated
plates were collected and counted using an automated CountessTM Cell Counter
(Invitrogen, Carlsbad, CA). The total cell number during each time point was then
graphed using Graphpad Prism 4.0. Student’s t-test between D3 and D3N fibroblasts or
between V216 and V216L fibroblasts after six days of growth was performed to
determine statistical significance (*p < 0.05).

2.2.10

TGFβ1 treatment

D3, D3N, V216 and V216L cells were seeded at a density of 1.5x105 cells per well in a
6-well culture dish. Cultures containing each human fibroblast population were either
left untreated or treated with 1 ng/mL TGFβ1 (Cat# 240-B, R&D Systems, Minneapolis,
MN). After four days, cultures were lysed using a RIPA buffer for Western blot analysis.

2.2.11

Western blot analysis

As previously described (Penuela et al., 2007), total proteins were isolated from human
fibroblast cell cultures using a RIPA buffer. Approximately 30 μg of total protein/lane
was separated by electrophoresis on 10% SDS-PAGE gels and transferred to
nitrocellulose membrane for immunoblotting. A polyclonal anti-Cx43 antibody (1:5000;
Cat# C6219, Sigma-Aldrich, St. Louis, MO) was used to detect endogenous Cx43 species
and an anti-alpha smooth muscle actin antibody (1:1000; Cat# A2547, Sigma-Aldrich,
St. Louis, MO) to detect alpha smooth muscle actin. The membranes were also probed
for GAPDH (1:10,000; Cat# MAB374, Chemicon, Temecula, CA) as a control for
protein loading. Primary antibody labeling was detected using IRDye 800 (1:5000; Cat#
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611-132-122, Rockland,

Glibertsville, PA)) and Alexa Fluor® 680 (1:5000;

Cat#A21076, Invitrogen, Carlsbad, CA) goat anti-rabbit and anti-mouse secondary
antibodies and the Li-Cor detection system. The relative densitometry intensities were
normalized to GAPDH and graphed using Graphpad Prism 4.0. Student’s t-test between
the levels of P2/Total Cx43, alpha smooth muscle actin, or fold change in alpha smooth
muscle actin expression was performed to determine statistical significance. Bars denote
which groups were compared and achieved significance (*p < 0.05).

2.3 Results
2.3.1 Clinical presentation of patients and detection of Cx43 gene
mutations
We recruited two families diagnosed with ODDD; one family has multiple members with
ODDD while the second family had one isolated case. All affected individuals had the
typical craniofacial appearance and limb involvement characteristic of ODDD.
Patient #1
This female individual was born with a tethered tongue, heart murmur and a kidney
malfunction. Her motor milestones were normal. She has a narrow nose with hypoplastic
alae nasi, and microphthalmia. Her teeth are dysplastic and irregularly enameled, but are
in good condition. She had fusion of digits 3-5, with the 5th digit brachydactyly and
clinodactyly. Neurologic symptoms of lower extremity paresthesias and weakness are
exacerbated by heat and exercise (Uthoff’s sign). Neurogenic bladder was managed with
tolterodine. At age 14, her neurologic exam was notable for normal strength and gait, but
lower extremity hyperreflexia and right Babinski sign, lower extremity hyperesthesia to
pinprick but normal vibratory threshold.
Patient #2
This male patient had congenital umbilical hernia, and bilateral fusion of digits 4 and 5 of
the hands, but no fusion of toes. He has a narrow nose with hypoplastic alae nasi,
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irregular and thinly enameled dentition, but no ocular involvement. Neurologic symptoms
began at age 29 with spasticity. He has had episodic gastrointestinal ilius and chronic
gastrointestinal hypomotility, neurogenic bladder, and also describes Uthoff’s sign. He
lost ambulation at age 54; his neurologic exam was notable for hyperreflexia, spasticity,
Babinski sign, and diminished vibratory threshold in the lower extremities. He has since
developed lower extremity lymphedema.
DNA was extracted from each patient’s skin fibroblasts. As expected, DNA sequence
analysis found that both patients had missense mutations in the GJA1 gene encoding for
Cx43 (Fig. 2.1A). Patient 1 exhibited a missense mutation in N-terminal region of Cx43
resulting in the substitution of an aspartic acid at position 3 for asparagine (p.D3N).
Patient 2 was found to harbor a mutation in the region of the molecule that would
represent the 4th transmembrane domain at reside 216 where valine was replaced by
leucine (p.V216L). No mutation was found in the coding region of the GJA1 gene from
fibroblasts of the matched family member of the D3N (the mother of the patient) or
V216L patients (the daughter of the patient). Those fibroblasts were used as normal
controls and are notated as D3 and V216, respectively.

2.3.2 Characterization of Cx43 in control and mutant fibroblasts
Previous studies have reported the existence of the D3N and V216L in ODDD patients
but no studies have investigated how human Cx43 mutants affect the trafficking of Cx43
and the assembly of gap junctions (Paznekas et al., 2003; Paznekas et al., 2009). To this
end, we established the first use of primary cell culture from patients expressing the D3N
and V216L mutant Cx43. Familial matched control fibroblasts (D3 and V216) were also
obtained from unaffected relatives to control for the fibroblast source, cell passage and
genetic variation which may have otherwise affected the interpretation of our results.
Cultured cells were verified as fibroblasts due to their spindle-shaped appearance and
positive staining for the intermediate filament, vimentin, confirming their mesenchymal
origin (Fig. 2.1B).
To characterize the subcellular localization of Cx43 in control and mutant fibroblasts,
cells were immunofluorescently double-labeled for Cx43 and a resident protein of the

46

Figure 2.1 D3, D3N, V216, and V216L cells are fibroblasts
A. Genomic DNA was extracted from patient’s blood samples or skin fibroblasts. DNA
sequence analysis identified the heterozygous missense mutation in the N-terminal
coding region of the GJA1 gene in patient 1 where GAC (Asp, D) changed to AAC (Asn,
N) (D3N). The mutation in patient 2 was found in the gene region encoding the fourth
transmembrane domain of Cx43 where GTG (Val, V) changed to TTG (Leu, L)(V216L).
The G60S mouse mutation is localized within the first extracellular loop domain. B. D3,
D3N, V216, V216L cells were immunofluorescently labeled with the mesenchymal
marker vimentin (green) and stained with DAPI to denote nuclei (blue). Spindle-like
morphology and vimentin-positive labeling support the identification of fibroblasts as the
human patient derived cells. Bar = 20 µm.
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Golgi apparatus, GM130 (Fig. 2.2). In D3, D3N and V216 fibroblasts, Cx43 was
localized extensively to punctate structures at sites of cell-to-cell apposition consistent
with the formation of gap junction plaques. However, the prevalence of gap junction
plaques was greatly reduced in the V216L fibroblasts and a large population of Cx43 colocalized with the resident Golgi protein, GM130. Collectively, these localization studies
would suggest that the D3N mutant readily assembles into gap junctions while the V216L
mutant is partially impaired from forming gap junctions. All fibroblasts were examined
for the presence of Cx26, Cx40 and Cx45 but no specific staining was found for these
connexin isoforms (data not shown).

2.3.3 Both human ODDD-linked mutants reduce GJIC
In order to examine GJIC in control and mutant fibroblasts, a preloading assay was
performed where calcein-loaded and DiI-labeled donor cells were seeded on fibroblast
cultures and the incidents of calcein spread were quantified and compared to control
counterparts (Fig. 2.3A). In all cases, the incidence of dye transfer in mutant fibroblasts
were significantly reduced in comparison to their control counterparts. To further
examine the degree of gap junction coupling in control and mutant human fibroblasts, the
coupling conductance between cells were measured by double whole cell patch-clamp
analysis (Fig. 2.3B). Electrical conductance results confirmed that both the D3N and
V216L mutants reduced the overall level of gap junction coupling compared to their
control counterparts.

2.3.4 Wound healing is delayed in mice expressing mutant Cx43
Since fibroblasts play a crucial role in wound healing (Greenhalgh, 2005; Kretz et al.,
2004) and ODDD-linked Cx43 mutants reduced GJIC in dermal fibroblasts, we
investigated whether this decrease in GJIC could alter wound healing. To determine if
wound healing is altered in an in vivo environment, skin punch biopsies were performed
on wild-type (WT) and G60S (Gja1Jrt/+) mutant Cx43 mice (Fig. 2.4) and the wound area
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Figure 2.2

A large proportion of mutant Cx43 co-localizes with the

Golgi

apparatus marker GM130
Fibroblasts denoted as D3, D3N, V216 and V216L were double-labeled for Cx43 (red)
and the resident Golgi apparatus protein GM130 (green). Overlayed images reveal that
Cx43 was partially localized to the Golgi apparatus especially in cells expressing the
V216L mutant. Bar=10 µm.
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Figure 2.3 Reduced gap junctional intracellular communication in D3N and V216L
fibroblasts
(A) D3, D3N, V216 and V216L fibroblasts were preloaded with calcein-AM and DiI, and
seeded onto a monolayer of phenotypically-matched fibroblasts for 3 h. Calcein spread
from DiI labeled cells was scored as incidences of functional dye transfer. (B) Pairs of
D3, D3N, V216 and V216L fibroblasts were double whole cell patch-clamped and
assessed for gap junction coupling conductance. Reduced gap junction conductance was
found in D3N and V216L fibroblasts when compared to the control D3 and V216
fibroblast counterparts. *p<0.05, **p<0.01.
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Figure 2.4 G60S mice wounds heal slower than WT mice wounds
Dermal punch biopsies performed on the backs of WT and G60S mice revealed a delay in
wound closure in G60S mutant mice. After nine days of healing, the wounds in the G60S
mice were significantly larger than the wounds in the WT mice. *p<0.05. Bar = 2.5 mm.

54

55

was quantified for twelve days after the punch biopsies were performed. One to six days
after the punch biopsies were performed; there was no significant difference in the size of
the wound between WT and G60S mice. After nine days however, G60S mice wounds
were significantly larger than those seen in the WT mice.
Since myofibroblast contraction during the later stages of wound healing is vital to
decrease the wound size, we sought to determine whether fibroblasts were responsible for
the delay in wound healing observed in the mutant G60S mice. To achieve this,
fibroblasts were assessed for their ability to proliferate, migrate and differentiate into
myofibroblasts.

2.3.5 ODDD mutants reduce dermal fibroblast migration and
proliferation
To assess whether dermal fibroblasts expressing mutant Cx43 can impact the
proliferation and migration dependent events which occur during wound healing,
explants derived from the WT and G60S punch biopsies were cultured on either plastic,
fibronectin, laminin 332 or collagen type I (Fig. 2.5). After five days in culture, a
fibroblast population could easily be identified surrounding the explants. Quantification
of the fibroblast population that migrated from explants derived from WT and mutant
mice revealed that mutant harboring fibroblasts migrated less well on fibronectin (Fig.
2.5B) and on collagen type I (Fig. 2.5C).
To determine if the migration of human dermal fibroblasts was affected by the expression
of mutant Cx43, time lapse imaging of scrape-wounded control and mutant fibroblasts
was evaluated. When assessed over 48 hours, we observed that migration was delayed in
the ODDD mutant containing fibroblast cultures (Fig. 2.6). Surprisingly, while migration
was analyzed under serum-free conditions, proliferative events were observed after 24
hours as evidenced by the presence of circular shaped cells. To quantify if the
proliferation was different in fibroblasts expressing Cx43 mutants, cell counts were
performed on human fibroblasts derived from ODDD patients and their familial matched
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Figure 2.5 Fibroblasts from mutant mice exhibited reduced migration on
fibronectin and collagen
A. Dermal punch biopsies obtained from the backs of WT and G60S mice were plated in
uncoated, fibronectin, laminin 332, or collagen-coated culture wells. After punch biopsies
were cultured for five days, cellular emigration away from the explants could be observed
(blue arrow). In these images the cells appear bright due to the nature of image
acquisition. B., C. The area of cellular emigration was quantified around the entire
explant and the total cellular emigration area was quantified. There was a significant
decrease in the area that fibroblasts derived from the G60S mice migrated out of the skin
explants when cultured on fibronectin (B) and collagen type I (C). Bar = 500 µm.
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Figure 2.6 ODDD-linked human fibroblasts exhibit impaired migration
Time-lapse imaging of a scrape wound assay was performed using human fibroblasts
from ODDD patients (D3N, V216L) and their matched control fibroblasts (D3, V216).
After 24 hours it was evident that ODDD-linked fibroblasts migrated into the wound area
slower than control fibroblasts. *p<0.05 Bar = 100µm.
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controls (Fig. 2.7). All cell lines were seeded at equal densities and cell counts were
performed on fibroblasts grown for two, four, and six days. Both mutant fibroblasts were
found to proliferate slower than their control counterparts. These results indicate that the
expression of mutant Cx43 decreases the proliferative ability of dermal fibroblasts and
may contribute to delays in wound healing. We recruited two families diagnosed with
ODDD; one family has multiple members with ODDD while the second family had one
isolated case. All affected individuals had the typical craniofacial appearance and limb
involvement characteristic of ODDD.

2.3.6 ODDD mutants hinder the ability of dermal fibroblasts to
differentiate into myofibroblasts
Wound closure was found to be delayed in the G60S mice nine days after a punch biopsy
was performed. At this stage in wound healing, fibroblasts are exposed to TGFβ1 which
facilitates the differentiation of fibroblasts into myofibroblasts. Myofibroblasts in turn
express alpha smooth muscle actin which plays a role in contraction of the wounded area
(Singer and Clark, 1999). To further investigate the mechanism(s) by which wound
healing may be compromised, fibroblasts derived from ODDD patients, as well as their
familial matched controls, were treated with TGFβ1 for four days and Western blots were
performed on untreated as well as TGFβ1-treated fibroblasts to assess the expression of
Cx43 and alpha smooth muscle actin. TGFβ1 treatment elevated the levels of the P2
phosphorylated species of Cx43 (P2) in D3 and V216 fibroblasts. However, in the mutant
Cx43 expressing fibroblasts (D3N and V216L), this increase in the P2 species of Cx43
was not observed upon TGFβ1 treatment (Fig. 2.8). To determine if this change in
phosphorylation could impact the ability of both familial matched control and ODDD
patient derived fibroblasts to differentiate into myofibroblasts, Western blots for alpha
smooth muscle actin were performed with and without TGFβ1 treatment (Fig. 2.9).
Control fibroblasts (D3 and V216) expressed high levels of alpha smooth muscle actin
after TGFβ1 treatment while ODDD patient-derived fibroblasts exhibited a smaller
increase in the expression of alpha smooth muscle actin. In addition, we found that due to
the presence of TGFβ1 in serum (without exogenous administration of TGFβ1), increases
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Figure 2.7 ODDD-linked human fibroblasts exhibited reduced proliferation
D3, D3N, V216 and V216L fibroblasts were plated and counted over a period of 6 days.
At day 6, there were significantly fewer cells in the culture wells containing V216L and
D3N fibroblasts when compared to V216 and D3 fibroblasts. # D3 vs. D3N p<0.05, *
V216 vs. V216L p<0.05.
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Figure 2.8 Aberrant Cx43 phosphorylation in mutant expressing fibroblasts
Cx43 levels (green) in untreated and TGFβ1 treated D3, D3N, V216 and V216L
fibroblasts as assessed by Western blot. Three bands of Cx43 are resolved and these
bands are noted as different phosphorylation states. The lowest band is notated as P0, the
middle band as P1 and the highest band as P2. Four days after D3, D3N, V216, and
V216L fibroblasts were treated with TGFβ1, the levels of the P2 Cx43 phosphorylated
species as compared to total Cx43 levels was significantly increased in D3 and V216
fibroblasts but this increase was not observed in D3N and V216L fibroblasts. GAPDH
was used as a loading control (red). *p<0.05.
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Figure 2.9 Reduced smooth muscle actin expression in mutant expressing fibroblasts
The expression of alpha smooth muscle actin was evaluated by Western blot in D3, D3N,
V216 and V216L fibroblasts exposed to TGFβ1 for four days. The expression of alpha
smooth muscle actin was significantly increased in D3 and V216 fibroblasts after TGFβ 1
treatment. The fold change in alpha smooth muscle actin expression after TGFβ1
treatment was also significantly larger in the D3 and V216 fibroblasts when compared to
the D3N and V216L fibroblasts. *p<0.05.

66

67

in the levels of alpha smooth muscle actin were observed from mutant Cx43 expressing
fibroblasts with each additional passage when compared to control fibroblasts. However,
the fold-change in alpha smooth muscle actin expression after exogenous administration
of TGFβ1 between control and ODDD fibroblasts cells was significantly different. This
result demonstrates that the expression of mutant Cx43 affects the differentiation of
fibroblasts into myofibroblasts. Collectively, these studies would suggest that ODDDpatients may have compromised wound healing as mutant Cx43 expressing fibroblasts
display defects in their ability to proliferate, migrate, and express alpha smooth muscle
actin.

2.4 Discussion
2.4.1 Understanding ODDD
Since the discovery that ODDD was specifically linked to mutations in the GJA1 gene
encoding Cx43 (Paznekas et al., 2003), there has been an expansion of interest in
understanding how Cx43 mutants lead to disease. Given the ubiquitous expression of
Cx43 in the human body including vital organs, it was somewhat puzzling that patients
harboring Cx43 mutants did not have even more disease burden. One possibility was that
the wide array of missense mutations found within the GJA1 gene only mildly
compromises the functional status of Cx43 in forming intercellular channels. However,
this explanation is not likely correct as all the ODDD-linked mutants examined to date
have moderate to severe deficiencies in forming intercellular gap junction channels when
expressed in GJIC-deficient cells (Dorsett-Martin, 2004; McLachlan et al., 2005).
However, these in vitro studies do not ideally mimic the human condition due primarily
to the difficulty in expressing Cx43 mutants and the wild-type Cx43 counterparts at the
1:1 ratio expected to be found in ODDD patients with autosomal dominant GJA1 gene
mutations. With the generation of mouse models of ODDD this genetic limitation was
overcome and three ODDD-linked Cx43 mutants were also found to be dominant to
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endogenous Cx43 resulting in a reduction in overall Cx43 function in many tissues
(Dobrowolski et al., 2008; Flenniken et al., 2005; Kalcheva et al., 2007). Even in these
mutant mouse studies, there was still a requirement to extrapolate the findings to the
human disease condition. In the present study we report on the first efforts to design and
study human models of ODDD with the anticipation that findings in these models will
extend our understanding of ODDD as a disease and to further determine the functional
role of Cx43.

2.4.2 Clinical presentation of ODDD in two patients with distinct GJA1
gene mutations
Clinically, ODDD is a complex disease as no two patients appear to have identical
disease burdens. While nearly all patients have craniofacial bone deformities, fusion of
digits, and thin enamel, the plethora of symptoms beyond these are highly diverse and
linked to defects in any number of organs that include the heart, skin, as well as a wide
array of conditions that are likely entrenched in neurogenic defects (Paznekas et al.,
2009). In the present study we obtained clinical histories and dermal fibroblasts from two
patients with ODDD. Importantly, we were also fortunate to have obtained dermal
fibroblasts from the parent (mother) / child (daughter) of these patients which allows for
all analytical tests to be matched to individuals sharing similar genetic profiles thus
eliminating variance often seen in unrelated controls. Furthermore, in this study we
control for any changes in Cx43 status through multiple cell passages by always using
fibroblasts from control and disease conditions at the same cell passage. Collectively, we
believe we established the best possible scenario to assess Cx43 and gap junctions in
control and mutant-expressing human dermal fibroblasts. Moreover, we complement our
approach by including in vivo wound repair studies using the G60S (Gja1Jrt/+) mouse
model of ODDD.

2.4.3 Cx43 and GJIC status in control and mutant fibroblasts
Previous in vitro studies using reference cell lines strongly suggest that all over-expressed
Cx43 mutants dramatically reduce GJIC and act as dominant-negatives on co-expressed
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Cx43 (Churko et al., 2010; McLachlan et al., 2005). In the case where the V216L mutant
was expressed in reference cells that lack connexins, the V216L expressing cells fail to
form functional intercellular channels (McLachlan et al., 2005). However, whether these
or any other ODDD-linked mutants in human cells naturally harboring the mutants can
affect GJIC had not been tested. In our studies we found that human fibroblasts harboring
the D3N or V216L mutant have reduced GJIC. Interestingly, the V216L mutant appears
to be twice as potent at reducing GJIC compared to the D3N mutant suggesting that the
impact of the autosomal dominant mutation on the coupling status in ODDD patient may
be dependent on the site of the mutation. This finding is in keeping with our previous
study where the G21R mutant was found to be twice as potent at reducing GJIC as a
G138R mutant when ectopically expressed and examined in reference cell systems (Gong
et al., 2007). Since both the D3N and G21R mutations are found on the N-terminus of
Cx43, these results may suggest that mutants within this domain are more potent than
mutations found in at least some other regions of Cx43. It is notable that the N-terminal
domain of some connexins has been reported to be involved in transjunctional voltage
gating (Purnick et al., 2000), oligomerization of connexins into connexons (Lagree et al.,
2003), and even in plugging the gap junction pore (Maeda et al., 2009; Oshima et al.,
2007) highlighting the functional importance of this domain.
In vitro studies using ectopically expressed Cx43 mutants have suggested that there are
two clear trafficking phenotypes where Cx43 mutants are either trapped within a
secretory compartment such as the endoplasmic reticulum or Golgi apparatus (e.g. fs230,
fs260, G60S mutants) or where the mutant traffics to the cell surface and assembles into
non-functional gap junction plaques (e.g., G21R, G138R) (Churko et al., 2010; Gong et
al., 2006). While the D3N and V216L mutants can form gap junction plaques, a
population of the V216L mutant, in particular, localized to the Golgi apparatus. Impaired
trafficking of the V216L mutant may also act to inhibit the delivery of wild type Cx43 to
the cell surface and partly explain how this particular mutant contributes to a disease
phenotype.
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2.4.4 Cellular consequences of reduced Cx43 function in dermal
fibroblasts
Given that patient-derived dermal fibroblasts exhibit a significant reduction in GJIC and
that wound healing is delayed in G60S mutant mice, we sought to determine if the
function of dermal fibroblasts is compromised (Greenhalgh, 2005; Kretz et al., 2004).
Interestingly, it has been reported that transient knockdown of Cx43 in the skin by
siRNAs or antisense leads to enhanced wound healing (Mori et al., 2006; Qiu et al.,
2003) but chronic down regulation of Cx43 had not previously been tested. Furthermore,
the reduction of total Cx43 in a knockdown study is mechanistically distinct from the
expression of a functionally dominant Cx43 mutant as exhibited in an ODDD patient as a
plethora of Cx43 binding partners may remain engaged (Toth et al., 2010). Since Cx43
may play distinct roles at the various stages of wound repair and within cell types (e.g.,
lymphatic endothelial cells, keratinocytes, fibroblasts) involved in wound healing,
temporal knockdown of Cx43 may be beneficial during the early stages of wound healing
while potentially detrimental during a later stage. For instance, acute down regulation of
Cx43 at the wound edge over a 24-48 h period leads to increased keratinocyte and
fibroblast migration (Mori et al., 2006; Wright et al., 2009). In addition, keratinocytes
were shown to play a significant role in accelerating the healing of incisional tail wounds
in mice with decreased levels of Cx43 levels (Kretz et al., 2003). Furthermore, transient
antisense-induced knockdown of Cx43 leads to improved wound healing in the skin (Qiu
et al., 2003) and cornea (Nakano et al., 2008) but functional recovery of Cx43 is thought
to be necessary for the final stages of wound healing. Conversely, chronic expression of
truncated Cx43 has been shown to be extremely detrimental as these mice die shortly
after birth due to epidermal barrier defects (Maass et al., 2004). In our mouse studies,
chronic reduction in overall functional Cx43 levels delayed wound healing and suggests
that some ODDD patients may have a subclinical delay in overall wound healing.
In the present study we demonstrated that ODDD fibroblasts are deficient in their ability
to proliferate, migrate and differentiate when compared to their respective familial
matched control fibroblasts.

Collectively, these cell characteristics are intimately

involved in regulating the efficacy of wound repair. Interestingly, the defect in G60S

71

mouse fibroblast migration was only observed to occur when skin explants were cultured
on fibronectin and collagen type I. It will be interesting to determine how Cx43 mutants
impact the expression and localization of adhesion proteins involved in the attachment of
fibroblasts to these substrates.
We have previously reported that the over-expression of several Cx43 mutants in
reference cell lines reduces the phosphorylation state of total Cx43 (Churko et al., 2010;
McLachlan et al., 2005). Importantly, the P2 phosphorylation state of Cx43 is correlated
with the presence of functional gap junctions (Solan and Lampe, 2005). In the present
study, both the D3N and V216L mutants significantly decreased the levels of the P 2
phosphorylated species. Thus, it appears that both mutants are acting to partially inhibit
the complete assembly of gap junction plaques which manifests as an overall reduction in
GJIC as we have shown. Interestingly, in control fibroblasts, the P2 species of Cx43
increased after TGFβ1 treatment, indicative of a greater number of fully assembled gap
junctions, but this increase was not observed in fibroblasts harboring ODDD-linked
mutants. TGFβ1 is critical in wound repair and acts to stimulate alpha smooth muscle
actin and the formation of myofibroblasts (Brenmoehl et al., 2009; Greenhalgh, 2005).
Quantification of alpha smooth muscle actin revealed that Cx43 mutant expressing
fibroblasts are deficient in regulating the differentiation of fibroblasts into
myofibroblasts. Mechanistically, the delay in wound repair observed in our mutant mice
is likely linked, at least in part, to a deficiency in the ability of fibroblasts to differentiate
into myofibroblasts.
In summary, this is the first study documenting and employing a human model of ODDD.
Here we isolated and characterized human dermal fibroblasts from two ODDD families
which included both affected and unaffected family members. We also employed a punch
biopsy assay to demonstrate a delay in wound course in our mouse model for ODDD.
Since fibroblast contraction plays a more important role in rodent wound healing
(Dorsett-Martin, 2004; Greenhalgh, 2005) and given the limited number of patients
studied and the lack of correlative data, we cannot generalize our results to all ODDD
patients. However, since our V216L and D3N expressing primary fibroblast do exhibit
impaired proliferation, migration, and differentiation, it is quite likely that this condition
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remains present but unreported or subclinical and would only be revealed in patients that
have severe skin wounds where dermal fibroblasts play a more active role.
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Chapter 3

3

Mutant Cx43 enhances keratinocyte proliferation
without impacting keratinocyte migration

Fibroblasts derived from ODDD patients were shown to be impaired in their ability to
proliferate, migrate and differentiate when compared to the familial matched control
fibroblasts. However, keratinocytes also play a critical role in wound healing and mutant
Cx43 may also impair the ability of keratinocytes to repair cutaneous wounds. Given that
primary human keratinocytes are difficult to obtain and culture, this chapter will assess
the ability of primary keratinocytes derived from the G60S mouse model of ODDD to
proliferate, migrate and differentiate.

A version of this chapter is in preparation:
Churko, J.M., McDonald,A., Shao, Q., Laird., D.W. Mutant Cx43 Enhances
Keratinocyte Proliferation without Impacting Keratinocyte Migration.
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3.1 Introduction
A gap junction channel is composed of six oligomerized connexin (Cx) subunits which
dock with six connexin subunits from a neighboring cell. These channels coalesce into
tightly packed arrays known as gap junctions (reviewed in Sohl and Willecke, 2004). Gap
junctions regulate the intercellular passage of small metabolites from cell to cell and
various Cx43 mutants have been shown to disrupt cell to cell communication (Churko et
al., 2010; McLachlan et al., 2005). Mutant Cx43 expression has been specifically linked
to the disease called oculodentodigital dysplasia (ODDD) (Paznekas et al., 2003) and
patients with ODDD commonly develop fusion of the digits and malformations of the
bones, eyes and teeth (Paznekas et al., 2009). To study how mutant Cx43 leads to this
disease, three mouse models have been engineered which also develop malformations
similar to those seen in ODDD patients (Dobrowolski et al., 2008; Flenniken et al., 2005;
Kalcheva et al., 2007). Specifically, we have used the ODDD mouse model expressing a
G60S mutant Cx43 to study how mutant Cx43 impacts the development and function of
the eyes (Tsui et al., 2011), teeth (Toth et al., 2010), and heart (Manias et al., 2008).
However, mutant Cx43 may also disrupt skin homeostasis and the regeneration of the
epidermis since Cx43 has previously been shown to be highly expressed during
epidermal development and in the steady-state adult epidermis (Goliger and Paul, 1994).
During rodent epidermal development, Cx43 is expressed at E12-14 in the outer periderm
and inner basal layer (Risek et al., 1992). At E17-E20, Cx43 expression can be seen in
the stratum basale as well as the stratum spinosum layers but not in the stratum
granulosum (Risek et al., 1992). In comparison to the mouse epidermis however, the
human epidermis expresses little Cx43 within the stratum basale and stratum granulosum,
but high levels of Cx43 were observed within the stratum spinosum (Salomon et al.,
1994). In addition, Cx43 has also been shown to be regulated during epidermal wound
healing. Twenty-four hours after injury, Cx43 expression is downregulated at the
wounded edge (Brandner et al., 2004; Goliger and Paul, 1995; Lampe et al., 1998) and
the S368 phosphorylated species of Cx43 is specifically expressed in the stratum basale
(Richards et al., 2004). Two-three days after wounding occurred, Cx43 was reported to
be absent at the wound border and at six days after wounding, Cx43 expression was
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observed in the reformed epidermis (Brandner et al., 2004; Goliger and Paul, 1995).
Since the expression of Cx43 dynamically changes during cutaneous wound healing,
Cx43 expression is hypothesized to modulate the ability of keratinocytes to repair the
damaged epithelium. To test this hypothesis, siRNAs and mimetic peptides against Cx43
have been used to transiently modulate wound healing. When Cx43 levels were inhibited
by an antisense oligodeoxynucleotide against Cx43 (Mori et al., 2006) or when blocking
the interaction between gap junction channels using a gap junction mimetic peptide,
Gap27 (Pollok et al., 2010), an increase in keratinocyte proliferation occurred at the
wounded edge. In addition, rodent wounds treated with Cx43 siRNAs and antisense Cx43
were reported to heal faster (Mori et al., 2006; Qiu et al., 2003).
While these studies have shown transient decreases in Cx43 expression and function can
accelerate wound healing, chronic reductions in Cx43 gap junction function had not
previously been studied until recently. By using the G60S ODDD mouse model we
recently showed that full excision wounds performed on the backs of G60S mice healed
slower than WT control littermate mice (Churko et al., 2011). In addition, fibroblasts
derived from the G60S mice and from patients with ODDD were shown to display
defects in fibroblast proliferation, migration, and differentiation (Churko et al., 2011).
However, mouse wounds heal primarily though contraction and this delay in wound
healing may not translate to a beneficial advantage in human wound healing. In addition,
keratinocytes also play a significant role in wound healing and how mutant Cx43 impacts
keratinocyte proliferation, migration and differentiation has not been investigated to date.
To investigate if mutant Cx43 impacts keratinocyte dependent wound healing, we used
primary keratinocyte cultures from mice expressing the G60S mutant and assessed the
ability of these keratinocytes to proliferate, migrate and differentiate.

3.2 Materials and methods
3.2.1 Cell lines and mice
All animal experiments were approved by the Animal Use Subcommittee of the
University Council on Animal Care at the University of Western Ontario. Mice
expressing the mutant Cx43 were generated from an N-ethyl-N-nitrosourea mutagenesis
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screen. This screen revealed a mouse with a point mutation within the Gja1 gene
encoding Cx43 and resulted in a glycine to serine substitution at amino acid position 60
(G60S). These mice were subsequently bred onto a mixed C57BL/6J and C3H/HeJ
background (Flenniken et al., 2005). Adult G60S mice were distinguished from WT mice
by the presence of fused digits and were genotyped for confirmation of the mutation.
Rat epidermal keratinocytes (REKs) were previously isolated and characterized by Baden
and Kubilus (Baden and Kubilus, 1983). REKs were engineered to express the full
length Cx43, G21R, G60S, G138R, fs230 and fs260 mutant Cx43 fused with GFP and
cultured as previously described (Churko et al., 2010).

3.2.2 Wound healing assay
Mouse wounds were created as previously described with some notable differences
(Churko et al., 2011). Full length incisions one inch long were created on the back of
anesthetized WT and G60S mice with a scalpel blade. Either twenty-four hours, three
days, or nine days after wounding, mice were euthanized with CO2 inhalation. The
wounded tissue was excised and processed for immunohistochemical analysis as
described below.

3.2.3 Immunofluorescent labeling of human and mouse skin
The derivation and use of human skin biopsies was approved by the Office of Research
Ethics at the University of Western Ontario and by the University of Utah Research
Ethics Board. Skin biopsies were derived from a patient with ODDD (expressing a pD3N
mutant Cx43) as well as a control skin biopsy from a relative not affected by ODDD
(D3). Cx43 was previously genotyped from fibroblasts derived from these patients
(Churko et al., 2011). To obtain mouse skin samples, mice were euthanized by CO2
inhalation and the dorsal back surface was shaved using electric clippers. A 1 cm2 piece
of skin was cut from the back of WT and G60S mice and fixed in 4% formalin. Mouse
and human skin biopsies were tissue processed, paraffin embedded, sectioned into 5 µm
sections, and hydrated as previously described in Langlois et al (Langlois et al., 2010).
Antigen retrieval was performed by simmering tissue sections in 1.8 mM citric acid and
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8.2 mM of sodium citrate for 10 minutes. Tissue sections were permeabilized with 0.2%
Triton X-100 in PBS for 12 minutes. A blocking solution containing 2% bovine serum
albumin (BSA) and 0.2% Tween-20 in PBS was placed on the tissue section for 30
minutes. Primary antibody labeling was performed using anti-Cx43 (Cat# C6219, Sigma
Aldrich, St. Louis, MO) diluted 1:500 in the blocking solution overnight at 4oC. The
following day, tissue sections were washed 3X with PBS containing 0.2% Tween-20 for
5 minutes each wash. Cx43 localization was detected using Alexa Fluor 488 goat antirabbit IgG (Cat# A11008, Invitrogen, Carlsbad, CA) for Cx43 localization in human and
mouse epidermis (Figure 1). For other immunofluorescent labeling, Alexa Fluor 555 goat
anti-rabbit (Cat# A21429, Invitrogen, Carlsbad, CA) was used to detect primary Cx43
labeling at a dilution of 1:500 and CK14 was detected using Alexa Fluor 488 goat antimouse IgG (Cat# A11017, Invitrogen, Carlbad, CA) at a dilution of 1:500. Secondary
antibodies were incubated for 1 hour at room temperature and washed 3X (5 min each)
with PBS containing 0.2% Tween-20. Nuclear staining was performed using Hoechst
33342 (Cat# 3570, Molecular Probes, Eugene, OR at a dilution of 1:1000) for 5 minutes
and washed once with water for 5 minutes. Airvol was used to mount a coverslip over
the tissue sections and a Zeiss LSM 510 microscope was used for imaging.

3.2.4 Primary keratinocyte culture
The back skin was dissected from postnatal day 2 littermates and rinsed in DPBS (Cat#
14190-136, Invitrogen, Carlsbad, CA) containing 5 µg/mL gentamycin (Cat# 14190-136,
Invitrogen, Carlsbad, CA). The dissected skin was placed dermal side down in a well of
a 6 well plate containing 2 mL of 25 cu/mL dispase (Cat# 17105-041, Invitrogen,
Carlsbad, CA) diluted in Ca+2 and Mg+2 free HBSS (Cat# 14170-112, Invitrogen,
Carlsbad, CA). The 6-well tissue culture dish was then placed on a rocker overnight at
4oC. The following morning, the epidermis was separated from the dermis with tweezers
and the epidermis was placed into 2 mL trypsin (Cat# 25200-056, Invitrogen, Carlsbad,
CA) for 5 min. The undigested epidermis was removed from the trypsin and 5 mL of
keratinocyte serum free media (Keratinocyte-SFM) 1X (Cat# 17005-042 Invitrogen,
Carlsbad, CA) and 1 mL of trypsin soybean inhibitor (Cat# 17075-029, Invitrogen,
Carlsbad, CA) was added to the trypsin containing the dissociated keratinocyte
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suspension. The keratinocytes were centrifuged into a pellet and resuspended into
Keratinocyte-SFM. Keratinocytes were then plated on tissue culture wells precoated with
collagen I (1.5 mg/ml, Cat# 354236, BD Biosciences, Bedford, MA). To induce
keratinocyte differentiation, 1.4 mM calcium chloride was added to the KeratinocyteSFM media. To verify the purity of primary keratinocyte cultures (and to visualize the
expression of Cx43 in low calcium and high calcium conditions) immunocytochemistry
labeling was performed. Primary keratinocytes were fixed with a mixture of 80%
methanol/20% acetone for 5 min, blocked with blocking solution for 30 minutes, and
labeled with anti-CK14 (Cat# MS-115-P, Neomarkers, Fremont, CA) and anti-Cx43
antibodies overnight. Secondary antibody labeling, nuclei labeling, and coverslip
mounting was performed as described above.

3.2.5 Electrophysiology
The dual whole-cell patch clamp technique was applied to assess the electrical coupling
level between paired wild-type and G60S keratinocytes. For conductance measurements
both cells were initially held at 0 mV, and a 30 mV impulse (Vj) was injected into cell
one while transjunctional current (Ij) was recorded from cell two. Then the gap junctional
conductance was calculated according to Ohm’s law. During the recordings, the
keratinocytes were continuously perfused with a bath solution containing (mM) NaCl
(135.0), KCl (5.0), HEPES (10.0), MgCl2 (1), CaCl2 (2), BaCl2 (1), CsCl (2), Na
pyruvate (2), D-glucose (5). Recording pipettes were filled with (mM) CsCl (130),
EGTA (10), CaCl2 (0.5), Mg-ATP (5), HEPES (10) and pipette resistance was between 25 mΩ. Signals were recorded using two Axopatch 200B amplifiers, low-pass filtered at 5
kHz and digitized at 10 kHz. *P<0.05.

3.2.6 Proliferation Assays
Proliferation of REKs expressing either full length Cx43 (Cx43-GFP) or G60S-GFP was
compared to vector control expressing REKs using a BrdU incorporation assay. REKs
were seeded at a density of 5 X 104 onto coverslips in a 6 well plate. After 24 hours, fresh
culture media containing 10 µM of BrdU was placed onto the growing REKs for four
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hours. After four hours, the coverslips were removed from 6 well plates and washed 2X
with PBS. Each coverslip was fixed using a mixture of 80% methanol/20% acetone and
washed an addition 2X with PBS. 2N HCL was then placed onto each coverslip for 20
minutes and then washed 2X with PBS. Immunofluorescent labeling was then performed
using anti-BrdU antibody (G3G4, Developmental Studies Hybridoma Bank at a 1:100
dilution) overnight followed by incubation with a goat anti-mouse Alexa fluor 555
secondary antibody. Coverslips were mounted with Airvol and 5 - 10 random fields of
view per N were taken using a Zeiss Meta 510 confocal microscope.
The proliferation of primary keratinocytes from wild type and mutant mice was
quantified by cell counting. Primary keratinocytes were seeded at a cell density of 5 X
104 cells per well in a 12 well plate. Three, six and nine days after initial cell plating, 400
µL of trypsin was added to the culture wells to dissociate the adherent cells. After five
minutes, 10 µL of the dissociated cells were mixed with 10 uL of trypan blue (0.4%, Cat#
T10282, Invitrogen, Carlsbad, CA) and 10 µL of this mixed sample was injected into a
chamber of the Cell Counting Chamber Slides (Cat# C10228, Invitrogen, Carlsbad, CA).
Cell quantification was then performed by using the Countess Automated Cell Counter
(Cat# C10227, Invitrogen, Carlsbad, CA).

3.2.7 Migration
REKs and primary keratinocytes were seeded at a cell density of 1 × 104 cells per culture
well in a 12-well tissue culture dish. After two to three days in growth medium, the
culture media was removed and a 1,000 µL pipette tip was scraped down the center of the
culture well. In REK cultures, REKs were washed 2X with Opti-MEM (Cat# 11058-021,
Invitrogen, Carlsbad, CA) and 1 mL of Opti-MEM with or without serum was added to
each culture well. In primary keratinocyte cultures, the culture wells were washed 2 x
with Keratinocyte-SFM (1X) media. To prevent differentiation of the primary cultures,
primary keratinocytes were imaged with 1 mL of Keratinocyte-SFM (1X) added to each
culture well. Time-lapse imaging was performed using a Zeiss LSM 510 microscope
equipped with Axiovision software. Time-lapse monolayer closure images were acquired
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every 10 min for 11 hr in REK cultures or every 10 min for 12 hours in primary
keratinocyte cultures.

3.2.8 Western blots
Western blots were performed as previously described (Penuela et al., 2007) with the use
of the following primary antibodies: anti-Cx43 (Cat# C6219, Sigma Aldrich, St. Louis,
MO), pan anti-cytokeratin (1:1000; Cat# ab7753 Abcam, Cambridge, MA), antiinvolucrin (1:1000; Cat# PRB-140C, Covance, Princeton, NJ), anti-GAPDH (1:5000;
Cat# MAB374, Millipore, Billerica, MA), anti-CK14 (1:1000; Cat# MS-115-P,
Neomarkers, Fremont, CA). Primary antibodies were detected using Alexa Fluor 680
(1:5,000; Cat # A21076, Invitrogen) or IRDye 800 (1:5,000; Cat# 611-132-122;
Rockland, Glibertsville, PA) goat anti-rabbit and anti-mouse secondary antibodies in
conjunction with the LiCor imaging system.

3.3 Results
3.3.1 Mutant Cx43 disrupts the overall localization pattern of Cx43 in
mutant mouse and patient epidermis
Cx43 is highly expressed within both the human and mouse epidermis but the role it
plays in this highly differentiated tissue is only beginning to be understood. To visualize
mutant Cx43 in the epidermis, we labeled Cx43 in the epidermis from an ODDD patient
expressing the pD3N mutant as well as in the mouse epidermis expressing the G60S
mutant Cx43 (Fig. 3.1). In the epidermis from the patient expressing the D3N mutant,
Cx43 was diffusely localized within the stratum spinosum and did not localize as a
punctate profile indicative of gap junction plaques. A reduction in the punctate plaque
localization was also observed in the epidermis from mice expressing the G60S Cx43
mutant. However in the control human epidermis (D3) and in the epidermis from WT
mice, punctate Cx43 labeling could be seen within the epidermis.
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Figure 3.1 Reduced Cx43 punctate localization in a human D3N patient skin
biopsy and in skin obtained from G60S mutant mice
Cx43 (green) immunofluorescent localization was performed on skin biopsies obtained
from a patient expressing the D3N mutant as well as from the patient’s unaffected parent
(D3). Cx43 localization in the D3N patient revealed less punctate Cx43 localization when
compared to the D3 control epidermis. Cx43 immunofluorescent labeling of the G60S
mouse epidermis also revealed a similar reduction in punctate Cx43 localization when
compared to the epidermis from WT littermate control mice. Dashed line represents the
division of the epidermis to the dermis. Intense unspecific staining was also observed in
the upper stratum corneum layer. Nuclei were stained with Hoechst and are
pseudocoloured blue. Bar= 10 µm.

86

87

Since this change in localization pattern observed in both human and mouse epidermis
may indicate that mutant Cx43 impairs Cx43 cellular trafficking, we sought to investigate
if mutant Cx43 expression affects the dynamic Cx43 trafficking which occurs during
wound healing. To evaluate this possibility, Cx43 immunofluorescent localization was
performed one, three, and nine days after incisional wounds were created on the backs of
WT and G60S mice (Fig. 3.2). One day after wounding, we observed a decrease in the
expression of Cx43 at the wound edge from WT mice but Cx43 levels appeared to be
slightly higher at the wound edge in the G60S mouse epidermis. Three days after
wounding however, abundant Cx43 was observed in cells bordering the wound edge and
Cx43 was primarily localized within intracellular compartments. Nine days of wounding,
Cx43 returned to the similar punctate profile observed in the uninjured epidermis in WT
mice and Cx43 was again diffusely localized in the epidermis from mutant mice.

3.3.2 Mutant Cx43 inhibits gap junctional intercellular communication
and enhances the proliferation of primary mouse keratinocytes
Since the localization of Cx43 is impaired in G60S mouse epidermis during steady-state
and during wound healing, we sought to determine if primary keratinocytes derived from
G60S mice are impaired in their ability to proliferate, migrate, and differentiate as
required during wound healing. Primary keratinocytes were isolated from both WT and
G60S mice and the purity of the keratinocyte cultures were assessed by
immunofluorescent labeling of a keratinocyte marker, cytokeratin 14 (CK14) (Fig. 3.3).
In both cases over 97% percent of the cells isolated labeled with CK14. Cx43 localization
studies revealed that keratinocytes from mutant mice had a reduced number of Cx43 gap
junction plaques. To determine if this decrease in gap junction plaques translated into
reduced gap junctional communication between keratinocytes, dual patch clamp analysis
was performed on WT and G60S derived mouse keratinocytes. The primary keratinocytes
derived from G60S mice had significantly reduced transjunctional conductance when
compared to keratinocytes derived from WT mice suggesting that the expression of
mutant Cx43 impairs gap junctional coupling.
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Figure 3.2 Cx43 is maintained localized within intracellular compartments during
the wound healing process in G60S mutant mice
Immunofluorescent localization of Cx43 revealed that the expression of Cx43 is
downregulated at the wounded edge (beneath the labeled clot) one day after injury in WT
mice. Three days after injury, Cx43 was predominantly localized within intracellular
compartments of cells at the proliferative edge in WT mice. Nine days after injury, Cx43
localized into punctate plaque structures between keratinocytes in WT mice. However, in
mutant mice Cx43 remained localized to intracellular compartments or diffusely localized
at the cell surface during all stages of the wound healing process (see enlarged panel).
Nuclei were stained with Hoechst and are pseudocoloured blue. Bar = 50 µm.
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Figure 3.3 Mutant G60S Cx43 impairs the localization of Cx43 and decreases the
transjunctional conductance in primary keratinocytes
A. Primary keratinocytes co-labeled for CK14 (green) and Cx43 (red) revealed that
keratinocytes derived from G60S mice had reduced Cx43 localized at the areas of cell to
cell apposition. B. Gap junctional coupling of paired wild-type or G60S keratinocytes
revealed a significant decrease in the transjunctional conductance in cells from mutant
mice as revealed by the dual whole-cell patch clamp technique. Bar = 20 µm.
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To determine if mutant Cx43 expression impacts the proliferation of keratinocytes, we
performed BrdU labeling on rat epidermal keratinocytes (REKs) expressing full length
Cx43 (Cx43-GFP), G60S mutant Cx43 (G60S-GFP) or on vector control (V) infected
REKs (Fig. 3.4). Cx43-GFP overexpression in REKs significantly lowered the proportion
of nuclei which labeled for BrdU while mutant G60S-GFP expression increased the
percent of BrdU labeled nuclei. This suggests that exogenous expression of mutant G60S
Cx43 can enhance the proliferation of rat keratinocytes and overexpression of wild-type
Cx43 lowers the proliferative ability of keratinocytes. In addition, cell counts revealed
that keratinocytes from G60S mice proliferated faster than WT keratinocytes.

3.3.3 Migration and the ability of keratinocytes to differentiate is not
affected by the expression of the G60S mutant
To determine if mutant Cx43 can impact the ability of keratinocytes to migrate, a scrape
wound assay was performed on monolayer keratinocyte cultures derived from WT and
G60S mice (Fig. 3.5). No significant difference was observed between the distances that
keratinocytes derived from WT or G60S mice migrated. Scrape wound assays were also
performed on REKs expressing different Cx43 variants either in the presence or the
absence of serum and no differences were observed between any REK cell line assayed
(Fig 3.6).
Primary keratinocyte from WT and G60S mice were also assayed for their ability to
differentiate. Under low calcium conditions, WT mouse derived keratinocytes expressed
abundant Cx43 gap junction plaques localized to the areas of cell to cell apposition while
Cx43 was predominantly localized within the cell in keratinocytes derived from G60S
mice. After two and four days under high calcium conditions, Cx43 expression at the
areas of cell to cell apposition appeared to decrease in both WT and G60S derived
keratinocytes while intracellular pools of Cx43 could still be observed in the
keratinocytes derived from G60S mice.
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Figure 3.4 Mutant G60S Cx43 expression enhances keratinocyte proliferation and
overexpression of wild-type Cx43 reduces proliferation
A. REKs were engineered to express either the G60S mutant (G60S-GFP) or full length
Cx43 (Cx43-GFP) tagged with green fluorescent protein. REKs were also infected with
the empty viral vector (V). Proliferative events were quantified by determining the
percent BrdU labeled nuclei compared to the total Hoechst stained nuclei. B. Cell counts
on WT and G60S primary keratinocytes cultured for nine days revealed that G60S
primary keratinocytes proliferated faster when compared to keratinocytes derived from
WT mice.
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Figure 3.5 Mutant G60S Cx43 expression does not change the migration of primary
keratinocytes
Scrape wounds were performed on primary keratinocytes derived from WT and G60S
mice and closure of the scraped monolayer was assessed by time lapse imaging. Primary
keratinocytes derived from WT and G60S mice migrated equal distances after 12 hours.
Bar = 100 µm.
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Figure 3.6 Rat epidermal keratinocytes engineered to express ODDD mutants
exhibited similar levels of migration
REKs were engineered to express ODDD mutants (G21R, G60S, G138R, fs230, fs260)
as well as full length Cx43 (Cx43-GFP) or a C-terminal truncated mutant with two
additional mutations (delta 244*). A. Scrape wound assays were performed on monolayer
cultures and time-lapse imaging was performed to compare the migration competence of
each of these cell lines. Images of Cx43-GFP and G60S-GFP expressing cells are
presented immediately after scraping and approximately 11 hours after the scrape wound
was performed. B. Quantification of the migration distance keratinocytes transverse over
11 hours with or without serum was not significantly different between the REK cell
lines. Bar = 100 µm.
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Under low calcium conditions, Western blots revealed high levels of Cx43 representing
multiple Cx43 phosphorylated states (Fig. 3.7) and, interestingly, the levels of Cx43 were
significantly higher in keratinocytes derived from G60S mice. After keratinocytes were
cultured in high calcium conditions for two or four days however, Cx43 levels were
significantly lowered in keratinocytes derived from both WT and G60S mice. To assess
the extent which keratinocytes had differentiated under high calcium conditions, Western
blots were performed to quantify the levels of a keratinocyte differentiation marker, totalcytokeratin, and a protein which is expressed in undifferentiated basale keratinocytes,
CK14 (Matic et al., 2005). Analysis of all keratins or CK14 did not reveal any significant
expression differences between keratinocytes obtained from WT or mutant mice.
However, when examining the expression of an additional marker of differentiation,
involucrin, keratinocytes derived from G60S mice expressed significantly higher levels
of involucrin under low calcium conditions and after 2 days, but not 4 days under high
calcium culturing conditions.

3.4 Discussion
Wound healing involves a combined effort between multiple cell types including
fibroblasts and keratinocytes. In wound healing, both fibroblasts and keratinocytes must
efficiently proliferate, migrate, and differentiate to rebuild the structural and functional
integrity of the skin (Hackam and Ford, 2002; Werner et al., 2007). Connexins are
thought to play a valuable role in the wound healing process since they have been shown
to affect the proliferation (Song et al., 2010; Vinken et al., 2011), migration (Olk et al.,
2009; Santiago et al., 2010) and differentiation (Belliveau et al., 2006; McLachlan et al.,
2008) of multiple cells types.
Knockdown studies which transiently lower Cx43 expression have demonstrated that
wounds heal faster when Cx43 levels are lowered (Mori et al., 2006; Qiu et al., 2003).
However, we have previously demonstrated that wounds in mice expressing mutant G60S
Cx43 did not heal as fast as their WT counterpart (Churko et al., 2011). Fibroblasts in this
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Figure 3.7 Keratinocyte Cx43 levels decrease under high calcium conditions
A. Immunofluorescent labeling of Cx43 was performed on keratinocytes derived from
WT and G60S mice under low and high calcium conditions. Under low calcium
conditions, a large proportion of Cx43 was expressed in the areas of cell to cell
apposition in the WT keratinocytes while intracellular labeling of Cx43 was observed in
keratinocytes derived from G60S mice. After calcium was added to the culture media cell
surface Cx43 plaques were greatly reduced. B. Western blots revealed that the addition of
calcium to the culture media significantly reduced the levels of Cx43 in keratinocytes
derived from both WT and G60S mice. Total cytokeratin and CK14 levels were not
significantly different between WT and G60S mice under low or high calcium culture
conditions. Involucrin levels were significantly higher in keratinocytes derived from
G60S mice under low calcium conditions and at two days but not four days after calcium
was added to the culture media. Bar= 10 µm.
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study were shown to have impaired proliferation, migration and differentiation. In
addition, Cx43 has been shown to be dynamically regulated in keratinocytes during
wound healing (Brandner et al., 2004; Goliger and Paul, 1995; Lampe et al., 1998) and
mutant Cx43 may also impair the ability of keratinocytes to heal wounds. In the current
study, we assessed the ability of keratinocytes expressing either wild-type or mutant
Cx43 to proliferate, migrate and differentiate to determine if mutant Cx43 impairs the
role that keratinocytes play during wound healing.
To date, the localization of Cx43 in any ODDD patient tissues has not been investigated.
Here we have attained a punch biopsy from a patient with ODDD (expressing the D3N
mutant) as well as from a family matched control. The reduction in Cx43 gap junctions
observed in the ODDD patient epidermis could indicate that mutant Cx43 impairs proper
cellular trafficking of Cx43 or it destabilizes the cell surface population of Cx43 that
assembles into gap junction plaques. Mislocalized Cx43 was also observed in primary
keratinocytes derived from G60S mice. It is possible that mislocalized Cx43 may affect
the ability of Cx43 to bind to one or more of its multiple protein binding partners
(reviewed in Laird, 2010). For example, Cx43 has been shown to compete with Smad2/3
to bind to microtubules (Dai et al., 2007). If the interaction between mutant Cx43 and
microtubules is impaired, it is possible that more Smad2/3 may bind microtubules thus
dysregulating the overall signaling action of Smad2/3. This may also have significant
consequences in TGFβ1 signaling since TGFβ1 signaling activates Smad2/3. In addition,
mislocalized Cx43 would be expected to reduce the overall coupling status of contacting
mutant containing keratinocytes as we have determined to be the case. If the function of
gap junction channels is reduced, keratinocytes may not efficiently transport metabolites
and signaling molecules required for differentiation (e.g. calcium (Kimyai-Asadi et al.,
2002)) and thus keratinocytes may be impaired in their ability to differentiate. However,
since WT and G60S expressing Cx43 keratinocytes differentiated to a similar degree,
mutant G60S co-expressed with wild-type Cx43 may allow sufficient metabolite/ion
transport through gap junction channels to differentiate.
In this study, keratinocytes from G60S mice have a reduction in Cx43 gap junction
plaque formation and this cellular status may result in a selective advantage in epidermal
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wound healing. As previously reported by others and demonstrated in the current study,
Cx43 levels decrease in cells bordering the wound edge twenty-four hours after injury
(Brandner et al., 2004; Goliger and Paul, 1995; Lampe et al., 1998). Three days after
injury however, abundant Cx43 was localized within the intracellular environment but
Cx43 was still prohibited from forming gap junctions. At this stage of wound healing,
keratinocytes are rapidly proliferating and migrating under the coagulum. Since
keratinocytes from mutant mice maintain Cx43 within intracellular compartments for an
extended, or even an indefinite period of time, this condition may further accelerate the
wound healing response. In addition, since connexins are naturally removed from the
plasma membrane prior to cell division (Solan and Lampe, 2009), the reduction of
plasma membrane localized Cx43 expression in mutant expressing keratinocytes may
further promote proliferation. This could also explain how lowering Cx43 levels by antisense oligonucleotide enhances keratinocyte proliferation (Mori et al., 2006). Here we
have also observed that mutant G60S Cx43 expression in both REKs and in primary
keratinocytes enhances the proliferation of keratinocytes. In addition, the expression of
full-length Cx43 into REKs lowered the ability of REKs to proliferate when compared to
vector control cells. However, it is unclear whether it is the physical presence of Cx43 on
the plasma membrane or the functional coupling mediated through gap junction channels
regulates this change in proliferation.
While keratinocyte proliferation is one of the earliest steps in wound healing,
keratinocytes must also migrate under the coagulum to repopulate the wounded area.
Fibroblasts derived from G60S mice and from patients with ODDD revealed a significant
delay in migration (Churko et al., 2011). However, scratch wound assays performed on
REKs expressing various Cx43 mutants and on primary keratinocytes derived from WT
and G60S mice did not reveal any differences in cell migration. The ability of mutant
Cx43 to impair migration in fibroblasts but not in keratinocytes suggests that there are
clear cell type differences. Interestingly, the migration rate in both human (Wright et al.,
2009) and mouse (Kandyba et al., 2008) keratinocytes were enhanced when treated with
a connexin mimetic peptide, Gap27. Since Gap27 is proposed to block the interaction
between connexons on the cell surface, coating the plasma membrane with Gap27 may
also block the interaction between other cell adhesion proteins or between different
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connexons expressed in keratinocytes. Therefore, the increase in migration observed
when keratinocytes were treated with Gap27 may be due to the nonspecific interactions
with other protein complexes expressed on the plasma membrane.
Previously, low calcium conditions have been shown to promote the expression of Cx43
and high calcium conditions have been shown to decrease the levels of Cx43 during
keratinocyte differentiation (Brissette et al., 1994). In our study, keratinocytes derived
from both WT and G60S mice were shown to express abundant Cx43 under low calcium
conditions and primary keratinocytes derived from G60S mice expressed significantly
more Cx43 when compared to primary keratinocytes derived from WT mice. This finding
is quite unique since total Cx43 expression and the levels of the phosphorylated Cx43
species were shown to be lower in whole skin extracted from G60S mice (Langlois et al.,
2007). It is possible that multiple cell passages may lead to an increase in Cx43
expression over time or keratinocytes derived from G60S mice may compensate for the
loss of gap junction dependent communication by upregulating the overall levels of
Cx43. In addition, given that keratinocytes derived from G60S mice exhibited reduced
coupling and that the phosphorylated species of Cx43 observed in Western blots is
associated with the functional plasma membrane localized pool of Cx43 (Solan and
Lampe, 2005), the increase in total Cx43 expression observed in our keratinocytes
derived from G60S mice is suspected to be due to an increase in the P0 (intracellular pool
of Cx43) band species. This is also supported by our immunofluorescent data which
revealed a large intracellular pool of Cx43 in keratinocytes derived from G60S mice.
Under high calcium conditions however, keratinocytes derived from both WT and G60S
responded similarly by lowering their expression of Cx43 at two and four days. In
addition, no difference was observed in the expression of a cytokeratin differentiation
marker between keratinocytes derived from WT and G60S mice after calcium-induced
differentiation. However, freshly isolated keratinocytes derived from G60S mice may be
somewhat better primed for differentiation since involucrin levels were elevated under
low calcium and after two days under high calcium. While keratinocytes expressing
mutant Cx43 may be initially primed to differentiate, this differentiation advantaged was
nullified by day four of high calcium treatment. This finding is also supported by
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previous Western blots which showed no significant difference in the levels of involucrin
expression between skin extracts derived from adult WT and G60S mice (Langlois et al.,
2007).
In general, there are few reports that suggest mutant Cx43 expression impairs skin
differentiation. With over 62 different mutants reported to cause ODDD (Paznekas et al.,
2009), only two patients expressing either the fs260 (van Steensel et al., 2005) or fs230
(Vreeburg et al., 2007) Cx43 mutants led to the development of palmar plantar
hyperkeratosis. While the majority of Cx43 mutants have not been reported to affect skin
physiology, some Cx43 mutants (e.g. fs260 and fs230 mutants) may be more potent at
causing skin disease and impairing wound healing.

Organotypic epidermal cultures

engineered to express the fs260 mutant drastically reduced the endogenous levels of both
Cx43 and Cx26 and disrupted the organotypic epidermal architecture (Churko et al.,
2010). Since the fs260 mutant lacks a large portion of the C-terminal domain, the Cterminal domain is hypothesized to play an important role in skin differentiation. In
support of this hypothesis, mice engineered to express a C-terminal truncation of Cx43
have also been shown to die prematurely due to epidermal barrier defects (Maass et al.,
2004).
The ability of each mutant to impair skin homeostasis may also be cell type dependent.
Mutant Cx43 drastically impaired the ability of fibroblasts to proliferate, migrate and
differentiate however in this study, keratinocytes expressing mutant Cx43 did not
demonstrate a significant difference in migration and did not show severe differentiation
differences. Given that fibroblasts have been shown to express Cx43, Cx45 and Cx40
(Wright et al., 2009) while keratinocytes have been reported to expresses Cx43, Cx26,
Cx30, Cx30.3, Cx31, Cx31.1, Cx37, Cx40, Cx57 (Goliger and Paul, 1994; Richard,
2000) the multitude of connexins expressed in keratinocytes may compensate for mutant
Cx43. Functional compensation of connexins in the epidermis has previously been
documented as an upregulation of Cx30 expression was observed within the epidermis of
mice with reduced levels of Cx43 (Kretz et al., 2003).
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In conclusion, the expression of mutant Cx43 may impart patients with a wound healing
advantage when the wounds are superficial and restricted primarily to the epidermis.
Under these conditions patient keratinocytes would be expected to proliferate faster and
close over the wounded area. However, since mutant Cx43 has been shown to impair
fibroblast proliferation, migration and differentiation, larger wounds requiring drastic
dermal remodeling may not heal as fast in ODDD patients.
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Chapter 4

4

The ability of the fs260 Cx43 mutant to impair
keratinocyte differentiation is distinct from other
disease-linked Cx43 mutants

In the previous chapter we found that mutant G60S Cx43 expression negligibly affected
the ability of primary mouse keratinocytes to differentiate. However ODDD patients
expressing the frame-shift mutations (fs230 and fs260) develop skin disease and thus
these mutants may be more potent at affecting the differentiation of the skin. In addition,
primary keratinocyte cultures grown in monolayer may not truly represent epidermal
differentiation since the epidermis is composed of multiple layers representing different
keratinocyte differentiation states. In this chapter we extended our evaluation of the
ability of keratinocytes expressing mutant Cx43 to differentiate by assessing threedimensional organotypic epidermal cultures expressing skin disease linked and non-skin
disease linked ODDD mutant Cx43.

A version of this chapter has been published:
Churko, J.M., Langlois, S., Pan, X., Shao, Q., Laird, D.W. (2010) The potency of the
fs260 connexin43 mutant to impair keratinocyte differentiation is distinct from other
disease-linked connexin43 mutants. Biochemical Journal., 429 (3):473-83.
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4.1 Introduction
Direct cell to cell communication relies heavily on the passage of small molecules
through gap junctions (Beyer et al., 1987). Structurally, gap junctions are composed of
connexin proteins which oligomerize in the Golgi apparatus to form connexons
(Vanslyke et al., 2009). Connexons are transported to the cell surface and dock with
connexons from an adjacent cell to form functional channels (Goodenough et al., 1996).
Given that connexins and gap junctions have a half-life of only 1-5 hours both in vitro
and in vivo, constant regulatory control of connexin translation, oligomerization, delivery
to the cell surface and assembly are all critical for the proper regulation of gap junctional
intercellular communication (GJIC). When regulatory processes involved in the life cycle
of connexins become disrupted, GJIC is compromised and disease may result. For
example, disease-linked mutations in the gene encoding connexin43 (Cx43) has been
shown to sequester endogenous and mutant Cx43 in intracellular compartments (Gong et
al., 2006), and inhibit the passage of small molecules through gap junction channels and
hemichannels (Lai et al., 2006; McLachlan et al., 2005). Clinically, germ line mutations
in nine connexin gene family members lead to human diseases that include skin diseases
(e.g. Cx26, Cx43) (Richard, 2005), cataracts (e.g. Cx45, Cx50) (White et al., 1999),
deafness (e.g. Cx26) (Petit, 2006), arrhythmias (e.g. Cx40, Cx43) (Gutstein et al., 2001),
Charcot Marie Tooth disease (e.g. Cx32) (Scherer et al., 1999) and oculodentodigital
dysplasia (ODDD) (e.g. Cx43) (Paznekas et al., 2009).
ODDD was first described as a disease displaying craniofacial abnormalities
(microphthalmia, dental anomalies, small nose and hypotrichosis), type III syndactyly,
and missing toe phalanges (Gillespie, 1964). Since its initial characterization, spastic
paraparesis, cerebral white matter abnormalities (Gutmann et al., 1991) and ectodermal
abnormalities (Kelly et al., 2006; Kjaer et al., 2004; Paznekas et al., 2009) have also been
associated with ODDD. ODDD is a rare condition as less than 1000 cases having been
fully documented although now that the genetic link to the disease is known; the number
of reported cases is likely to grow substantially. To date, ODDD is associated with 62
familial or sporadic mutations in the gene encoding Cx43 with the majority (~85%) being
dominant missense mutations (Paznekas et al., 2009). Functional assays employing some
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of these mutations have found that the mutants encoded are dominant-negative and result
in a drastic reduction in normal Cx43 function (Gong et al., 2006; McLachlan et al.,
2005). These mutations are associated with a wide array of phenotypic outcomes and
generally, domain specific mutations were not found to correlate with a specific ODDD
symptom. For example, ODDD has been diagnosed in patients having mutations in the
N-terminal (e.g. Y17S, G21R), first extracellular loop (e.g. A40V, G60S, P59S),
cytoplasmic loop (e.g. V96M, G138R), second extracellular loop (e.g. H194P) and Cterminal tail (fs230, fs260) (Paznekas et al., 2009). While most of these mutations often
result in syndactyly and cranial facial abnormalities, two ODDD mutants that truncate the
C-terminal tail (fs230 and fs260) have been reported to additionally cause the skin
disease palmar plantar hyperkeratosis (van Steensel et al., 2005; Vreeburg et al., 2007).
While both of these mutants have been reported to cause palmar plantar hyperkeratosis, a
newly identified patient expressing the fs230 mutant did not exhibit this skin disease
phenotype (Alao et al., 2010). Importantly, the fs260 mutant has a polypeptide extension
of 46 non-connexin related amino acids before a stop codon is encountered while the
fs230 mutant has only a 6 amino acid extension prior to reaching a stop codon (van
Steensel et al., 2005). Thus, although these two mutants both lack the C-terminal tail they
differ extensively in non-connexin polypeptide sequence that may contribute to the
disease phenotype in the skin.
Palmar plantar hyperkeratosis has been linked to a wide array of abnormal processes.
Palmar plantar hyperkeratosis involves a thickening of the epidermis in the friction and
weight bearing surfaces of the palms and the plantar region of the feet (Chopra et al.,
1997). Congenitally, palmar plantar hyperkeratosis can also be caused by mutations in the
genes which code for epidermal proteins. Mutant keratin 1, keratin 10 (Kimonis et al.,
1994), Cx26 (Vohwinkel's syndrome)(de Zwart-Storm et al., 2008) and desmosomal
proteins (Bragg et al., 2008) have all been reported to be genetically linked to palmar
plantar hyperkeratosis. In the case of Cx43 mutations, it is currently not known whether
the mechanism by which Cx43 mutants cause palmar plantar hyperkeratosis is somehow
associated to these other skin disease-linked proteins. However, it has previously been
shown that a mutant Cx26 which causes palmar plantar hyperkeratosis can have
transdominant effects on Cx43 (Rouan et al., 2001). Thus, it may also be possible that
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mutant Cx43 causes palmar plantar hyperkeratosis through transdominant effects on
Cx26. It is also reasonable to assume that, since keratins, desmosomes and tight junctions
are all responsible for maintaining the integrity of the epidermal barrier, Cx43 mutants
that disrupt any one of these components may lead to disruptions in the membrane barrier
and contribute to palmar plantar hyperkeratosis. In the present study we examined the
mechanism by which mutations in the gene encoding Cx43 can affect skin differentiation
and how some mutations associated with ODDD, but not others, can lead to skin disease.

4.2 Materials and methods
4.2.1 Cell lines
Rat epidermal keratinocytes (REKs) were originally characterized by Baden and Kubilus
(Baden and Kubilus, 1983) and were grown in REK growth medium composed of
Dulbecco's modified Eagle's medium (DMEM) supplemented with 2 mM L-glutamine,
10% fetal bovine serum, 100 μg/ml streptomycin and 100 U/ml penicillin

4.2.2 Transfection and infection
Transfection of packaging 293 cells was carried out using the previously reported and
characterized AP2 vector encoding full length Cx43 (Cx43-GFP) or the Cx43 mutants,
G21R, G60S, G138R, Δ244 with mutations G58R and S158A (Δ244*) (Simek et al.,
2009) and fs260. In addition, a fs230 mutation was also created using a Qiagen
QuikChange

Site-Directed

Mutagenesis

Kit

with

Forward

5’-

ATCATTGAACTCTTCTGTTTTCTTCAAGGGCGTTAAGGATCGGG and Reverse
5’-CCCGATCCTTAACGCCCTTGAAGAAAACAGAAGAGTTCAATGAT

primers

for human Cx43 pcDNA3.1. Untagged fs230 pcDNA3.1 was used to rule-out effects
caused by the GFP tag. The mutant fs230 sequence was then fused in frame into a EGFPN1 (Clontech Lab., Inc) vector and further incorporated into a AP2 vector using the
Forward

5’-ATCTCGACATGGGTGACTGGAGCGC

and

Reverse

5’-

GGTGGATCCGGACGCCCTTGAAGAA primers. The fs230-GFP mutant construct
encodes the first 229 amino acids of Cx43, six amino acids resulting from the frame shift
(CFLEGR), seven amino acid linkers (PDPPLAT) and the EGFP protein sequence.
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To perform transfections of packaging 293 cells, 2.5 mL of Opti-MEM was placed into
two separate 5 mL tubes. 10 µg of the AP2 vector was placed into one tube while 15 uL
of lipofectamine 2000 was added to the second tube. Within 5 minutes, both tubes were
combined and were incubated for 20 mins. Packaging cells in a 100 mm culture dish were
then washed two times in Opti-Mem medium and the combined lipofectamine/AP2
vector solution was administered onto the growing packaging 293 cells. After six hours,
the lipofectamine solution was aspirated and the packaging cells were grown overnight in
low glucose DMEM supplemented with 10% FBS, 10 µg/mL tetracycline, 20 µg/mL
G418. The next day, 5 mL of fresh REK growth media was placed onto the transfected
packaging cells and viral collections were made every day for four days. Collected viral
media was concentrated by centrifugation in sealed 5.1 mL tubes for 90 mins in a
Beckman TL100 ultracentrifuge at 4oC at 25,000 rpm (Beckman Instruments, Palo Alto,
CA). After centrifugation, the viral pellet was resuspended in 0.5 mL of REK growth
media and stored at -80oC.
REKs were grown to 20% confluence and the viron containing supernatant was exposed
to the cells overnight and 5 g/ml of polybrene was also added to the media. The next
day, fresh media was placed onto each REK infected cell line and these cell lines were
passed five times before being visualized under a confocal microscope. Each REK cell
line was successfully transduced with 95-100% of all cells expressing the Cx43 mutants.

4.2.3 Antibodies and imaging
Immunofluorescence was performed by incubating the cells overnight with an anti-Cterminal Cx43 antibody (P4G9; from the Fred Hutchinson Cancer Research Center
Antibody Development Group, Seattle, WA) at a dilution of 1:200; an anti-GP130
antibody (to denote the Golgi apparatus) (GP130, Stressgen, Ann Arbor, MI) at a dilution
of 1:250; an anti-PDI antibody (to denote the endoplasmic reticulum) (Stressgen, Ann
Arbor, MI) at a dilution of 1:500; and an anti-E-cadherin (Zymed (Invitrogen), 18-0223,
Carlsbad, CA), anti-claudin-1 (Zymed (Invitrogen), 71-7800, Carlsbad, CA) and antioccludin (Zymed (Invitrogen), 71-1500, Carlsbad, CA) to view proteins involved in tight
junction and cadherin based adhesion at a dilution of 1:250. For secondary antibody
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labeling, anti-mouse Alexa 555 (Invitrogen, A21425, 1:500), or anti-rabbit Alexa 555
(Invitrogen, A21429, 1:500) antibodies were used. DAPI staining was also performed to
visualize nuclei and immunolocalization imaging was performed using a Zeiss 510
META confocal microscope (Zeiss, Toronto, ON). Endogenous Cx43 plaques were
labeled with the P4G9 anti-Cx43 antibody and immunofluorescent images of equal cell
culture area were acquired from both the vector control and the fs230 expressing REKs.
An experimenter blinded to the identity of each cell line was asked to count the number
of punctate structures present at sites of cell-cell apposition in each image. A gap junction
plaque was defined as a punctate immunolabeled structure of a size greater than 0.1 m.
The total number of nuclei (as revealed by DAPI staining) was also counted and the
number of punctate structures was divided by the total number of nuclei per image to get
the average number of gap junction plaques per cell.
Primary antibodies for Western blot analysis were used as follows: C-terminal Cx43
(Sigma, 1:5000), N-terminal Cx43 (from the Fred Hutchinson Cancer Research Center
Antibody Development Group, Seattle, WA; dilution of

1:500), p368 Cx43 (Cell

Signaling Technologies, 3511, 1:1000), E-cadherin (Zymed, 18-0223, 1:1000), occludin
(Zymed, 71-1500, 1:1000), loricrin (Covance, PRB13-145P, 1:1000), Cx26 (Zymed, #710500, 1:1000), CK14 (Neomarkers MS-115-P, 1:1000), claudin-1 (Zymed, 71-7800,
1:1000) and GAPDH (Millipore, MAB374, 1:15,000). Primary antibodies were diluted
in 5% Blotto (Santa Cruz) or 3% bovine serum albumin (for p368 Cx43 antibody) and
nitrocellulose membranes were incubated with each antibody overnight. Depending on
the antibody used, primary antibody detection was performed using mouse or rabbit IgG
IRdye 800 (Rockland Immunochemicals, PA) and mouse or rabbit IgG Alexa 680
(Invitrogen, Burlington, ON) secondary antibodies. Imaging and densitometry was
performed using the Odyssey software packaged with the Odyssey infrared imaging
system (Licor) and data values were graphed using Graphpad Prism v4.0.

4.2.4 Microinjection
REKs were grown to a confluent monolayer and single cells were pressure-microinjected
with 5% Lucifer yellow (Molecular Probes) using an Eppendorf microinjection system
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coupled to a Leica inverted epifluorescent microscope. One minute after microinjection
of Lucifer yellow dye, the incidence of dye transfer was determined where dye transfer to
one or more adjacent cells was deemed positive dye transfer.

4.2.5 Organotypic culture
Culture inserts with a 3.0 µm pore size (BD, Bedford, MA) were coated with a collagen I
substrate by mixing 4.25 mL of type I collagen (BD, Bedford, MA) with 0.5 mL of 10X
HBSS with Phenol Red (Sigma), 50 µL of 1.0M HEPES (Gibco) and 75-100 µL of 1M
NaOH. Collagen was polymerized by incubation at 37oC for two hours. The collagen
layer was then washed with REK growth medium and REKs were plated at a density of
1.5 x 105 per well in the upper chamber and 2 mL of REK growth medium was placed in
the lower chamber. After three days, media from the upper chamber was removed to
expose the confluent REKs to air and to induce differentiation. Cultures were fed daily by
replacing the lower chamber media with 2 mL of fresh REK growth media. After two
weeks under differentiation conditions, REKs were processed for histological and
Western blot analysis.

4.2.6 Histological analysis
Two week organotypic epidermis was fixed with 3.8% formalin for five hours. After five
hours, samples were stored at 4oC in PBS. Tissue processing, embedding, sectioning (5
µm sections) and haemotoxylin & eosin staining was performed as previously described
(Langlois et al., 2010).

4.2.7 Acetone induced injury
Acetone induced injury was performed as previously described (Ajani et al., 2007). After
one week under differentiation conditions, organotypic epidermal cultures were left
untreated or treated with 0.5 mL of 100% acetone for 30 seconds. Acetone was then
washed off and the cultures were placed back in the incubator. Acetone treatment was
repeated following three days of recovery. Four days after the organotypic cultures were
allowed to respond to the acetone insult, they were processed for histological analysis.
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4.2.8 Scrape loaded dye transfer assay
As previously describe in Lai et al (Lai et al., 2006), monolayer cultures of REKs were
washed once with Hanks Balanced Salt Solution (HBSS) and a scrape was made down
the center of each culture plate using a 1 mL pipette tip. Wells were washed once with
HBSS and 1.5 mg/mL sulforhodamine B diluted in HBSS was added to the scraped
monolayer. After ten min on ice, cultures were rinsed with PBS and evaluated under a
fluorescence microscope. As a control, 2 mg/mL rhodamine-dextran, which cannot pass
though gap junctions, was used in a separate set of wells to control for fluorescence
uptake due to cell death. Since the specific fluorescence generated from GFP-tagged
Cx43 and mutant variants was high, this prevented the use a dye which fluoresces with
the same emission as GFP. The area of fluorescence in both groups were outlined and
calculated using ImageJ and the area of dye transfer in the rhodamine-dextran group was
subtracted from the area of dye transfer in the sulforhodamine group and graphed.

4.2.9 Transepithelial resistance
Transepithelial resistance measurements were taken as previously reported (Langlois et
al., 2007). Briefly, 1.5 X 104 REKs were seeded on a 3.0 µm pore transwell insert (BD,
Bedford, MA). After 24 hr a Millicel-ERS voltmeter (Millipore) was used to measure
resistance in ohms. Measurements were taken for five consecutive days and the
measurements from days 2-4 were averaged and graphed.

4.2.10

Statistics

All statistical tests were performed and graphed using GraphPad Prism 4.0 software.
Given the multiple variability factors, assay comparisons between full length Cx43
expressing REKs and each individual mutant REK cell line created were performed using
a t-test with a statistical cut off at p<0.05.
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4.3 Results
4.3.1 Localization and functional characterization of REKs expressing
mutant Cx43
Rat epidermal keratinocytes (REKs) were engineered to express Cx43 or Cx43 mutants
associated with ODDD to determine how only a subset of Cx43 mutants can cause skin
disease. Two frame-shift mutants that have been reported to cause ODDD and palmar
plantar hyperkeratosis (fs230, and fs260) (van Steensel et al., 2005; Vreeburg et al.,
2007) and one previously characterized Cx43 trafficking mutant was included in the
study (Simek et al., 2009). In addition, a mouse G60S mutant (Flenniken et al., 2005) that
results in a phenotype mimicking the ODDD condition, and further represents a mutation
in the 1st extracellular loop region of Cx43, was also included. The missense human
G21R and G138R mutants were selected since these mutants represent amino acid
changes in Cx43 motifs within the N-terminal tail and cytoplasmic loop domain,
respectively. Finally, controls included a REK cell line that expressed the empty viral
vector as well as an REK cell line that expressed full length Cx43. To assist in Cx43
localization, all Cx43 variants were tagged with GFP at the C-terminal which has been
shown to have minor effects on Cx43 distribution and function (Laird et al., 2001).
Localization of the Cx43 variants when expressed in REKs revealed that almost all cells
were in fact expressing the Cx43 variants (Fig. 4.1). Similar to the full-length Cx43 and
endogenous Cx43, the G21R and G138R mutants exhibited a cell surface distribution
with abundant gap junction plaques. The G60S mutant, on the other hand, revealed few
plaques with the bulk of the mutant retained within intracellular compartments. Both the
∆244* and fs230 mutants exhibited an ER-like phenotype with little to no evidence of
gap junction plaques. Finally, the fs260 mutant was predominantly expressed in the
perinuclear region which we have previously shown to be localized within the
endoplasmic reticulum and the Golgi apparatus (Gong et al., 2006). To determine which
subcellular organelle retained the fs230 mutant, fs230 expressing REKs were
immunolabeled for the endoplasmic reticulum resident

protein, protein disulphide

isomerase (PDI), and the resident Golgi protein, gp130 (Fig. 4.2A). Only a small fraction
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Figure 4.1 Cx43 mutants display different localization profiles in rat epidermal
keratinocytes.
REKs were engineered by retroviral infection to stably express GFP-tagged full length
(Cx43), two ODDD mutants that cause skin disease (fs230 and fs260), a C-terminal
truncation with two additional mutations (∆244*), as well as three ODDD-linked mutants
not associated with skin disease (G21R, G60S and G138R). Full length Cx43, as well as
G21R, and G138R mutants, traffic to the plasma membrane and display large gap
junctions while G60S, ∆244*, fs230 and fs260 mutant expression is largely confined to
intracellular compartments. Endogenous Cx43 was detected by immunolabeling (red) and
nuclei were labeled with DAPI (blue). Bar = 10 µm.
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Figure 4.2 The fs230 mutant is predominantly localized within the endoplasmic
reticulum and reduces the number of endogenous gap junctions and the extent of
GJIC.
A. fs230 expressing REKs were labeled with antibodies specific for protein disulfide
isomerase (PDI; ER resident protein) or gp130 (Golgi marker). The bulk of fs230
colocalized primarily with PDI. B. Both vector control and fs230 expressing REKs were
immunolabeled with a C-terminal specific anti-Cx43 antibody that detected only
endogenous Cx43. C. fs230 expressing REKs exhibited a 34% decrease in endogenous
Cx43 plaques formation when compared to vector control REKs. D. Lucifer yellow dye
was microinjected into both vector control and fs230 expressing REKs. All vector control
REKs passed Lucifer yellow dye while only 33% of fs230 expressing REKs passed dye
to neighboring cells. *p<0.05. Nuclei were stained with DAPI (blue). Bar = 10 µm.
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of the fs230 mutant was localized to the Golgi apparatus while a large population of the
mutant was retained within the endoplasmic reticulum. Since the majority of the ODDD
mutants examined thus far have been found to be dominant negative to endogenous Cx43
(McLachlan et al., 2005), the frequency of endogenous Cx43 gap junction plaques were
assessed after labeling with an antibody directed to C-terminal domain of Cx43 that is
lacking in the fs230 mutant variant. Compared to cells expressing an empty vector, the
number of detectable endogenous Cx43 gap junction plaques was reduced when the fs230
mutant was expressed (Fig. 4.2B, C). To determine if the fs230 mutant expressing REKs
could functionally pass Lucifer yellow dye to their neighboring cell, Lucifer yellow dye
was injected into REKs expressing the empty vector or the fs230 mutant (Fig. 4.2D).
Incidence of dye transfer revealed that 33% of the fs230 mutant expressing REKs and
100% of vector control REKs passed dye. This result suggests that the over-expressed
fs230 mutant is also dominant-negative to the endogenous Cx43 protein.
To further evaluate the gap junction functional status of each REK cell line created, a dye
transfer assay was performed on a wounded monolayer (Fig. 4.3). Scraped monolayers
were either treated with a small dye (sulforhodamine B) which can pass through gap
junctions (Fig. 4.3A) or, as a negative control, a large dye (rhodamine dextran) which
cannot spread from one cell to another via gap junctions. In each ODDD mutant Cx43
expressing cell line, with the exception of the ∆244* expressing REKs, there was a
significant decrease in the area of dye spread when compared to REKs expressing the full
length Cx43 (Fig. 4.3B). These results suggest that all mutants (except ∆244*) have the
capacity to inhibit the function of endogenous Cx43 consistent with previous reports
(Gong et al., 2007; Langlois et al., 2007; McLachlan et al., 2005).

4.3.2 Organotypic epidermal differentiation is affected by REKs
expressing mutant Cx43
Given that the G21R, G60S, G138R, fs230, and fs260 mutants inhibit overall gap
junction coupling in REKs, we sought to determine if this reduced cell coupling state
could affect epidermal differentiation (Fig. 4.4). Surprisingly, all REK cell lines possess
the ability to differentiate and establish multiple cellular layers (Fig. 4.4A). A basal layer,
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Figure 4.3 Cx43 mutants reduce dye transfer in REKs.
A. To assess the ability of REKs to transfer dye to neighboring cells, a scrape assay was
performed using a gap junction permeable dye, sulforhodamine. B. With the exception of
∆244*, there was a significant reduction in dye spread in mutant expressing REKs
compared to Cx43 over expressing REKs. v = empty vector. *p<0.05. Bar = 100 µm.
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Figure 4.4 Cx43 mutant expressing REKs differentiate into organotypic epidermis.
REKs were plated onto collagen type I coated well inserts and media from the upper
chamber was removed to allow REKs to differentiate and stratify. After two weeks of
organotypic differentiation, all mutant expressing Cx43 REK cell lines differentiated. To
determine the extent of organotypic differentiation, histological sections of each
organotypic culture were stained with haematoxylin and eosin, imaged, and the upper
stratum corneum and lower vital layer thicknesses were measured. When comparing the
stratum corneum height to total epidermal height, there was a significant decrease found
in the G21R, G60S, G138R, and fs260 expressing cultures when compared to
organotypic cultures derived from Cx43 expressing REKs. In addition, parakeratosis was
observed in the fs260 expressing cultures (arrows). *p<0.05. Bar = 20 µm.

129

130

stratum spinosum, stratum granulosum and stratum corneum developed suggesting that
epidermal formation can proceed with greatly reduced Cx43 gap junction function. Cx43
expressing REKs predominantly developed a tightly packed stratum corneum while in
other REK cell lines, spaces were observed within the stratum corneum. In addition,
nuclei were often observed in the stratum corneum of fs260 expressing REKs (typically
called parakeratosis). The differentiation state was also analyzed by measuring the total
organotypic architecture and stratum corneum layer thicknesses (corrected for the spaces
in the stratum corneum) (Fig. 4.4). The stratum corneum thickness compared to the entire
construct thickness was graphed and revealed that the G21R, G60S, G138R and fs260
organotypic epidermal cultures all developed a slightly thinner stratum corneum. This
suggests that the expression of these ODDD-linked mutants in keratinocytes inhibits the
formation of the stratum corneum.

4.3.3 Mutant Cx43 expression reduced the levels of phosphorylated
Cx43, Cx26 and loricrin
Since endogenous Cx43 is co-expressed with the Cx43 variants during the differentiation
process, the endogenous Cx43 content was examined in organotypic epidermal cultures
(Fig. 4.5A). Western blots of organotypic epidermal cultures were performed using an
antibody directed to the C-terminus of Cx43 which only detects endogenous Cx43, as
well as an antibody directed to the N-terminus of Cx43 suitable for detecting all of the
GFP-tagged Cx43 variants. As expected, all REK cell lines expressed the exogenous
Cx43 variants to an approximately similar level as ectopic Cx43 with the exception that
the ∆244* mutant was under-expressed and the fs230 mutant was over-expressed
compared to the other mutants

(Fig. 4.5A, B,). It was notable the over-expression of

GFP-tagged Cx43 resulted in an increase in the detectable levels of endogenous Cx43
suggesting that exogenous Cx43 was serving a role in stabilizing the endogenous
population of Cx43 (Fig. 4.5A, B).

Interestingly, the phosphorylated species of

endogenous Cx43 (P-Cx43) was reduced (compared to Cx43 over-expressing cells) when
the ODDD associated Cx43 mutants (G21R, G138R, fs230 and fs260) were co-expressed
(Fig. 4.5B). Moreover, when Cx43 or the ∆244* mutant was over-expressed, there was
an increase in Cx26 levels and this increase was not evident when any other ODDD
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Figure 4.5 Assessment of endogenous and mutant Cx43, Cx26 and loricrin protein
expression in organotypic epidermis.
Western blots were performed on REK cells lines after two weeks of differentiation. A.
Anti-Cx43 N-terminal specific antibody was used to detect GFP-tagged mutant Cx43
variants while an anti-Cx43 C-terminal specific antibody was used to detect endogenous
Cx43 expression. B. The G138R and fs260 expressing REKs had significantly lower total
endogenous Cx43 levels when compared to full length Cx43 REKs. ODDD mutants also
reduced the highly phosphorylated species of endogenous Cx43. Densitometry analysis
of GFP-tagged Cx43 variants also revealed a significant decrease in the expression of the
∆244* mutant while the expression of the fs230 mutant was signficantly elevated.

In

addition, Western blot analysis of Cx26 (C) revealed that all ODDD Cx43 mutants
reduced the levels of Cx26 compared to cells expressing full length Cx43 while loricrin
(D) was only reduced in fs260 expressing REKs. *p<0.05.

132

133

linked mutant was over-expressed (Fig. 4.5C). Of all the mutants tested, only the fs260
mutant reduced the P0 state of endogenous Cx43 when compared to ectopic Cx43 and this
mutant was the only one to significantly inhibit the state of organotypic differentiation as
assessed by a reduction in a key molecular marker of differentiation, loricrin (Fig. 4.5D).

4.3.4 Reduced barrier function in REKs expressing G60S, G138R,
and fs260 Cx43 mutants
Since the epidermal barrier is important for proper epidermal function and Cx43 has been
found to cross-talk with other junctional complexes (Li et al., 2009; Nagasawa et al.,
2006), we assessed if mutant Cx43 expressing REKs can disrupt the transepithelial
resistance (Fig. 4.6). Collectively, REKs which expressed the G60S, G138R and fs260
ODDD-linked mutants exhibited lower transepithelial resistance when compared to
ectopic Cx43 expressing REKs (Fig. 4.6A). However, this reduction in transepithelial
resistance was not due to expression level (Fig. 4.6C, D) or subcellular localization
changes in occludin or claudin-1 or change in the cell adhesion protein, E-cadherin (Fig.
4.6B). In addition, reduced transepithelial resistance was not due to differences in cell
death as revealed through the use of the multitox cell death assay (data not shown).

4.3.5 Organotypic epidermis expressing fs260 increased the vital
layer thickness after acetone induced injury
We showed that organotypic cultures expressing the fs260 mutant developed a thinner
stratum corneum thickness and exhibited parakeratosis. In addition, REKs expressing the
fs260 mutant lowered the endogenous expression of Cx43, Cx26, loricrin and lowered the
transepithelial resistance. Given these changes, REKs expressing this mutant may
develop an aberrant epidermal barrier. To determine if the expression of mutant Cx43 in
organotypic cultures can affect the epidermal cultures response to injury, an acetone
induced injury and recovery assay was performed (Fig. 4.7). The stratum corneum in the
full length Cx43 expressing REKs remained compact after acetone treatment while nuclei
were enriched in the stratum corneum of fs260 expressing organotypic cultures (Fig.
4.7A). Since acetone treatment has been shown to induce a proliferative response
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Figure 4.6 Cx43 mutant expressing REKs exhibited reduced transepithelial
resistance
Cx43 mutant expressing REKs exhibited reduced transepithelial resistance when
compared to Cx43 over expressing REKs in the absence of changes in the expression or
localization of junctional proteins. A. Transepithelial resistance measurements of
confluent monolayer cultures were taken daily for five days and the resistance from days
2-4 were averaged and graphed. B. E-cadherin, claudin1 and occludin were localized by
immunofluorescent labeling in REKs over expressing GFP-tagged Cx43, G138R or
fs260. Western blot analysis did not reveal any changes in the expression of occludin, Ecadherin, or claudin-1 (C and D). *p<0.05.
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Figure 4.7 Acetone treatment increased the vital layer thickness in fs260 expressing
organotypic cultures
A. Organotypic cultures of REKs expressing endogenous Cx43 or over expressing Cx43
or Cx43 mutants were left untreated or treated with acetone. Note that in fs260
expressing REK epidermis there were nuclei present in the stratum corneum (arrows). B.
Vital layer measurements of all REK cell lines either untreated or treated with acetone
revealed a significant increase in the vital layer thickness in both the vector and fs260
expressing REKs when compared to full length Cx43 expressing organotypic cultures. B.
*p<0.05. Bar = 10 µm.
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(Ajani et al., 2007), vital layer thickness measurements were graphed between untreated
and acetone treated organotypic epidermal cultures (Fig. 4.7B). While no differences
were observed in the vital layer thickness in full length Cx43 expressing cultures, the
fs260 expressing cultures formed a significantly larger vital layer thickness after
treatment with acetone.

4.4 Discussion
4.4.1 Understanding skin disease in ODDD patients
Mutations in the gene encoding Cx43 have been conclusively linked to ODDD. Although
there are currently 62 mutations that have been reported to cause ODDD (Paznekas et al.,
2009), only the fs230 and fs260 Cx43 mutants have been reported to result in an
additional skin disease phenotype (van Steensel et al., 2005; Vreeburg et al., 2007). In the
case of the fs230 mutant, this is not always the case as a recent patient harboring this
mutant exhibited no evidence of skin disease (Alao et al., 2010). The skin disease
associated with these two mutants has been classified as palmar planter hyperkeratosis
and the molecular etiology by which Cx43 mutations can cause skin disease remains
unknown. To determine how select mutants can cause skin disease, various Cx43
constructs were expressed in REKs and assessed for their cellular localization, functional
status, organotypic differentiation potential, transepithelial resistance, effect on
endogenously expressed connexins, and finally response to chemical injury. In all assays
performed, only the fs260 mutant expressing REKs consistently exhibit epidermal defects
and we propose that the additive effects of these defects ultimately lead to palmar plantar
hyperkeratosis.

4.4.2 Subcellular localization may reflect the disease burden of
ODDD mutants
The fs230 and fs260 mutants are similar in that they result in C-terminal tail truncations
but they differ dramatically in the extra non-connexin amino acid length. The fs230
mutant only has 6 extra amino acids (Vreeburg et al., 2007) while the fs260 mutant
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possesses an additional 46 amino acids (van Steensel et al., 2005). While both of these
mutants have been shown to be linked to palmar plantar hyperkeratosis, the fs230 mutant
does not consistently cause this skin disease in all patients (Alao et al., 2010), which may
be mechanistically linked to their primary subcellular residence. Immunofluorescent
localization studies revealed that the fs230 mutant primarily resides in the endoplasmic
reticulum. While the fs260 mutant is also found in the endoplasmic reticulum when it is
expressed in REKs (Gong et al., 2006), a significant population escapes this
compartments and reaches the Golgi apparatus (Gong et al., 2006). The importance of
this finding is rooted in the fact that Cx43 oligomerization does not occur in the
endoplasmic reticulum, possible though its interaction with ERp19 (Das et al., 2009),
with final oligomerization being delayed until the Golgi apparatus (Musil and
Goodenough, 1993). Thus, the bolus of the fs260 mutant in the Golgi apparatus would
have an increased opportunity to oligomerize and inactivate co-expressed wild-type Cx43
by both preventing further transport to the cell surface and inhibiting channel function. Of
all the frame-shift and missense Cx43 mutants examined to date, this characteristic of
accumulating in the Golgi apparatus is unique to fs260. Thus, our results suggest that the
fs230 mutant is not as potent in causing skin disease and this etiology may not manifest
in all patients harboring this mutation as seems to be the case.

4.4.3 fs260 expressing REKs develop epidermal defects not
observed by other ODDD mutants
A major advantage in using the REK cell line is the ability to model epidermal
differentiation in culture. Surprisingly, all cell lines examined retain the ability to
differentiate and form epidermal layers as found in thin skin. It was observed that the full
length Cx43 expressing REKs did however form a very compact stratum corneum. Since
proper calcium signalling in the upper stratum granulosum has been shown to facilitate
the release of keratohyalin granules, cleave stratum corneum precursor proteins
(profillagrin) and activate transglutaminases to crosslink proteins of the stratum corneum
(loricrin) (Kimyai-Asadi et al., 2002), over-expression of functional Cx43 may enhance
calcium signalling and facilitate the formation of this phenotype.

Morphological

evaluation of the organotypic epidermal cultures revealed that the stratum corneum layer
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thickness was largest in the REK cell lines which expressed Cx43 variants (Cx43 and
∆244*) that both maintained their dye transfer ability and the expression of the most
phosphorylated Cx43 species.

Since cells expressing both the Cx43 and ∆244*

constructs developed a larger stratum corneum, we suggest that functional Cx43 levels
can enhance the differentiation state of the epidermis. This is also supported by evidence
that Cx43 is enhanced during restratification of the epidermis during development and
after wound healing (Choudhry et al., 1997; Goliger and Paul, 1994; Kretz et al., 2003;
Richards et al., 2004).
Given that a feature of hyperkeratosis is an enlarged stratum corneum, the observed
decrease in the stratum corneum thickness in the fs260 expressing organotypic cultures
was not expected. Since palmar plantar hyperkeratosis is only seen in a thick skin
environment, our organotypic epidermal cultures may model a thin skin environment and
not fully mimic the disease state found in thick skin. In addition, the relatively short
time period used to establish organotypic epidermal cultures may only assess how mutant
Cx43 affects the development of the epidermis and not represent the resulting steady state
and maintenance after differentiation. Over time, keratinocytes expressing ODDD
associated mutants may undergo unnecessary proliferative and regenerative events to
result in an enlarged stratum corneum. The fs260 expressing organotypic epidermal
cultures did however reveal nuclei present in the stratum corneum. This feature is
however often observed in hyperkeratosis (Chopra et al., 1997) and suggests that the
fs260 expressing keratinocytes may have a higher propensity to develop hyperkeratosis in
vivo.

4.4.4 Cx26 cross-talk with Cx43 mutants
To biochemically assess the differentiation state of these organotypic cultures, Cx26,
loricrin, and CK14 were evaluated using Western blot analysis. Cx26 is normally
expressed in the stratum granulosum layer under terminal differentiation conditions and
this expression was found to be lower in the ODDD mutant Cx43 expressing organotypic
cultures as compared to REKs over-expressing full length Cx43. Mutant Cx26 has
previously been shown to be transdominant to Cx43 (Rouan et al., 2001) and thus mutant
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Cx43 may also be transdominant to Cx26. Since Cx26 mutants are strongly correlated
with skin disease (hyperkeratosis) (Iossa et al., 2009; Maestrini et al., 1999; Uyguner et
al., 2002), Cx43 mutants which reduce Cx26 levels may also contribute mechanistically
to any resulting skin disease phenotype and also wound repair (Goliger and Paul, 1995).

4.4.5 Decreased levels of Cx43 may lead to epidermal barrier defects
Truncation of the C-terminal tail of Cx43 has previously been shown to disrupt the
epidermal barrier in mice (Maass et al., 2004). To determine if the epidermal barrier
function could also be affected in REKs expressing mutant Cx43, transepithelial
resistance measurements and an acetone induced injury assay was performed on
organotypic cultures derived from each REK cell line created. Although transepithelial
resistance measurements assess the paracellular barrier formed by tight junctions,
nevertheless, the introduction of Cx43 mutants lowered the transepithelial resistance
values but had no effect on the levels or localization of claudin-1 or occludin, suggesting
that the cross-talk between the gap junction status and tight junctions may be at the level
of junction assembly and not at gene expression (de Carvalho et al., 2006). Given that the
G60S, G138R, and fs260 mutants all moderately reduce transepithelial resistance, palmar
plantar hyperkeratosis cannot be rooted solely to this finding. The fs260 mutant however
did cause the greatest decrease in transepithelial resistance and since this mutant reduces
the levels of phosphorylated Cx43 which is typically reflective of assembled gap
junctions, other junctional complexes may be disrupted leaving the epidermis more prone
to dysregulation when placed under stress. This in turn may lead to a proliferative
response, an increase in epidermal thickness, and hyperkeratosis. Topical application of
retinoic acid has been used to treat hyperkeratosis (Braun-Falco, 2009) and retinoic acid
treatment has been shown to up regulate Cx43 expression (Guo et al., 1992; MasgrauPeya et al., 1997). Thus, the up regulation of Cx43 may promote and stabilize the
formation of junctional complexes and further maintain keratinocytes in a nonproliferative state.
To further determine if keratinocytes expressing mutant Cx43 have a normal epidermal
barrier, acetone was administered to organotypic cultures and histological analysis was
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performed after one week of injury. Acetone treatment has previously been shown to
induce a proliferative response in organotypic cultures (Ajani et al., 2007). Organotypic
cultures expressing full length Cx43 formed a compact epidermal barrier and no increase
in the vital layer was seen as found in cultures that lacked Cx43 over expression.
However, a significant increase in vital layer thickness was observed in fs260 expressing
organotypic cultures. Collectively, these results suggest that Cx43, as well as most of the
mutant variants of Cx43 but not fs260, can protect against acetone-induced injury.
While all mutations in the gene encoding Cx43 lead to ODDD, some mutations are
clearly more potent leading to skin abnormalities. Typically, domain-specific Cx43
mutants all cause one or more measureable defects in processes related to epidermal
differentiation. However, the fs260 mutant consistently caused quantifiable defects in
REKs. In particular, organotypic cultures grown from cells expressing the fs260 mutant
developed a thinner stratum corneum with nuclei often present and an enlarged vital layer
when exposed to acetone.

We proposed that the additive effects of these changes

ultimately cause the skin disease phenotype observed in ODDD patients that express this
mutant. Thus our findings demonstrate how one Cx43 mutant can cause increased disease
burden over and above that caused by other Cx43 mutants.
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Chapter 5

5

The G60S Connexin43 Mutant Regulates Hair Growth
and Hair Fiber Morphology in a Mouse Model of Human
Oculodentodigital Dysplasia

Hair development relies on the proper signaling between modified epithelial
keratinocytes and dermal fibroblasts (reviewed in Botchkarev and Paus, 2003). Since
fibroblasts derived from ODDD patients and organotypic epidermal cultures expressing
ODDD mutants displayed defects in their ability to differentiate, in vivo development and
differentiation of the hair follicle may also be impaired by the expression of mutant
Cx43. In addition, since ODDD patients have often been cited as developing hair defects,
mutant Cx43 expression in the hair follicle is hypothesized to affect hair follicle structure,
growth, and regeneration. This chapter evaluates the ability of mutant Cx43 to impair hair
follicle structure, growth, and regeneration by using the G60S mouse model of ODDD
and by studying hair samples derived from ODDD patients.

A version of this chapter is in press:
Churko, J.M., Chan, J., Pan, X., Shao, Q., Laird., D.W. Mice Expressing the G60S Mutant Cx43
Develop Similar Hair Abnormalities Commonly Presented by Oculodentodigital Dysplasia
Patients (Journal of Investigative Dermatology, in press)
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5.1 Introduction
A gap junction channel is composed of two connexin hexamers which allow direct
intercellular communication between two contacting cells. These channels proceed to
cluster into tightly packed arrays known as gap junctions. Connexin43 (Cx43) has been
implicated in a wide variety of physiological events that include the synchronous beating
of the heart (Jalife et al., 1999), bone development (Civitelli, 2008), and epidermal
differentiation (Churko et al., 2010; Langlois et al., 2007). However, our current
knowledge on the role of Cx43 in hair follicle differentiation and hair growth is limited.
In the skin, Cx43 is reported to be expressed in keratinocytes, dermal fibroblasts, the
arrector pili muscle, sweat glands, sebaceous glands, and the hair follicle (Choudhry et
al., 1997). In addition, Cx43 has also been reported to be expressed in the inner and outer
root sheath, the dermal papilla, and the proliferating matrix in the rat hair follicle (Risek
et al., 1992). While the expression of Cx43 within each histological distinct cellular layer
of the hair follicle has been reported, to our knowledge, there are no studies that examine
how Cx43 is linked to hair growth, the structure of the hair fiber or hair regeneration. In
the present study we assess these physiological events in a mouse model of a Cx43-linked
disease.
Oculodentodigital dysplasia (ODDD) is a disease associated with mutations in the gene
that encodes Cx43. The majority of ODDD patients develop craniofacial defects, teeth
abnormalities and syndactyly of the digits (Paznekas et al., 2003). In addition to these
common developmental defects, poor hair growth or hair abnormalities is observed in
approximately 25% of these patients (Paznekas et al., 2009). These same patients are also
often reported to have hair that is dry, dull, thin, curly and sparse (Gorlin et al., 1963;
Kelly et al., 2006; Kjaer et al., 2004; Paznekas et al., 2009; Sugar et al., 1966; Thoden et
al., 1977). Hair fiber abnormalities were reported as early as 1977 in an ODDD patient
who developed monilethrix and pili annuli changes in their hair fibers (Thoden et al.,
1977). In addition, hair fibers from a patient expressing the L11P mutant were recently
reported to develop a nodule/beaded appearance along the hair shaft (Kelly et al., 2006).
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Given that a sub-populations of ODDD patients develop these hair abnormalities, Cx43 is
proposed be involved in the differentiation and growth of hair.
Several mutant mouse lines (G60S, I130T and G138R) have now been established that
mimic ODDD (Dobrowolski et al., 2008; Flenniken et al., 2005; Kalcheva et al., 2007).
To date, the only reported hair defect in these mouse models are seen in the G138R
mouse where ~30% of the mutant mice are born with sparse hair and this phenotype
becomes more apparent in adulthood (Dobrowolski et al., 2008). However, it is not
known whether any of these mouse models of ODDD also mimic other hair abnormalities
present in ODDD patients. This study is the first to use a mutant mouse model as well as
hair samples obtained from ODDD patients to examine the role of Cx43 in hair
development, growth, and structure.

5.2 Materials and methods
5.2.1 Skin tissue collection
All animal experiments were approved by the Animal Use Subcommittee of the
University Council on Animal Care at the University of Western Ontario. The G60S mice
were developed by Dr. Janet Rossant at the Centre for Modeling Human Disease
(University of Toronto, ON) (Flenniken et al., 2005). Dorsal neck and back skin samples
from 5 WT and 5 G60S six- to eight-week old male mice from either untreated or
epilation treated mice were dissected and placed in fixative solution of 4% formalin for 4
hours before being transferred into phosphate buffered saline (PBS). Paraffin embedded
samples were cross sectioned at 5 μm thickness. Tissue sections used to determine the
hair follicle density were subjected to hematoxylin and eosin staining while tissue
sections used to determine the localization of Cx43 were further immunolabeled.

5.2.2 Hematoxylin and eosin staining to determine hair follicle density
Skin sections were deparaffinized in xylene via 3 changes at 3 minute intervals followed
by immersing in a series of ethanol solutions (100%, 100%, 100%, 95%, and 70%) for 3
minutes each. Sections were then stained in hematoxylin (Lerner Laboratories, Pittsburg,
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PA) solution for 5 minutes followed by tap water for 5 minutes after rinsing. Slides were
quickly dipped 8 times in acid ethanol (1% HCl in 70% ethanol) before staining with
eosin (Lerner Laboratories, Pittsburg, PA) solution for 5 min. Slides were then put in
ethanol (95% and 100%) for 3 changes each of 3 minutes followed by xylene for 3
changes of 5 minutes each and mounted using Cytoseal® 60 (Thermo Scientific,
Waltham, MA). Slides were imaged using a Zeiss Axioplan 2IE microscope (Zeiss,
AxioVision 4.7.2 software).

5.2.3 Cx43, phosphorylated histone H3 and cytokeratin 15
immunolabeling
Skin sections from untreated, WT Day 6 post-epilation and G60S Day 9 post-epilation
mice were deparaffinized in xylene and passed through a series of ethanol solutions
(95%, 95%, 70%, 70%, 50%, and 50%) for 2 minutes each. Sections were washed in PBS
before antigen retrieval treatment with aqueous 1.8 mM citric acid and 8.2 mM sodium
citrate solution in boiling water for 10 minutes. Sections were permeabilized with 0.2%
Triton X-100 in PBS for 12 minutes, washed with 0.2% Tween-20 in PBS, and blocked
with 2% BSA (Sigma-Aldrich, St. Louis, MO) in PBS containing 0.2% Triton X-100 for
30 min. Primary antibodies: rabbit anti-Cx43 polyclonal antibody (Sigma-Aldrich, St.
Louis, MO) at a 1:500 dilution, cytokeratin 15 (CK15, Cat# ab17765, clone SPM190,
Abcam, Cambridge, MA) at a 1:4 dilution or phospho-histone H3 (Ser28) antibody (Cat#
9713, Cell Signaling, Danvers, MA) at a 1:400 dilution in blocking buffer were incubated
for 1 hour at room temperature. Alexa Fluor 555 (Invitrogen, Carlsbad, CA) goat antirabbit secondary antibody or Alexa Fluor 488 (Invitrogen, Carlsbad, CA) goat anti-mouse
secondary was used at a dilution of 1:250 in blocking buffer for 1 hour. Nuclei were
stained with DAPI dye (1:1000; Molecular Probes, Eugene, OR) for 5 min. Before
mounting with Airvol (Air-products and Chemicals, Allentown, PA), sections were
washed 1X with PBS for 3 minutes and 1X with water. To quantify phospho-histone H3
positive cells, 150 WT and 178 G60S mouse hair follicles were imaged from mouse skin
six and nine days after epilation occurred. DAPI labeled nuclei and phospho-histone H3
labeled nuclei surrounding the dermal papilla were counted and the percent of phosphohistone H3 labeled nuclei were graphed.
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5.2.4 Hair growth experiment
Four male WT and four male G60S six- to eight-week old mice (littermate grouping)
were used to determine the hair growth rate. Mice were first anaesthetized using 5%
isoflurane in combination with oxygen before the dorsal hair was shaved using electric
clippers (Oster Golden A5 2-speed universal motor clipper). Initial shaving was
performed to prepare the skin surface for either epilation or depilation treatments. For
epilation treatment (complete removal of hair fiber and bulb), approximately 1-square
inch of a NAIR® wax strips was used to remove the hair fiber and bulb. In a separate set
of mice, the bulb region was kept intact and the visible hair fiber was removed using a
NAIR® Hair Removal Cream containing calcium thioglycolate (depilation treatment).
Hair length measurements were performed by plucking an average of 35 hairs from the
post-treated (Day 12, 15, 18) regions following initial epilation or depilation treatment
(Day 0). Hair fibers were mounted on slides using glycerol/water (4:1 v/v) solution. Hair
fiber lengths were measured by first taking photographs using a Zeiss Axioplan 2IE
microscope with camera (Zeiss AxioVision 4.7.2 software) and then using computer
software (ImageJ 1.42) to manually determine lengths of individual hair fibers.

5.2.5 Analysis of coat hair
Adult dorsal hair was plucked using tweezers from the lateral non-treated region of adult
mice coat hair (8 to 11 week old male mice). For adult hair length and diameter
measurements, hair fibers were mounted using glycerol/water (4:1 v/v) solution. For finer
analysis of hair under higher magnification, hair fibers were mounted using Cytoseal® 60
(Thermo Scientific, Waltham, MA). Photographs were taken using a Zeiss Axioplan 2IE
microscope (Zeiss AxioVision 4.7.2 software) and measurements were made manually
using computer software (ImageJ 1.42). Determination of pelage hair subtype of at least
200 hairs per mouse was done visually using light microscope under low magnification
(2X).
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5.2.6 Ultrastructural analysis
To analyze the hair samples from WT and G60S mice, scissors were used to gently cut
the dorsal coat hair fibers. Human hair samples were obtained from ODDD patients with
consent and under a University of Western Ontario approved research ethics protocol.
Three separate hairs from both a mother and a son expressing the G143S mutant along
with a three hairs from a patient expressing the T154A mutant Cx43 were obtained.
Tweezers were then used to transfer the hairs to an aluminum stub coated with a sticky
tape. The proximal region of the hair was handled to ensure handling did not damage the
imaged region of the hair fiber. To analyze the proximal bulb and hair fiber region of WT
and G60S mice, the mice were shaved using electric clippers (Oster Golden A5 2-speed
universal motor clipper) and a Nair wax strip was used to epilate the embedded hair fiber
and bulb. The wax strip was then cut into approximately 7 mm square pieces and placed
onto the aluminum stubs. Stubs were then sputter-coated (Polaron THERMO, SC7620)
with a 5 nm layer of Au/Pd. Hairs were then examined using a Hitachi S3000N scanning
electron microscope (Hitachi Science Systems, Hitachinaka-Shi, Japan) at 15 kV and at a
working distance of 15 mm

5.2.7 Statistical analysis
At least four mice were used per WT or G60S group for all experiments. Statistical
analysis was done using Student's t test or ANOVA test and p<0.05 was considered
significant. All statistics were performed using GraphPad Prism version 4.02 for
Windows (GraphPad Software).

5.3 Results
Since Cx43 was previously reported to be expressed in the skin (Choudhry et al., 1997;
Risek et al., 1992), we sought to determine if Cx43 localization was altered in mice
harboring a mutant form of Cx43. Immunofluorescent localization of Cx43 in skin taken
from the backs of WT mice was consistent with previous reports (Choudhry et al., 1997;
Risek et al., 1992) and Cx43 was also found to be localized to various regions of the hair
follicle. During anagen, high Cx43 expression could be observed in the hair matrix
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(HM), the outer root sheath (ORS) [basale, suprabasal, the companion layer (Cl)], the
inner root sheath (IRS) [Huxle (Hx) and the cuticle (iCu) layer] and low Cx43 levels
were observed in the dermal papilla (DP) and the connective tissue sheath (CTS) (Fig
5.1). Hair follicles were also co-labeled for Cx43 and a bulge stem cell marker
cytokeratin 15 (CK15). Little Cx43 was found to be present in CK15-positive cells (Fig
5.1c). In hair follicles from WT mice, Cx43 localized to punctate plaque-like structures
while the localization of Cx43 within the hair follicles of mutant mice was more diffused
in appearance (Fig. 5.1a, inserts).
To determine if the observed difference in Cx43 localization in mutant mice might
adversely affect the development and differentiation of the hair follicle, we analyzed hair
follicle density, growth rates, and hair fiber structure in both WT and mutant mice.
Visually, there was a decrease in hair density (hypotrichosis) in a subset of mutant mice
(~20%) and this observation was most evident in the neck region of aged mice (Fig.
5.2a). The coat hair from these mice also appeared dull and had a “wooly” appearance.
To empirically determine if mutant mice develop hypotrichosis, tissue sectioning of the
neck and back skin was performed and the number of hair follicles per epidermal length
was analyzed. Quantification of the number of hair follicles of 6-8 week old mice
however, did not reveal any statistically significant differences between WT and mutant
mice in either the neck or back region (Fig. 5.2b).
Since Cx43 is expressed in zig zag, guard, awl, and auchene hair follicle subtypes we
sought to determine if Cx43 mutant expression could selectively impact the development
of different hair subtypes. Within the WT and G60S mice (Fig. 5.3a), we found no
significant differences between the proportion of any hair subtype suggesting that the
Cx43 mutant does not selectively impact the differentiation of different mouse hair
subtypes. When analyzing the different subtypes by light microscopy, hair fibers taken
from the G60S mice revealed slight notching (arrows) as well as some twisted regions
along the hair fiber (Fig. 5.3b). A notable difference in the size of the hair derived from
the mutant mice was also observed. By quantifying both the length and thickness
(diameter) of the most abundant hair subtypes (zigzag and awl), we found a statistically
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Figure 5.1 Cx43 expression in the mouse hair follicle
A. Cx43 immunolabeling revealed that Cx43 is highly expressed in the hair matrix (HM)
while little Cx43 expression was observed in the dermal papilla (DP). Cx43 gap junctions
formed between cells in WT hair follicles while Cx43 was diffusely localized in mutant
mouse follicles (inserts). B. Above the bulb region, Cx43 is expressed in multiple layers
of the hair follicle. Med= medula, Cor= cortex, Cu= cuticle layer of the hair shaft, iCu=
cuticle layer of the inner root sheath, Hx= Huxle layer, He= Henle layer, IRS= inner root
sheath, Cl= companion layer of the outer root sheath (ORS), CTS= connective tissue
sheath. C. Little Cx43 localized with CK15-positive cells in the hair bulge region
(inserts). SG= sebaceous gland, HS= hair shaft. Bars= 20 µm.
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Figure 5.2 A subset of G60S mutant mice have sparse hair in the back and neck
regions but overall hair density in mutant mice remains unchanged from wild type
mice.
A. In approximately 20% of G60S mice, a decrease in hair follicle density could visually
be observed. B. Quantification of the number of hair follicles per field of view after
hematoxylin and eosin staining; however, revealed no significant difference in the adult
hair follicle density of mutant mice. N=5. Bar= 100 µm.
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Figure 5.3 G60S mutant mice have the same frequency of hair subtypes as WT mice
but develop thinner and shorter hair fibers
A. Fifty hairs from both WT (N=4) and G60S (N=4) mice were identified as being either
zigzag (Z), guard (G), awl (Aw), or auchene (Au). There were no significant differences
observed between the proportion of hair subtype between G60S and WT mice. B. Hair
fiber diameter (C) and length (D) measurements were taken from four WT and four G60S
mice (250 hairs measured). Hair fibers derived from G60S mice were significantly
shorter (***p<0.001, N=4) and thinner (***p<0.001, N=4) when compared to WT mice.
Bar= 1 mm in panel A and 100 µm in panels B.
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significant decrease in both the thickness (Fig. 5.3c) and length (Fig. 5.3d) of mutant
mouse hair.
To analyze the ultrastructure of the hair fiber, scanning electron microscopy was
performed on WT and G60S mouse hair fibers (Fig. 5.4). Both the distal (Fig. 5.4a) and
the proximal region (Fig. 5.4b) of the hair fiber was imaged to distinguish between the
hair fiber morphology from newly formed hair (proximal region) to that of hair fibers
which may have undergone greater exposure to environmental stresses (distal region). In
comparing the distal hair fiber region from eight week old WT and G60S mutant mice,
the WT hair fibers contained well-formed scaling with little to no observable cuticle
degradation. However, when analyzing the distal hair fiber from mutant mice, we found
severe cuticle degradation. Some hair fibers even completely lacked this cuticle layer and
the underlying cortical layer could be observed (Fig. 5.4a). To analyze the proximal
region of the hair fiber, the dorsal coat hair was epilated, and the epilated hairs were
analyzed again by scanning electron microscopy (Fig. 5.4b). Normal cuticle scales were
evident in the proximal hair fibers taken from mutant mice but surprisingly, hair fiber
nodule formation was observed (arrows). These nodules were not uniform, irregularly
spaced, and could span 2-5 cuticle scale lengths.
An ultrastructural analysis of scalp hair obtained from ODDD patients harboring the
T154A or G143S mutant was also performed by scanning electron microscopy (Fig.
5.4c). A female ODDD patient expressing the T154A mutant self-reported that her hair
was thick, dry and fast growing while a patient with the G143S Cx43 mutant described
her, and her son’s, hair as curly and thin. Ultrastructural examination revealed no overt
hair fiber abnormalities in a patient expressing the T154A mutant while the hair fibers
from both the mother and son expressing the G143S mutant revealed significant scale
weathering with irregular scale borders (Fig. 5.4c arrows).
Another common condition reported in ~25% of patients with ODDD is that their hair
grows slowly (Paznekas et al., 2009). To determine if G60S mutant mice also mimic the
human ODDD cases of slow growing hair, hair fiber length measurements were
performed on WT and G60S mice hair that was previously epilated or depilated with the
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Figure 5.4 Structural defects are observed in hair fibers from human ODDD
patients and in the G60S mouse.
A. The distal region of the hair fiber from WT and G60S mice was compared by scanning
electron microscopic analysis. Hair fibers from the G60S mice revealed significant
weathering in the cuticle layer. B. The proximal region of the hair fiber was also
evaluated under low and high magnification by scanning electron microscopy to reveal
nodules along many hair fibers (arrows). C. Cuticle weathering was also observed in
patients expressing the G143S mutant. Scanning electron microscopic examination of the
T154A hair fibers did not reveal any significant structural abnormalities. However, hair
from two patients (parent and sibling) expressing the G143S mutant revealed cuticle
weathering.
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application of calcium thioglycolate (Nair cream) (Fig. 5.5). Images of hair regrowth
were evaluated on the day of treatment (Day 0) and Day 6, 9, 12, 15, and 18 after
epilation (Fig. 5.5a). Hair length measurements after epilation (Fig. 5.5b) and depilation
(Fig. 5.5c) revealed that hair fibers plucked from the G60S mice were consistently
shorter than hair fibers plucked from the WT mice. In addition, after epilation treatment,
the WT mice hair re-grew uniformly while hair growth from the backs of mutant mice
was not synchronized (Fig. 5.5d). The largest delay in re-growth was determined to be
within the neck (cranial) region of these mice.
Since G60S mutant mouse hair fibers grew slower than WT hair fibers, we investigated if
the mitotic output was lower in hair follicles from mutant mice. WT and G60S mouse
anagen hair follicles from skin regions previously epilated (day 6 and day 9 after
epilation) were labeled with the M-phase specific marker phosphorylated-histone H3 and
the percentage of the phosphorylated-histone H3-positive nuclei in the hair matrix was
quantified (Fig. 5.5e).

In WT mouse hair follicles, there were significantly more

phosphorylated-H3-positive nuclei when compared to hair follicles form G60S mutant
mice. In addition, there was significantly more cells (nuclei) in the WT mouse hair matrix
(p<0.05, average nuclei ± SEM: WT= 106 ± 02.8, G60S= 86 ± 2.1, N=5, n=328 follicles
analyzed) while no differences were observed in the amount of dermal papilla nuclei
(average nuclei ± SEM: WT=10.15 ± 0.45, G60S= 10.07 ± 0.35, N=5, n=328 follicles
analyzed).

5.4 Discussion
Cx43 is the most widely expressed connexin within the human body and it has been
reported to regulate many developmental processes (Elias and Kriegstein, 2008; Hatler et
al., 2009; Nagata et al., 2009; Toth et al., 2010). Cx43 is expressed in the follicular and
interfollicular epidermis however; the various roles that Cx43 may play in regulating
these compartments have not been characterized. Given that the expression of mutant
Cx43 in some patients leads to structural hair fiber abnormalities (Adamski et al., 1994;
Kelly et al., 2006; Thoden et al., 1977) and slow growing, thin, dry and dull hair (Gorlin
et al., 1963; Kjaer et al., 2004; Paznekas et al., 2009; Sugar et al., 1966), we postulated
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Figure 5.5 Hair regrowth is delayed in G60S mice.
A. The backs from WT and G60S mice were imaged at Day 0, 6, 9, 12, 15, and 18 after
epilation. Regrowth of hair was quantified by measuring the length of plucked hairs Day
12, 15, and 18 after epilation (B, *p<0.05, N=4) or depilation (C, *p<0.05, N=5). D.
Asynchronous regrowth was observed in the neck region (cranial region) of G60S mice
after epilation when compared to WT littermates. After both treatments, hair regrowth in
mutant mice was delayed by approximately three days. E. Assessment of cell
proliferation revealed that G60S hair follicles had significantly less phospho-histone H3positive (Phos-H3+) cells in the hair matrix. (*p<0.05, N=5). Bars= 50 µm.
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that Cx43 may play a key role in hair development and growth. In this study, we found
that Cx43 in mutant mice has a distinct Cx43 localization profile within the hair follicle,
displays hair fiber structural abnormalities and grows slower. While the G60S mutant has
not been reported in the human population (Paznekas et al., 2009), these mice display
many similar hair defects also associated with ODDD patients. In addition, ultrastructural
analysis of hair fibers from ODDD patients expressing the G143S mutant, but not the
T154A mutant, also displayed cuticle degradation.
Cx43 was localized in a punctate pattern at sites of cell-cell apposition in WT mouse hair
follicles while a diffuse pattern was observed in cells from the hair follicles of G60S
mice. There appeared to be a notable reduction in gap junction plaques in mutant mice,
and by definition a predicted reduction in gap junctional intercellular communication, but
this is somewhat difficult to conclude with certainty as a putative up-regulation of Cx43
could mask the punctate gap junction plaque profile. We previously observed
significantly reduced gap junctional coupling when the G60S mutant was expressed in
reference cell lines that contained or lacked endogenous Cx43 (Churko et al., 2010;
McLachlan et al., 2005) as well as in primary cardiomyocytes (Manias et al., 2008) or
osteoblasts (McLachlan et al., 2008) obtained from G60S mutant mice. Thus, it is highly
liked that resident cell types of the hair follicle also have reduced gap junctional
coupling, which could in turn impact the growth and development of the hair follicle and
the hair fiber. However, in theory, mutant Cx43 may also impact hair growth and
differentiation by other mechanisms such as disrupting the gap junction proteome (Laird,
2010).
Although hair abnormalities have been reported in some patients with ODDD, this is not
the case for all ODDD patients suggesting that some Cx43 mutants may be more potent
in altering hair growth and differentiation. This concept is supported in a previous study
which demonstrated that keratinocytes expressing the frame-shift 260 mutant was more
potent than several missense Cx43 mutants at altering cell coupling levels, epidermal
organotypic formation, and transepithelial resistance (Churko et al., 2010). Alternatively,
patient disease heterogeneity may extend beyond these criteria as phenotype variability is
also seen in mutant mice. For instance, it has been reported that only 1/3rd of sibling mice
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expressing the G138R Cx43 mutant develop slow growing and sparse hair (Dobrowolski
et al., 2008). This variability was also observed in our study as a subset of mice (~20%)
expressing the G60S mutant exhibited visually less hair density near the neck region.
However, when the entire mutant mouse population was considered, no hair density
differences were observed between G60S and WT mice. In the G60S mice, hair regrowth was asynchronous and delayed by approximately 3 days. Our results suggest that
Cx43 is linked to mechanisms which regulate the outward growth of the hair fiber since
hair growth was delayed after both epilation and depilation treatment. The bulge cell
population in human hair follicle development has been reported to express Cx43 (Arita
et al., 2004), however another group reported that mouse bulge stem cells do not express
Cx43 (Matic and Simon, 2003). Consistent with the latter report, we also observed little
Cx43 expression in CK15 (bulge stem cell marker) expressing cells suggesting that the
telogen-anagen transition in G60S mutant mice may be unaffected. As Cx43 expression
increases in hair follicle growth (anagen), mutant Cx43 may impair the formation and
growth of the hair follicle. Proliferation analysis in cells which highly express Cx43 (the
hair matrix) revealed that the total mitotic output was lower in G60S mouse hair follicles.
This could also explain the delay in hair re-growth observed in the G60S mice and why
G60S mice develop significantly shorter and thinner hair fibers. However, since Cx43 is
also expressed in the dermal papilla, it is not known whether mutant Cx43 expression in
this region impairs the signaling interactions that occur between the dermal papilla and
the hair follicle epithelium.
Scanning electron microscopy revealed cuticle degradation in both family members
expressing the G143S mutant, but these same structural defects were not observed from
the hair sample derived from a patient expressing the T154A mutant. A patient
expressing the G143S mutant self-reported that their hair was thin and curly while the
patient expressing the T154A self-reported that their hair was thick and grew fast. Since
slow growing hair is often reported as a hair abnormality associated with ODDD and
since only ~25% of patients with ODDD report any hair abnormalities, we were not
surprised that the hair fibers from the T154A patient documented in this study appeared
normal. Nevertheless, cuticle weathering was observed in the patients expressing the
G143S mutant and this defect was consistent with previous reports which linked Cx43
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mutants with hair fiber structural defects such as monilethrix, pili annuli, nodule/beaded
and cuticle weathering (Adamski et al., 1994; Kelly et al., 2006; Thoden et al., 1977).
Similar to hair fiber bulging and cuticle weathering as seen in a patient with ODDD
(Adamski et al., 1994), the proximal region of the hair fiber from some mutant mice
formed nodules at irregular intervals while the distal portion of the mutant mouse hair
fibers showed extreme cuticle layer weathering. This defect was sometimes so severe that
the underlying cortical layer was exposed. Since keratinization defects have been
reported in ODDD patients (Kelly et al., 2006; Paznekas et al., 2003; van Steensel et al.,
2005; Vreeburg et al., 2007), improper keratinization may also explain the cuticle
weathering and nodule formation observed in the mutant mice. In the absence of proper
keratinization, the hair fiber may be prone to structural defects and premature
degradation.
Given that loss-of-function mutant Cx43 expression delays hair re-growth in mutant
mice, future studies should address the question as to whether Cx43 overexpression
would enhance hair follicle health and the rate of hair growth. In addition, since a
reduction in functional Cx43 leads to a decline in the health of the hair fiber shaft,
elevating the expression of Cx43 during hair growth may also improve the structural
integrity of the developing hair fiber.
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Chapter 6

6

Discussion

Cx43 modulates the correct development and function of various organs (Laird, 2010;
Santiago et al., 2010; Toth et al., 2010; Tsui et al., 2011). The goal of this thesis was to
determine how mutant Cx43 affects the development and differentiation of the skin. With
the combinatory use of mouse, cell lines and organotypic models, this thesis examined
how Cx43 can modulate keratinocyte and dermal fibroblast proliferation, migration, and
differentiation. We have also studied the G60S Cx43 mutant mouse model for hair
defects often observed in ODDD patients. In this section I will address the wider
implications of our findings.

6.1 G60S mice exhibit a delay in wound healing
We have determined that wounds heal slower in G60S mice compared to WT littermates.
This is particularly interesting since topical knockdown of Cx43 in the skin has been
shown to accelerate wound healing (Ghatnekar et al., 2009; Mori et al., 2006; Qiu et al.,
2003). Administration of topical anti-sense Cx43 during wound healing may have only
significantly lowered Cx43 in the superficial epidermal layer and not effectively lowered
Cx43 levels in the deep dermal layer. Since the G60S mutant mouse contains a germ
line mutation in the gene encoding Cx43, all cells expressing Cx43 would also express
mutant Cx43. Fibroblasts do express Cx43, are present in the deep dermal layer, and also
play a pivotal role in wound healing (Hackam and Ford, 2002; Werner et al., 2007). In
this thesis we have demonstrated that mutant Cx43 expression in human fibroblasts
hinders fibroblast proliferation, migration and differentiation (Churko et al., 2011) and
cumulatively, the delay in wound healing in the G60S mice might specifically be
attributed to the role that dermal fibroblasts play in wound healing.
Topical administration of Cx43 anti-sense also transiently lowers the total levels of Cx43
whereas the G60S mice have overall chronically lower functional levels of Cx43.
Transient knockdown of Cx43 in the wound area has proven to be beneficial in the initial
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proliferation and migration stages of wound healing but unless Cx43 anti-sense treatment
is repeated daily, functional Cx43 levels return to normal to support the keratinocyte
differentiation stage of wound healing.

In our studies, mutant Cx43 enhanced the

proliferation of keratinocytes but negligibly affected the calcium-induced differentiation
of primary keratinocytes. However, in the organotypic epidermal cultures, some Cx43
mutants were shown to impair epidermal differentiation given that the expression of some
Cx43 mutants generally lowered the transepithelial resistance values, Cx26 levels and
affected the size of the stratum corneum. In addition, fs260 expression was particularly
potent at lowering the levels of endogenous Cx43 and disrupting the stratum corneum
architecture. Langlois et al also demonstrated that exogenous administration of Cx43
shRNA to organotypic cultures disrupts the organotypic tissue architecture to further
emphasize that extreme changes in Cx43 levels can impair epidermal differentiation
(Langlois et al., 2007). Collectively, these findings suggest that the functional state of
Cx43 may be more vital in the stratification of the epidermis and certain Cx43 mutants
may also be more potent at disrupting the three-dimensional organization of the
epidermis. In cases where mutant Cx43 drastically lowers the total and functional levels
of Cx43, skin disease and defects in wound healing may result.
The anatomical site of wounding may also favor the role that keratinocytes or fibroblasts
play during wound healing. Since the back skin in rodents is loosely adherent, wound
contraction plays a significant role in healing full-thickness excisional wounds (Reid et
al., 2004). Thus wound healing assessed in our mutant mice would be highly dependent
on fibroblast contraction. In contrast, head skin in mice is tightly adherent to the
underlying bone and fibroblast dependent contraction would be expected to play a lesser
role (Reid et al., 2004). Human skin, like the skin localized to the head area in mice, is
strongly adherent to the underlying bones/connective tissue and human wound healing is
more dependent on the formation of new tissue and not contraction (Davidson, 1998).
Therefore, it would be interesting to determine if head wounds performed on the G60S
mice would also demonstrate a delay in wound healing.

In addition, it would be

interesting to determine if wounds, which primarily damaged the epidermal layer (topical
abrasions) in G60S mice, also impact the rate of wound healing. Given that keratinocytes

175

expressing mutant Cx43 enhanced their proliferation, it is possible that wounds which
primarily damage the epithelium heal faster.

6.2 Combined use of multiple ODDD models
Overexpression of mutant Cx43 in rat epidermal cells was performed to determine how
mutant Cx43 impacts the endogenous Cx43 expression levels and GJIC. Overexpression
of ODDD-linked Cx43 mutants in these cells significantly inhibited the passage of dye
through gap junction channels suggesting that mutant Cx43 impairs the function of gap
junction channels. Interestingly, by assessing the organotypic epidermal growth of rat
epidermal cells expressing various Cx43 mutants, we have also determined that some
mutants are more potent at impairing the functional and differentiation properties of rat
epidermal cells. Specifically, the G138R and fs260 mutants significantly lowered
endogenous Cx43 levels whereas other ODDD mutants had no effect. In addition,
organotypic epidermal cultures grown from REKs expressing mutant fs260 also formed
nuclei in the stratum corneum whereas this phenotype was not seen in organotypic
epidermal models grown from other ODDD mutant expressing REKs. The unique disease
burden of the fs260 mutant suggests that all ODDD patients may develop various levels
of disease burden. This is particularly evident in the only two reported cases where
patients expressing the fs260 (and fs230) have been shown to develop palmar plantar
hyperkeratosis (van Steensel et al., 2005; Vreeburg et al., 2007).
While it is difficult to control the dosage of mutant Cx43 being expressed in these
organotypic models, we have also investigated primary cultures derived from G60S mice
and primary fibroblast cultures from patients with ODDD to ensure that mutant Cx43 to
wild-type Cx43 expression is properly controlled at a 1:1 ratio. In addition, to better
understand human ODDD and to rule-out species differences, we examined the G60S
mouse model of ODDD and compared our results with assays performed using human
ODDD patient cells and tissues.

By comparing the ability of mouse and human

fibroblasts expressing mutant Cx43 to migrate, we found that both mouse and human
fibroblasts demonstrate impaired migration. Future studies on primary cultures and
tissues derived from multiple patients expressing various ODDD mutants will be
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important to evaluate how mutant Cx43 causes common ODDD symptoms and how
specific Cx43 mutants may be more potent at causing disease.
Given the complexity of tissue development, it may be necessary to study the
development of organs in vivo.

Hair follicle development is one such example which

needs an in vivo environment to effectively progress and we have used G60S mice to
demonstrate that mutant Cx43 expression delays hair growth and causes hair fibers
structural defects. Studying hair development in vivo also added an additional level of
complexity since only a subpopulation of littermate matched mice demonstrate defects in
their coat appearance. Given that hypotrichosis was only observed in a subset of G60S
mice, hair defects in these mice are not fully penetrant suggesting that additional genes
may work in a multifactorial manner to affect hair development. In addition, since
observable differences could only be seen in aged mice (2-3 months), future studies using
the in vivo environment will be important to determine how the ODDD disease manifests
with age.

6.3 Cell type differences
Since wound healing involves an interplay between keratinocytes, dermal fibroblasts,
immune cells, endothelial cells and other cell types (Yamaguchi and Yoshikawa, 2001), it
is important to separately assess each cell type and to determine what role each cell type
plays in the wound healing process. By separately assessing keratinocytes and dermal
fibroblasts for their ability to proliferate, migrate, and differentiate, we have found that
keratinocytes and fibroblasts react differently when mutant Cx43 is expressed.
Interestingly, mutant G60S Cx43 expression in mouse primary keratinocytes enhances
proliferation while the expression of D3N and V216L mutant Cx43 in human dermal
fibroblast hinders proliferation. Since mutant Cx43 could both enhance and reduce
proliferation, the roles that Cx43 plays in tissue homeostasis or function may also be
dependent on the cell type assessed. For example, given that ODDD patients commonly
develop defects in their bones, digits, and eyes, perturbation in the expression and
function of Cx43 in osteoblasts, digit mesenchymal cells and corneal epithelial cells may
be more potent at causing developmental defects when compared to other cell types.

177

Other organs and cells types expressing mutant Cx43 may also contribute to the delay in
wound healing we observed. For example, macrophages express Cx43 and are known to
infiltrate into the wound area and modulate wound healing (Martin and Leibovich, 2005;
Rodero and Khosrotehrani, 2010). Specifically, macrophages secrete TGFβ1 and this
growth factor is important for the differentiation of fibroblasts into myofibroblasts which
occurs during wound healing (Rodero and Khosrotehrani, 2010). Since mutant Cx43 may
also impair the function of other cell types involved in wound healing, further
examination into other cell types involved in wound healing would lead to a greater
understanding of the role that Cx43 plays in wound healing.
One possible explanation as to why Cx43 may differentially affect each cell type may be
proteomic expressional differences between cell types. Given that Cx43 interacts with
multiple proteins (reviewed in Laird, 2010), expression of a subset of proteins unique to
keratinocytes may be required for specific keratinocyte functions. For example,
keratinocytes require cell to cell contacts through tight junctions to maintain a proper
epithelial barrier (Niessen, 2007). Connexins are also found within the same adhesive
domains as tight and adherens junctions (reviewed in Laird, 2010) and wild-type
expression of connexins may facilitate this adhesive environment. Since ODDD mutants
expressed in rat epidermal keratinocytes lowered the transepithelial resistance values,
indicating a reduction in tight junction adhesion, mutant Cx43 may disrupt cell to cell
adhesion between keratinocytes and impair the epithelial barrier formed by keratinocytes.
Fibroblasts however, sparsely populate the dermis and disruption of cell to cell adhesion
in these cells may not be as important as the adhesive environment required by
keratinocytes.
Keratinocytes and fibroblasts also express different integrin subunits which differentially
affect the ability of each cell type to adhere to specific extracellular matrix proteins.
Keratinocytes residing on the basement membrane interact with laminin 332 though
connections with α6β4 integrin (Lampe et al., 1998). Under wound healing conditions
however, keratinocytes interact with laminin 332 though α3β1 integrin and express, α5β5
and α5β1integrins (De Luca et al., 1994; Lampe et al., 1998). In contrast, fibroblasts
express α1β1, α2β1, and α11β1 integrins which facilitates fibroblasts adherence to
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collagen (Eckes et al., 2006). Since the interaction between integrins and extracellular
matrix proteins regulate migration (De Luca et al., 1994), mutant Cx43 may selectively
disrupt specific integrin subunit interactions and effectively impair the migration of cells
expressing these integrin subunits. In our study, the migration of primary keratinocytes
derived from G60S mice did not differ when compared to keratinocytes derived from WT
mice. However, fibroblasts derived from G60S mice did not migrate as well as fibroblasts
derived from WT mice when plated on collagen type I and fibronectin. This suggests that
mutant Cx43 may selectively impair the interaction between α1β1 or α11β1 integrins
since keratinocytes do not express these integrin subunit combinations. The link between
integrin interactions and gap junction communication is also supported in a study which
demonstrated that keratinocytes plated on laminin 332 promoted gap junction
communication in comparison to keratinocytes plated on collagen and fibronectin
(Lampe et al., 1998).

6.4 Therapeutic implications
It is apparent that connexins affect skin physiology. By studying how connexin
expression modulates the function of keratinocytes and fibroblasts, connexin
manipulation in the skin may be important in mitigating connexin-linked skin diseases
and enhancing wound healing. Given that the skin is a readily accessible organ, connexin
levels may be manipulated with the topical administration of therapeutic creams.
In treating Cx43-related skin disorders, it is important to consider whether it is more
appropriate to overexpress wild-type Cx43 or to inhibit the expression of mutant Cx43.
Our results have shown that human fibroblasts derived from ODDD patients have
reduced intercellular conductance levels and it remains to be determined whether
overexpression of wild-type Cx43 in cells expressing mutant Cx43 could raise the
coupling status and improve defects (e.g. slow growing hair, syndactyly, microcornea)
associated with ODDD. However, the exogenously expressed Cx43 may be rendered
non-functional since the endogenously expressed mutant Cx43 may continue to disrupt
connexin trafficking and channel function.
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Determining how various Cx43 mutants cause skin disorders will be important in
deciding the proper therapeutic action to take. For example, if palmar plantar
hyperkeratosis is caused by the mutant ability to disrupt cell to cell adhesion between
keratinocytes, over expression of Cx43 may strengthen the weakened contacts between
keratinocytes. If however, palmar plantar hyperkeratosis is caused by a deficient transport
of metabolites through gap junction channels, increasing wild-type Cx43 expression may
prove ineffectual since mutant Cx43 may continue to impair channel function. In addition
knowing how mutant Cx43 affects the skin of ODDD patients may have wider
implications for the general population. Since the function of Cx43 channels are indeed
impaired in ODDD patients (Churko et al., 2011), understanding how a decrease in gap
junction function affects skin physiology will be important to evaluate the role of Cx43 in
disease free skin.
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OF ANY INFORMATION CONTAINED IN THE MATERIALS, INCLUDING, WITHOUT
LIMITATION, ANY IMPLIED WARRANTY OF MERCHANTABILITY, ACCURACY,
SATISFACTORY QUALITY, FITNESS FOR A PARTICULAR PURPOSE, USABILITY,
INTEGRATION OR NON-INFRINGEMENT AND ALL SUCH WARRANTIES ARE
HEREBY EXCLUDED BY WILEY AND ITS LICENSORS AND WAIVED BY YOU.
6. WILEY shall have the right to terminate this Agreement immediately upon breach of this
Agreement by you.
7. You shall indemnify, defend and hold harmless WILEY, its Licensors and their respective
directors, officers, agents and employees, from and against any actual or threatened claims,
demands, causes of action or proceedings arising from any breach of this Agreement by you.
8. IN NO EVENT SHALL WILEY OR ITS LICENSORS BE LIABLE TO YOU OR ANY
OTHER PARTY OR ANY OTHER PERSON OR ENTITY FOR ANY SPECIAL,
CONSEQUENTIAL, INCIDENTAL, INDIRECT, EXEMPLARY OR PUNITIVE DAMAGES,
HOWEVER CAUSED, ARISING OUT OF OR IN CONNECTION WITH THE
DOWNLOADING, PROVISIONING, VIEWING OR USE OF THE MATERIALS
REGARDLESS OF THE FORM OF ACTION, WHETHER FOR BREACH OF CONTRACT,
BREACH OF WARRANTY, TORT, NEGLIGENCE, INFRINGEMENT OR OTHERWISE
(INCLUDING, WITHOUT LIMITATION, DAMAGES BASED ON LOSS OF PROFITS,
DATA, FILES, USE, BUSINESS OPPORTUNITY OR CLAIMS OF THIRD PARTIES), AND
WHETHER OR NOT THE PARTY HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH
DAMAGES. THIS LIMITATION SHALL APPLY NOTWITHSTANDING ANY FAILURE OF
ESSENTIAL PURPOSE OF ANY LIMITED REMEDY PROVIDED HEREIN.
9. Should any provision of this Agreement be held by a court of competent jurisdiction to be
illegal, invalid, or unenforceable, that provision shall be deemed amended to achieve as nearly as
possible the same economic effect as the original provision, and the legality, validity and
enforceability of the remaining provisions of this Agreement shall not be affected or impaired
thereby.
10. The failure of either party to enforce any term or condition of this Agreement shall not
constitute a waiver of either party's right to enforce each and every term and condition of this
Agreement. No breach under this agreement shall be deemed waived or excused by either party
unless such waiver or consent is in writing signed by the party granting such waiver or consent.
The waiver by or consent of a party to a breach of any provision of this Agreement shall not
operate or be construed as a waiver of or consent to any other or subsequent breach by such other
party.
11. This Agreement may not be assigned (including by operation of law or otherwise) by you
without WILEY's prior written consent.
12. Any fee required for this permission shall be non-refundable after thirty (30) days from
receipt.
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13. These terms and conditions together with CCC’s Billing and Payment terms and conditions
(which are incorporated herein) form the entire agreement between you and WILEY concerning
this licensing transaction and (in the absence of fraud) supersedes all prior agreements and
representations of the parties, oral or written. This Agreement may not be amended except in
writing signed by both parties. This Agreement shall be binding upon and inure to the benefit of
the parties' successors, legal representatives, and authorized assigns.
14. In the event of any conflict between your obligations established by these terms and
conditions and those established by CCC’s Billing and Payment terms and conditions, these terms
and conditions shall prevail.
15. WILEY expressly reserves all rights not specifically granted in the combination of (i) the
license details provided by you and accepted in the course of this licensing transaction, (ii) these
terms and conditions and (iii) CCC’s Billing and Payment terms and conditions.
16. This Agreement will be void if the Type of Use, Format, Circulation, or Requestor Type was
misrepresented during the licensing process.
17. This Agreement shall be governed by and construed in accordance with the laws of the State
of New York, USA, without regards to such state’s conflict of law rules. Any legal action, suit or
proceeding arising out of or relating to these Terms and Conditions or the breach thereof shall be
instituted in a court of competent jurisdiction in New York County in the State of New York in
the United States of America and each party hereby consents and submits to the personal
jurisdiction of such court, waives any objection to venue in such court and consents to service of
process by registred or certified mail, return receipt requested, at the last known address of such
party. . BY CLICKING ON THE "I ACCEPT" BUTTON, YOU ACKNOWLEDGE THAT YOU
HAVE READ AND FULLY UNDERSTAND EACH OF THE SECTIONS OF AND
PROVISIONS SET FORTH IN THIS AGREEMENT AND THAT YOU ARE IN
AGREEMENT WITH AND ARE WILLING TO ACCEPT ALL OF YOUR OBLIGATIONS AS
SET FORTH IN THIS AGREEMENT. v1.4
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Biochemical Journal
For terms and conditions for online usage of journals published by Portland Press Ltd, please visit
the following websites:
Biochemical Journal
Clinical Science
Bioscience Reports
Biochemical Society Transactions
Biology of the Cell
Biotechnology and Applied Biochemistry
ASN NEURO
Cell Biology International
Essays in Biochemistry
Biochemical Society Symposia
Licensing enquiries
The guidelines below refer to articles published in the following journals, published by
Portland Press Limited:
ASN NEURO
Cell Biology International
Biochemical Journal
Cell Biology International Reports
Biochemical Society Symposia
Cell Signalling Biology
Biochemical Society Transactions
Clinical Science
Biology of the Cell
Essays in Biochemistry
Bioscience Reports
The Biochemist
Biotechnology and Applied Biochemistry
Authors of articles published in the above journals
Authors do NOT usually need to contact Portland Press Limited to request permission to reuse
their own material, as long as the material is properly credited to the original publication. It is
usual to provide the citation of the original publication thus:
“This research was originally published in Journal Name. Author(s), Title. Journal Name. Year;
Volume: pp-pp © copyright holder”
The copyright holder for each publication is as follows:
© the Biochemical Society
© Portland Press Limited
Biochemical Journal
ASN NEURO
Biochemical Society Symposia
Biology of the Cell
Biochemical Society Transactions Biotechnology and Applied Biochemistry
Bioscience Reports
Cell Biology International
Clinical Science
Cell Biology International Reports
Essays in Biochemistry
Cell Signalling Biology
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The Biochemist
Provided the original publication of the article, or portion of the article, is properly cited, Authors
retain the following non-exclusive rights:
1. To reproduce their article in whole or in part in any printed volume (book or thesis)
of which they are the Author or Editor
2. To reproduce their article in whole or in part at the Author's current academic institution
for teaching purposes
3. To reuse figures, tables, illustrations or photos from the article in commercial or noncommercial works created by them
4. To post a copy of the Immediate Publication (i.e. the Accepted Manuscript*) at the
Author's Institutional Repository, 6 months after publication, provided that this is linked
to the article on the journal website (e.g. through the DOI).
In addition, authors of Opt2Pay articles, or authors of articles published in the open access
journals ASN NEURO and Cell Biology International Reports, may post the Version of Record**
to their Institutional Repository. Portland Press Limited will deposit the Version of Record in
PubMed Central on behalf of the author, where applicable.
Requests for non-commercial use
Other parties wishing to use reuse an article in whole or in part for educational purposes (e.g. in
lectures or tutorials) may do so at no cost providing the original source is attributed, as outlined
above.
You may also reproduce an article in whole or in part in your thesis at no cost providing the
original source is attributed.
If you wish to copy and distribute an article in whole for teaching (e.g. in a course pack), please
contact your librarian who will advise you on the various clearance options available.
STM Permission Guidelines
Portland Press Limited is a signatory of the STM Permission Guidelines, which aims to reduce
the administration involved in clearing permissions.
Publishers who are also signatories to the STM Permission Guidelines may re-use work published
in Portland Press Limited journals, without contacting us, as long as the work is appropriately
used and attributed as stated in the Guidelines.
All other usage requests, including Books
For all other requests please download and complete the permission request form and send by
email or fax to:
(e) permissions@portlandpress.com
(f) +44 (0) 20 7685 2469
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*Accepted Manuscript – (also known as Immediate Publication) - the version of the article that
has been accepted for publication and includes the revisions made following Peer Review.
**Version of Record - the version of the article, after processes such as copyediting, proof
corrections, layout and typesetting have been applied.
Please see the NISO/ALPSP guidelines for a full description of these terms.
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Journal of Investigative Dermatology
If you are the author of this content (or his/her designated agent) please read the following. Since
2003, ownership of copyright in original research articles remains with the Authors*, and
provided that, when reproducing the Contribution or extracts from it, the Authors acknowledge
first and reference publication in the Journal, the Authors retain the following non-exclusive
rights:
1. To reproduce the Contribution in whole or in part in any printed volume (book or
thesis) of which they are the author(s).
2. They and any academic institution where they work at the time may reproduce the
Contribution for the purpose of course teaching.
3. To reuse figures or tables created by them and contained in the Contribution in other
works created by them.
4. To post a copy of the Contribution as accepted for publication after peer review (in Word
or Tex format) on the Author's own web site, or the Author's institutional repository, or
the Author's funding body's archive, six months after publication of the printed or online
edition of the Journal, provided that they also link to the Journal article on NPG's web
site (eg through the DOI).
NPG encourages the self-archiving of the accepted version of your manuscript in your funding
agency's or institution's repository, six months after publication. This policy complements the
recently announced policies of the US National Institutes of Health, Wellcome Trust and other
research funding bodies around the world. NPG recognizes the efforts of funding bodies to
increase access to the research they fund, and we strongly encourage authors to participate in such
efforts.
Authors wishing to use the published version of their article for promotional use or on a web site
must request in the normal way.
If you require further assistance please read NPG's online author reuse guidelines.
Note: British Journal of Cancer and Clinical Pharmacology & Therapeutics maintain copyright
polices of their own that are different from the general NPG policies. Please consult these
journals to learn more.
* Commissioned material is still subject to copyright transfer conditions
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Curriculum Vitae
Education Background


PhD Candidate, University of Western Ontario, London, ON, 2007- Current
Department: Anatomy and Cell Biology
Supervisor: Dr. Dale Laird
Thesis Topic: Mutant Connexin43 in skin development and disease



MSc degree, University of Western Ontario, London, ON, 2004-2006
Department: Anatomy and Cell Biology
Supervisor: Dr. Peter Merrifield
Thesis Topic: Muscle satellite cell lineage and differentiation



Hons BSc degree, McMaster University, Hamilton, ON, 2000-2004
Program: Honors Biology and Psychology- Graduated with Distinction

Scholarships/Awards
International/National
 Alexander Graham Bell NSERC- $70,000, London, ON, 2009-2011
 ASCB/JSCB/Riken CDB Travel Award- $1,000, Kyoto, Japan, 2009
 International Gap Junction Conference Travel Award- €500, Ghent, Belgium, 2011
Provincial
 Ontario Graduate Scholarship- $15,000, London, ON, 2008-2009
 General Proficiency Award Saskatchewan Education- $400, Yorkton, SK, 2000
Local












Graduate Thesis Research Award- $437, London, ON, 2011
Anatomy and Cell Biology PhD Entrance Scholarship- $2000, London, ON, 2007
Schulich Graduate Scholarship, London, ON, 2007
Western Graduate Research Scholarship, London, ON, 2007
Schulich Enhancement Scholarship, London, ON, 2007
Schulich School of Medicine and Dentistry Travel Award-$1000, London, ON, 2006
Anatomy and Cell Biology Altman Award-$250, London, ON, 2005
Special University Scholarship (University of Western Ontario), London, ON, 2005
Anatomy and Cell Biology Graduate Entrance Scholarship- $1000, London, ON, 2004
McMaster University Entrance Scholarship- $1000, Hamilton, ON, 2000
Co-operative Association Student Award, Yorkton, SK, 2000

Publications
Peer Reviewed Publications
 Churko, J.M., McDonald,A., Shao, Q., Laird., D.W. 3 Mutant
Cx43
enhances
keratinocyte proliferation without impacting keratinocyte migration. (in preparation)
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Churko, J.M., Chan, J., Pan, X., Shao, Q., Laird., D.W. Mice Expressing the G60S
Mutant Cx43 Develop Similar Hair Abnormalities Commonly Presented by
Oculodentodigital Dysplasia Patients (Journal of Investigative Dermatology, in press)



Churko, J.M., and Shao, Q., Gong, X., Swoboda, K.J., Bai, D., Sampson, J., and Laird,
D.W. (2011) Human dermal fibroblasts derived from oculodentodigital dysplasia patients
suggest that patients may have wound-healing defects. Human Mutation, Apr;32(4):45666.



Churko, J.M., Langlois, S., Pan, X., Shao, Q., Laird, D.W. (2010) The potency of the
fs260 connexin43 mutant to impair keratinocyte differentiation is distinct from other
disease-linked connexin43 mutants. Biochemical Journal., 429 (3):473-83.



Celetti S.J., Cowan K.N., Penuela S, Shao Q, Churko J, Laird D.W. (2010) Implications
of Pannexin 1 and Pannexin 3 in Keratinocyte Differentiation. Journal of Cell Science
123(Pt 8):1363-72.



Gehi, R.B., Penuela S., Churko J.M., Shao, Q., and Laird D.W. (2010) Panx1 and
Panx3 Delivery, Cell Surface Dynamics and Cytoskeletal Interactions. Journal of
Biological Chemistry, 285(12):9147-60.



Simek J., Churko, J., Shao, Q., Laird, D.W. (2009). Cx43 demonstrates distinct mobility
within plasma membrane domains indicative of progressive gap junction plaque
formation. Journal of Cell Science. Feb 15;122(Pt 4):554-62.



Manias, J.L., Plante, I., Gong, X.Q., Shao, Q., Churko, J., Bai, D., Laird, D.W. (2008).
Fate of Cx43 in Cardiac Tissue Harbouring a Disease-Linked Cx43 Mutant.
Cardiovascular Research. Dec 1;80(3):385-95.

Invited Book Chapters


Churko, J.M., Laird, D.W., (2010) “Gap junctions as a Cellular Domain” in Cellular
Domains edited by Ivan Robert Nabi, John Wiley & Sons, Inc. N.J. (in press)



Langlois, S., Churko, J.M., and Laird, D.W. (2008) “Optical and biochemical dissection
of connexin and disease-linked connexin mutants in 3D organotypic epidermis” In:
Epidermal Cells: Methods and Protocols, Second Edition, Kursad Turksen, Ed. The
Humana Press Inc. N.J.

Local and International Meetings


Churko, J.M., Shao, Q., Sampson, J., Laird, D.W. (2010) Subclinical skin disease in
oculodentodigital dysplasia patients as revealed by organotypic cultures, mutant mouse
models and patient derived fibroblasts. International Gap Junction Conference 2011.
Ghent, Belgium, Aug. 6-11. (Ph.D., International conference)
o This abstracts is invited for a platform session to be presented on August 9th.
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Churko, J.M., Shao, Q., Sampson, J., Laird, D.W. (2010) Cutaneous Wound Healing
Defects Associated with Mutant Cx43 Expression. American Society of Cell Biology.
Philadelphia, PA; Dec. 11-15. (Ph.D., International conference)



Churko, J.M., Shao, Q., Sampson. J., Flanigan, K.M. Swoboda, K.J., Laird, D.W. (2009)
Delayed wound healing in mouse and human models of oculodentodigital dysplasia
suffering from compromised Cx43 gap junctions. ASCB/JSCB/Riken CDB Meeting,
Kyoto, Japan: Sept. 21-23.



Churko, J.M., Chan, J., Shao, Q., Laird D.W. (2009) Hair follicle development and
epidermal differentiation in mice and organotypic epidermal cultures expressing mutant
Cx43. International Gap Junction Conference. Sedona, AZ.; July. 25-30.



Churko, J., Shao, Q. C., Sampson, J., Flanigan, K., Swoboda, K., Laird, D. W. Mapping
oculodentodigital dysplasia-linked genetic mutations in Cx43 to an epidermal phenotype
using cell, mouse, and human reference models. American Society of Cell Biology. San
Francisco, CA; Dec. 12-17, 2008.
o This abstracts was invited for a platform session in a Sub-Group meeting which
was presented on December 13th.



Q. Shao, J. Churko, J. Sampson, K.M. Flanigan, K.J. Swoboda, and D.W. Laird (2008)
“Aberrant Cx43 localization and function in cells and tissues obtained from
oculodentodigital dyplasia patients mimic findings form mutant mouse models of Cx43linked disease. 48th American Society for Cell Biology Meeting, San Francisco, CA



Churko, J., Clow, C., Conway, K. and Merrifield, PA.* Fiber-Type Specific Expression
of Contractile Protein Isoforms in Different Myogenic Lineages and Cell Lines. EMBO
Conference Series. Conference I, The Molecular and Cellular Mechanisms Regulating
Skeletal Muscle Development and Regeneration. Sant Feliu de Guixols, Spain; Sept. 2429, 2008.



Churko, J., Shao, Q.,Laird, D.W. (2008) An oculodentodigital dysplasia-linked frameshift Cx43 mutant is retained within the endoplasmic reticulum of keratinocytes and
exhibits dominant-negative properties. Margaret P. Moffat Graduate Research Day,
London, ON; May 2008.



Churko, J. and Merrifield, P.A. (2006). Regulating myogenic differentiation through p38
signalling in C2C12 cells. Frontiers in Myogenesis Conference, Pine Mountain, GA.
2006



Churko, J. and Merrifield, P.A. (2005). Early p38 activation in C2C12 myoblasts
maintains myoblast proliferation, while later p38 activation is required for fusion. 45th
Annual meeting of the American Society for Cell Biology, San Francisco, CA; Dec 2005.



Churko, J. and Merrifield, P.A. (2005). Satellite cells from neonatal rat muscle co-express
multiple myosin heavy chain isoforms in vitro. 45th Annual meeting of the American
Society for Cell Biology, San Francisco, CA; Dec 2005
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Churko, J., Mehta, S., Punch, V. and Merrifield, P.A. (2005). Origin and Fate of Muscle
Satellite Cells in Developing Rat Hindlimb Muscle. FASEB Summer Research
Conference on Skeletal Muscle Satellite and Stem Cells, Tucson, AZ; June 11-16, 2005.



Churko, J. Mehta, S., Punch, V. and Merrifield, P.A. (2005). Identification, isolation and
characterization of satellite cells from developing rat hindlimb muscles. Margaret P.
Moffat Graduate Research Day, London, ON; May 2005
- Awarded Altman Award for best poster presentation



Churko, J. Mehta, S., Punch, V. and Merrifield, P.A. (2005). Identification, isolation and
characterization of satellite cells from developing rat hindlimb muscles Great Lakes
Mammalian Meeting, Toronto, ON; Dec 2005.

Teaching Experience





Mentored 4th year Undergraduate Honors Thesis Projects
Xinyue Pan – 2009
Jason Chan – 2008
Teaching Assistant for Medical Science Honors Thesis Course, (University of Western
Ontario), London, ON, 2009-2011
Lab Coordinator for Anatomy 319, (University of Western Ontario), London, ON,
2006,08-09
Teaching Assistant for Anatomy 319, (University of Western Ontario), London, ON,
2005

Platform Presentations









International Gap Junction Conference, Ghent, Belgium, Aug 9, 2011
o Talk entitled "Subclinical skin disease in oculodentodigital dysplasia patients as
revealed by organotypic cultures, mutant mouse models and patient derived
fibroblasts”
Gap Junction Research Day, London, ON, Jan 14, 2011
o Talk entitled "Hair abnormalities associated with the expression of mutant
Connexin43"
Anatomy and Cell Biology Seminar Series, London, ON, May 7, 2010
o Talk entitled "The role of Cx43 in skin disease and wound healing"
American Society of Cell Biology Conference, San Francisco, CA, December 13, 2008
o Platform session in a Sub-Group meeting
o Talk entitled "Mapping oculodentodigital dysplasia-linked genetic mutations in
the GJA1 gene to phenotypic outcomes using cell, mouse and human reference
models"
Western Research Forum, London, ON, 2006
o Talk entitled "Muscle Satellite Cells and the Expression of MyHCs"
Lawson Health Research Institute Research Days, London, ON, 2005
o Talk entitled "Identification, isolation and characterization of satellite"
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Other Contributions
Leadership Roles
Elected student representative on Anatomy and Cell Biology Graduate Affairs Committee, 2007
Elected President of the McMaster Biology and Psychology Society, Hamilton, ON, 2003
Community Outreach/Volunteer
“Movember”- Raised funds for Prostate Cancer Research, London, ON, 2010
Anatomy and Cell Biology Recruitment Event, London, ON, 2008, 2009
Schulich Graduate Open House, London, ON, 2007, 2009
Canadian Cancer Society Relay for Life, London, ON, 2005, 2006, 2008, 2009
Mentor for Big Brothers of London, London, ON, 2006-2008
Let's Talk Science Volunteer, London, ON, 2005-2007, 2009
Lawson Affiliation of Fellows and Students, London, ON, 2004-2006
Captain of Labatt 24 Hour Relay (raised >$2300 for the London hospitals), London, ON, 2005
Easter Seals, "Tee Up for Easter Seals Golf Tournament," Dundas, ON, 2005
Canadian Medical Hall of Fame Discovery Days (Moderator), London, ON, 2005
May at Mac- Promoted Psychology at McMaster, Hamilton, ON, 2005
Canadian Foundation for AIDS Research, Bloor Street Entertains, Toronto, ON, 2004
Exercise Assistant for disabled individuals at the McMaster University Hamilton, ON, 2004
Rick Hansen: Wheels in Motion 5 km Race, Hamilton, ON, 2003
Prevention of Colorectal Cancer 5K race, Hamilton, ON, 2002
Taught Tae Known Do on a First Nations Reserve, Fort Qu'Appelle, SK, 1999
Boys on the move- After School Sports for Grade 4-6, Yorkton, SK, 1998

